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Abstract  
Molecular engineering by means of the development of artificial 
organelles that can be implanted in cells to treat pathological conditions 
or to support the design of artificial cells has been regarded as a major 
goal in medical research. In order to achieve this goal, active compounds, 
such as enzymes, proteins and enzyme-mimics were encapsulated or 
entrapped in polymer compartments to create highly active hybrid 
nanoreactors. However, probably due to the early stage of research, only 
few of these nanoreactors were active in cells, and none was proven to 
mimic a specific natural organelle. In the present thesis, the engineering 
of polymeric vesicles for the development of artificial organelles 
mimicking natural peroxisomes is accomplished. In addition, a detailed 
study of the permeabilisation of polymeric vesicle membranes by 
incorporation of ion-channels is elaborated. The detailed study of metal-
functionalised polymeric vesicle membranes for targeting approaches – 
an important factor for site specific action of e. g. artificial organelles –
gives a further key aspect. These three parts of fundamental research 
play a key role in further development of advanced nanoreactors to be 
used as specific artificial organelles. In the first study, we designed 
systems that contained two different highly active antioxidant enzymes, 
which worked in tandem in polymer nanovesicles. The membrane of the 
nanovesicles was specifically permeabilised by the incorporation of 
natural channel proteins and the functional nanoreactor was optimised 
with regard to properties and function of natural peroxisomes. These non-
toxic artificial peroxisomes combat oxidative stress in cells after cell-
uptake, which prolong cell life-time and which can be regarded as the first 
instance of treatment of various pathologies (e.g. arthritis, Parkinson’s, 
cancer, AIDS) effectively controlled by conditions of oxidative stress. The 
second study proofs the successful incorporation of small ion-channels in 
P. Tanner 
 
iv 
the vesicle membrane. These ion-channels are specifically permeable for 
monovalent cations, for example to design a pH-sensitive artificial 
organelle, where the active compound can be switched on/off 
respectively, depending on the conditions of the environment. The third 
project focussed on the decoration of metal-functionalised polymersomes 
with a small model peptide, a His6-tag, in order to characterise the change 
of the metal coordination site upon binding of the model peptide. This 
provided important information about the binding behaviour of ligands in 
processes of molecular recognition, a key principle in nature. 
Understanding of specific and efficient binding will allow to further target 
the polymersomes to specific locations to either release their content, 
such as drugs, or to act as an artificial organelle. 
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1. Introduction 
The design of new, functional and smart materials or assemblies is 
mainly driven to understand biological systems in more detail and to 
mimic biological structures and functions. There is a high need to obtain a 
profound knowledge of the working principle of biological systems in order 
to repair many diseases on molecular basis. Furthermore, the 
understanding of the complexity, specificity and accuracy of biologic 
pathways forms the basis of technological progress. Hence, it is a key 
challenge in life- and nanosciences to fuse biomolecules, such as 
enzymes or proteins, with synthetic materials, for example block 
copolymers, in order to create new, complex bio-synthetic nanodevices. 
The combination of the specificity and efficiency of biological molecules 
with the robustness and the possibility of tailoring synthetic materials 
allows the design of efficient systems in terms of activity, sensitivity and 
responsiveness.1,2 In addition, this strategy allows protecting sensitive 
compounds, for example enzymes, proteins, or nucleic acids, while 
providing optimal working conditions − the same principle as in the 
compartmentalisation strategy in nature. Successful protection was put 
into practice in recent years by shielding various biological compounds in 
nanometre-sized supramolecular assemblies. The purpose of shielding 
was already commercialized by using liposomes, which are bio-adapted, 
lipid-based supramolecular assemblies. However, limitations in the use of 
liposomes such as increased, intrinsic mechanical instability and low 
blood circulation life-time could only be partially solved through their 
combination with polymers such as polyethylene glycol (PEG), which has 
shown to have “stealth” behaviour (by means of no association with non-
targeted serum and tissue proteins thus being able to evade the immune 
system).3 
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Consequentially, polymer supramolecular structures in the form of 
particles, micelles, vesicles and films are of particular interest, because 
they can adapt their properties to support combination with biological 
molecules while preserving material properties such as stability and 
mechanical robustness.4,5 Polymer supramolecular assemblies exhibit 
morphologies and properties, which can be adapted by choosing from a 
variety of highly diverse block copolymers. By triggering the block length 
of each block unit of the block copolymer, the entire molecular 
architecture is provided. In addition, properties such as charge, flexibility 
or stimuli-responsiveness can be tuned for further system integration.6 In 
conclusion, this outstanding adaptability makes these assemblies very 
versatile for a wider range of applications.7,8  
Elegant combinations of nanometre-sized, supramolecular assemblies 
that protect active compounds and support their in situ activity are 
polymer nanoreactors.9,10 Nanoreactors based on polymer vesicles 
encapsulating active molecules and with a membrane rendered 
permeable for small molecules provide fully active compounds in 
biologically relevant conditions inside the carrier over long time. This 
approach eliminates the drawbacks related to conventional drug carriers, 
where active compounds may act only after their release from the carrier 
or are released into a different biological compartment, other than 
desired.11 When nanoreactors are used in vitro, sensitivity and overall 
activity are essential properties to be coped with, while for in vivo 
applications (therapeutics or theranostics) more complex requirements 
are imposed in terms of nanoreactor-assemblies properties, in situ 
functionality, and biodistribution.  
Our aim here was to engineer artificial organelles focussing on three 
aspects: i.) design and development of a functional cascade reaction 
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inside polymersomes ii.) engineering triggerable nanoreactors and iii.) 
studying a specific molecular recognition process in detail. 
i.) In a bio-inspired approach, the nanoreactor design was used to 
mimic a specific artificial organelle by the combination of two different 
antioxidant enzymes, superoxide dismutase together with lactoperoxidase 
or catalase. Implementation of the cascade reaction into the 
polymersomes enabled the use of the SOD/LPO co-encapsulated as 
artificial peroxisomes inside cells to repair the condition of oxidative 
stress.  
ii.) Another approach of nanoreactor design, focussing on pH-triggered 
nanoreactors, was realised by incorporation of an ion-channel, gramicidin, 
in the membrane of pH-sensitive acid phosphatase-encapsulated 
polymersomes. Feasibility of pH-stimulation of the enzymes in vesicles 
was proven. 
iii.) We used molecular recognition interactions and metal-
functionalised block copolymers in order to form vesicles with specific 
metal points at the outer vesicle surface. Binding studies of small ligands 
and detailed investigation of the metal-centre coordination spheres before 
and after binding gave information about optimal binding conditions. 
1.1.  Concept of molecular engineering 
Controlling the structure of materials/compounds at molecular 
dimensions opens the possibility to produce nanosystems or 
nanofactories, which do not occur in nature having for instance new 
functionalities or are mimics of biological systems. In general, two 
important strategies in molecular engineering can be followed as bottom 
up approaches in the design of nanofactories. One involves highly 
developed technologies such as a scanning tunnelling microscopy, which 
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enables the control of individual molecules and allows arranging them in a 
functional way in order to create an active nanosystem. The other 
strategy makes use of the self-assembly principle naturally evolved in 
biological systems to build more complex systems. The self-assembly 
principle has the advantage that molecules assemble into structures 
based on molecular interactions such as hydrogen bonds, Van der Waals 
or electrostatic interactions without the need of expensive techniques and 
time-consuming procedures. Complex templates can be engineered by 
using molecules, for example, lipids or amphiphilic block copolymers. In 
order to design functional nanofactories, active molecules such as 
enzymes, proteins or enzyme-mimics need to be combined with the self-
assembled structure. Preservation of the functionality of the active 
molecules during this process is a key step to engineer functional 
nanodevices such as nanoreactors. This requires the working principle 
and optimised conditions of the active molecule to be studied in detail. 
After proof of concept, application of the engineered nanofactories either 
in the technological or biomedical domain has to fulfil further 
requirements, addressing for example maximising efficiency in sensor 
systems or increased efficacy and low immunotoxicity in therapeutic 
applications.  
1.2. Building blocks for molecular engineering 
Different building blocks to engineer supramolecular assemblies as 
template structures for medical applications can be used: Biopolymers, 
synthetic polymers or combinations of bio- and synthetic polymers. 
Biopolymers include lipids, polysaccharides, polypeptides and 
polynucleotides. Their inherent biocompatibility and biodegradability in 
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human bodies and cheap production qualify them for technological 
applications such as carrier systems.12  
The category of synthetic polymers can be divided into homopolymers, 
polyelectrolytes and block copolymers.10,13-15 Homopolymers are built 
from covalently attached identical repeating units in linear or branched 
form. Polyelectrolytes have repeating polymer units with charged 
functional groups. 
 
Fig.  1 Amphiphilic block copolymer architectures: A) AB-diblock; B) ABA-
triblock; C) ABC-triblock; D) dendrimer; E) star-shape; F) linear grafted shape. 
 
This thesis is mainly based on amphiphilic block copolymers. Block 
copolymers belong to a special class of synthetic macromolecules 
consisting of at least two different groups of repeating structural units 
called homopolymers. The different homopolymer units are either 
covalently linked or are linked by a junction block, which is an 
intermediate and non-repeating spacer.16 Amphiphilic block copolymers 
are composed of at least two subunits, where one homopolymer subunit 
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has hydrophilic (water soluble) properties while the other has hydrophobic 
(water insoluble) character. The homopolymer block is abbreviated for 
clarity as A, B, C etc., and their order in the block copolymer is directly 
used for its classification. According to this classification, block copolymer 
architectures such as AB – diblock, ABA – triblock, ABC – triblock, 
dendrimer shape, star-shape and grafted are shown in Fig.  1. These 
architectures can have either linear, cyclic, multi-arm star, comb, hyper-
branched or dendritic shapes.17  
1.2.1  Bio-related properties of the amphiphilic di- and tri-block copolymers used 
in this thesis 
In this work, three different kinds of amphiphilic block copolymer were 
employed: A triblock copolymer consisting of an amphiphilic poly(2-
methyloxazoline)-b-poly-(dimethylsiloxane)-b-poly(2-methyloxazoline) 
(PMOXA-PDMS-PMOXA), a diblock copolymer based on poly(2-
methyloxazoline)-b-poly-(dimethylsiloxane) (PMOXA-PDMS) and a 
diblock copolymer made of poly(butadiene)-b-poly(ethylene oxide) (PB-b-
PEO).  The biologically relevant properties of the individual 
homopolymers are summarised here: 
PMOXA: PMOXA is often used as the hydrophilic block in either AB 
diblock or ABA triblock copolymers as building block in supramolecular 
assemblies for biological applications.2,11 Recent studies on the 
biodistribution and excretion of well-defined radiolabelled PMOXA in mice 
demonstrated no accumulation in tissue and rapid clearance from the 
bloodstream, thus apportion a good biocompatibility of biodegradability of 
PMOXA.18 Cell-viability measurements of block copolymers containing 
PMOXA indicated low toxicity, which makes it an ideal candidate to build 
functional artificial organelles. 
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PDMS: Silicones, and in this special case, PDMS are widely used in 
medical applications, such as breast implants.19 As it is non-irritating and 
non-sensitising, it shows good biocompatibility. In block copolymers, it is 
widely used as the hydrophobic block. Also block copolymers containing 
PDMS were widely used to build supramolecular assemblies such as 
nanovesicles for diagnostic or therapeutic applications. 
PEO: PEO is widely applied in drug delivery applications. It has a good 
biocompatibility, hydrophilicity, versatility and stealth behaviour.18 Studies 
have demonstrated a protein repellent character.20 This linear polymer 
can be easily modified for example by covalent binding of a metal-
chelating agent for targeting purpose.21  
PB: PB has vinyl groups attached to the backbone and is soluble only 
in organic solvents such as acetone, but insoluble in water.22 PB is often 
used as the hydrophobic block in amphiphilic block copolymers.21-23 The 
monomer 1, 3-butadiene is highly toxic. It is expected to be involved in 
cardiovascular disease, leukaemia and other cancer as described by the 
national pollutant inventory. Therefore its use in bio-related applications is 
not recommended. Because PB was used in this thesis as a part of the 
diblock copolymer PB-b-PEO, which formed nanovesicles, in order to 
study the geometry changes of the metal-functionalised part in the 
process of molecular recognition, the potential toxicity of this block 
copolymer was no matter of interest. 
1.3.  Amphiphilic block copolymer superstructures 
Amphiphilic molecules, such as lipids, surfactants or amphiphilic block 
copolymers, possess the ability to form self-assembled superstructures in 
aqueous media. The hydrophilic part and the hydrophobic part thereby  
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Fig.  2 Self-assembled structures based on block copolymers and surfactants: 
spherical micelles, cylindrical micelles, vesicles, fcc- and bcc-packed spheres (FCC, 
BCC), hexagonally packed cylinders (HEX), various minimal surfaces (gyroid, F 
surface, P surface), simple lamellae (LAM), as well as modulated and perforated 
lamellae (MLAM, PLAM). Reprinted with permission from Ref. 24 Copyright 2002 
WILEY-VCH Verlag GmbH & Co. KGaA. 
 
describe the overall amphilicity of the molecule. The two blocks were 
covalently linked in order to avoid macrophase separation,24  which 
occurs for example by water and oil emulsions. At defined conditions, 
molecular ordered superstructures were formed via self-assembly 
depending on the insoluble to soluble ratio, the molecular weight and the 
concentration.25,26 In this case, different morphologies such as micelles, 
vesicles, tubes, lamellar structures, etc. are obtained (Fig.  2). The type of 
morphology can be also modulated by different solvents, where only one 
block of the amphiphile is soluble.27 
Amphiphilic block copolymer superstructures are well suited to mimic 
biological structures in order to engineer new functional materials for 
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therapeutic, diagnostic and theranostic applications due to serious 
advantages compared to their natural counterparts (e.g. lipids). 
1.3.1.  Principle of self-assembly 
The self-assembly process is a fundamental principle in nature to 
organise molecules from a disordered system to highly organised 
structures or patterns without the aid of external trigger factors. Well-
ordered biological assemblies can be formed spontaneously by the self-
assembly process. For example lipid bilayers, the matrix of cell 
membranes, are formed by the self-assembly of lipids. Other self-
assembled structures are proteins, nucleic acids and viruses. The self-
assembly process is essential for these structures to fulfil their biological 
function. 
The self-assembly process is based on intermolecular and/or 
intramolecular interactions, whereas the process is mainly driven by non-
covalent hydrophobic interactions. During the self-assembly process in 
aqueous solution, the hydrophobic parts of amphiphiles preferentially 
align with each other, which is favourable compared to the interaction with 
water leading to an increased entropy (hydrophobic effect).28 In order to 
predict the self-assembly behaviour of amphiphilic block copolymers 
containing hydrocarbons, the packing parameter P describes the shape of 
the molecules (equation 1).29  
  
       
⁄    (1)       
V is described as the hydrophobic chain volume, l as the preferred 
length and a0 the area, which is occupied by the hydrophilic head group of 
the amphiphile. In the case of lipid-like molecules, a P > 0.5 was 
attributed to the favoured formation of spherical and cylindrical micelles. 
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The situation 0.5 < P < 1 leads to less curved bilayers. Nevertheless it is 
more appropriate for amphiphilic block copolymers to use the volume or 
weight fraction of the hydrophilic block to describe their shape.30 
1.3.2.  Polymeric vesicles (polymersomes) 
The most important representatives among the self-assembled 
superstructures in this thesis are polymer vesicles, known as 
polymersomes, which were generated by self-assembling amphiphilic 
copolymers in dilute aqueous solutions, in a similar way to lipids.26,31 
These vesicles are spherical objects with closed-block-copolymer 
membranes in diameters ranging from 50 nm to approximately 10 μm, 
depending on the chemical composition, the size as well as the 
hydrophobic/hydrophilic ratio32,33 of the polymer blocks, the preparation 
method and the preparation conditions. These polymer vesicles are 
significantly more stable to lysis by classical surfactants than liposomes, 
while preserving low immunogenicity.26,34 In addition, they are highly 
impermeable compared to liposomes,34 can be stimuli responsive and 
can be functionalised for targeting approaches.35,36 Various techniques 
were used to generate polymersomes such as direct dissolution of 
copolymers (direct dissolution method), addition of the copolymer 
previously dissolved in an organic solvent to aqueous media (cosolvent 
method), or hydration of a copolymer film (film hydration method).31 
Depending on the intended application, polymersomes may be adapted to 
specific sizes for particular routes of administration. The polymer 
membrane is organised in the way that the hydrophilic part is exposed to 
the inner and outer aqueous environments34 and serves to partition 
aqueous volumes with different compositions and concentrations, due to 
a selective permeability towards hydrophobic and hydrophilic molecules.24 
The molecular weight of the used block copolymers directly reflects 
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membrane thickness, which can be up to 30 nm.37 The high mechanical 
polymersome membrane stability leads to a long-lasting retention of 
payloads, ideally suited for technological applications. Beside the 
possibility to encapsulate hydrophilic guest molecules, polymersomes can 
simultaneously carry hydrophobic molecules in their membrane.38 
Vesicular morphologies are illustrated based on AB diblock and ABA 
triblock copolymer (Fig. 3). 
Fig.  3 Polymersome formation based on AB-diblock copolymer in comparison to 
ABA-triblock copolymer. 
1.3.3.  Polymersome preparation methods 
The procedure to prepare polymersomes requires that the specificity of 
the building blocks, the conditions for the active compounds in case of 
nanoreactor (see chapter 1.4) preparation, the architecture etc. are 
adequate for the intended application. Especially in medical applications, 
when polymersomes are used in the human body, the safety issue 
increases considerably.  
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Only the relevant techniques applied in the framework of our project, 
the film hydration technique and the direct dissolution method will be 
further discussed. 
The film rehydration method consists of two stages: Firstly, the 
amphiphiles are dissolved in an organic solvent and subsequently the 
solvent is evaporated to form an uniform, thin film on the surface of a 
glass flask.39 Afterwards, the self-assembly process towards 
macromolecular superstructures such as vesicles is initiated by the 
addition of the aqueous solution, accompanied by additional forces such 
as stirring, vortexing or sonication. The aqueous solution may contain 
active compounds, which will result in their encapsulation in the aqueous 
cavity or their incorporation in the membrane of the supramolecular 
structures (e.g. vesicle membrane).  
In the direct dissolution method, polymers are directly dissolved in the 
aqueous solution, which may contain active compounds for nanoreactor 
preparation, by extended agitation until the polymer is completely 
hydrated.24  
1.3.4.  Characterisation methods of polymersomes 
Polymersome characterisation starts with the detailed investigation of 
the building blocks and continues with the characterisation of the 
architectures with regard to their size, stability, flexibility, charge, etc. 
When active compounds are involved, overall nanoreactor activity needs 
to be determined.  
Polymersome size and size distribution24,40 (polydispersity index), the 
aggregation concentration,41 morphology42 and change of size or shape 
with variation of pH, temperature or detergent addition43,44 can be 
determined by light scattering (static and dynamic light scattering) 
experiments. Parameters such as weight averaged molecular mass, 
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radius of gyration, hydrodynamic radius as well as information about 
particle – particle and particle – solvent interactions can be deduced.42  
For direct visualisation of self-assembled structures most commonly 
microscopy techniques, such as optical microscopy, laser-scanning 
microscopy, or electron microscopy are used. These techniques allow to 
extensively characterise structures in a broad range from a few 
nanometres (super resolution microscopy such as STED (Stimulated 
Emission Depletion) or STORM (Stochastic Optical Reconstruction 
Microscopy)) to a few micrometres.45 
The simplest method to visualise the assemblies under ‘physiological’ 
conditions is offered by optical microscopy, but the limited resolution – 
max resolution corresponds to the half of the used wavelength (around 
200 nm) – of these devices is a disadvantage compared to electron 
microscopy. Therefore, only large assemblies such as giant liposomes or 
giant polymersomes can be observed by optical microscopy. 
Electron microscopy techniques, including transmission electron 
microscopy (TEM), scanning electron microscopy (SEM), cryo-TEM and 
cryo-SEM, provide higher resolution and allow to visualise self-assembled 
superstructures and nanoreactors.46-48 Thickness and structure of a 
vesicle membrane and their phase behaviour can be observed by cryo-
TEM, cryo-SEM and the freeze-fracture technique.49  
Fluorescence microscopy is established for observation of 
fluorescently labelled nanocompartments, which contain fluorescent dyes 
or fluorescent proteins. This method is used to study polymer assemblies 
with respect to dye encapsulation behaviour or dye binding properties,50-53 
and to investigate cellular uptake of polymersome nanocarriers or 
nanoreactors. Furthermore, activity of nanoreactors after cellular uptake 
can be proven by visualisation of fluorescent products in real-time. 
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Confocal laser-scanning microscopy (CLSM) is a special kind of 
fluorescence microscopy, where the specimen is point-wise irradiated and 
its fluorescence emission is point-wise measured to create an image. The 
main difference is the use of a confocal aperture, the pinhole, which is 
adjustable and determines how fluorescence light coming from non-
focused planes is detected. This allows to image small sections and to 
reconstruct 3D images containing different focus planes. 
Fluorescence correlation spectroscopy (FCS) is used to investigate the 
dynamic properties of fluorescent molecules such as dyes, 
macromolecules and nanoparticles.54 The experimental technique is 
based on monitoring fluorescence intensity fluctuations in a small 
observation volume – a confocal volume. A correlation analysis of the 
fluctuations yields information on the diffusion coefficients and times, 
population distributions, concentrations, etc. It is also possible to 
determine the size and quantify the number of encapsulated fluorescent 
dyes or proteins in nanocontainers.51,52,54 The technique is widely used for 
studies concerning encapsulation/entrapment/binding of fluorescent 
molecules in/on polymer assemblies in order to determine the sensitivity 
and stability of nanoreactors.46,51,55 
1.4.  Concept of nanoreactors based on amphiphilic block copolymers 
In this thesis, a nanoreactor is defined as a polymersome 
encapsulated with an active compound (for example enzymes, proteins, 
enzyme-mimics) and rendered permeable for substrates/products by the 
insertion of membrane proteins or ion channels in the polymersome 
membrane (Fig.  4). 
The concept of nanoreactor originates from the compartmentalisation 
strategy in nature, where compartments are used to separate biological 
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processes. Prominent examples in cells are organelles such as the 
endoplasmic reticulum, the Golgi apparatus, mitochondria, peroxisomes, 
the nucleus, etc., where biological molecules are produced, transported, 
detoxified, stored or disposed of. The advantage of the 
compartmentalisation strategy is that different biological processes can 
simultaneously run without interfering each other due to portioning of 
biological tasks. It further allows the protection of sensitive biomolecules 
or provision of adapted conditions, while communication (exchange of 
signals) enables complex cascade reactions. Similar to cell 
compartments, nanoreactors are regarded as nanometre-sized reaction 
compartments/spaces used for chemical and biological reactions.   
 
 
Fig.  4 a) Polymersomes containing active compounds inside their aqueous cavity. b) 
Polymer membrane, which is intrinsically permeable. c) A polymer membrane with 
an inserted channel protein. Adapted with permission from Ref. 11 Copyright 2011 
American Chemical Society. 
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The concept of nanoreactors implies that the active compounds are 
kept permanently in its aqueous cavity or in its membrane. This 
compartmentalisation strategy has also the dual ability: the protection of 
the content from proteolytic attack and providing a reaction space for in 
situ activity.11 Nanoreactors were used to monitor11 or detoxify51,56 
substances, to produce drugs and were applied for enzyme replacement 
therapy.57  
In medical applications, an increased efficacy of nanoreactors is 
desirable compared to unspecific drug administration, which could be 
realised by their site-specific action. Site-specific action can be triggered 
by a specific targeting, which can be put into practice by functionalisation 
of the nanoreactor`s surface with, for example, peptides, proteins, 
antibodies or chelating agents to generate molecular recognition 
points.52,53,55 Based on the highly specific molecular recognition, surface-
functionalised nanoreactors were able to act at specific locations.47,58,59 
Also stimuli-responsive nanoreactors were generated, which can be 
predetermined on or off “on demand” by different stimuli such as physical 
(light, temperature, mechanical, magnetic, etc.), chemical (solvent, pH, 
ionic strength) and biological (receptor, enzyme) triggers.60  
1.4.1.  Requirements for nanoreactors used in medical applications 
In case of nanoreactor preparation, the proper combination of active 
compounds with the polymersome architecture is needed (in the aqueous 
cavity of the polymersome or in the polymersome membrane). 
Nanoreactor functionality depends on the activity of the active compound, 
which is specific and depends on the preparation method, the pH, ionic 
strength, temperature and traces of solvents.10 Therefore, nanoreactor 
preparation requires the preservation of the activity of the active 
compound starting with the choice of the building blocks, which are 
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treated with organic solvents. These solvents, even in traces, could have 
considerable effects on the activity of the biological compound. When 
using a preparation method, the use of organic solvents should be 
minimised or entirely organic solvent free preparation methods should be 
used.24 
Medical applications differ if nanoreactors are meant to be used inside 
a cell as an in vivo application for diagnostics or therapeutics, or as ex 
vivo, when nanoreactors are used as medical sensor for diagnostics. 
When a nanoreactor is used outside a body, nanoreactor performance 
with regard to ideal working conditions (pH, ionic strength, temperature, 
etc. for the encapsulated, active compound is aspired solely. On the other 
hand, nanoreactors applied in vivo have to fulfil complex requirements, 
which belong to the safety standards provided by the U.S Food and Drug 
Administration (FDA) and the European Medicines Agency (EMA). This 
guarantees that the in situ biological activity of encapsulated active 
molecules is ensured,2,61 the integrity and activity of the nanoreactor is 
preserved in biological conditions and that the nanoreactor and its 
components (nanoreactor building blocks and the active molecules) are 
biocompatible and biodegradable25,56,62 and do not accumulate in the 
body. 
The size and morphology of a nanoreactor is crucial for its cellular 
interactions. In this respect, nanoreactors of around 200 nm in diameter 
have shown to be uptaken by cells.47,56 Therefore, nanoreactor 
preparation methods need to be aimed to this size range. Preparation 
methods also play an important role for preserving the biological activity 
of the active species. Hence, solvents, which potentially lower enzymatic 
activity, must be avoided.2 Also the chemical constitution and properties 
of the nanoreactor system such as charge flexibility and density of the 
building blocks can influence the activity of the active compound. Stability 
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and integrity of the nanoreactors avoid the release of potential toxic 
substances in the body. Nevertheless, nanoreactor membrane 
permeability is desired for substrates and products. The efficacy of the 
nanoreactor is enhanced by nanoreactors having stealth-like characters. 
1.4.2.  Active compounds supporting nanoreactor functionality 
Which active compounds were used for nanoreactor engineering? 
Most commonly, proteins, enzymes, enzyme-mimics, or photoactive dyes 
have been entrapped in the nanoreactor compartments.10,25,60  
Proteins are key molecules in cell activities. They catalyse metabolic 
reactions, transcribe and replicate DNA, are stimuli responsive, transport 
oxygen, etc. For example, haemoglobin was encapsulated in 
polymersomes with a dual functionality of oxygen transport and 
detoxification of peroxinitrite.63 
A special class of proteins are enzymes, which specifically and 
efficiently catalyse biological reactions to sustain life. They contain either 
ion metal groups or organic functional groups, which can accelerate 
metabolic reactions up to the diffusion-limit. Prominent catalytic 
mechanisms were transition-state binding, entropic control of reactions, 
acid-base catalysis, etc. 
Enzyme-mimics were developed as artificial enzymes in order to 
understand the functionality of biological counterparts in more detail, to 
generate artificial enzymes with improved functionalities62 or to adopt 
functions of enzymes.64 
Also, photoactive dyes were encapsulated in nanoreactors to generate 
reactive oxygen species for applications in cancer therapy.60 In this 
context, encapsulation is important in order to reduce toxicity of the 
photoactive dyes, while their efficacy can be increased due to application 
of a local high dosage. 
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1.4.3.  Incorporation of membrane proteins and ion-channels in amphiphilic 
block copolymer polymersome membranes 
The low permeability of the membrane of polymersomes towards a 
great variety of molecules such as substrates requires that the active 
compounds in the aqueous cavity of the polymersomes must be made 
accessible. A strategy therefore is to permeabilise the membrane either 
by using substrate-permeable membranes65 or by inserting membrane 
proteins that serve as “gates”.66-68 Even though the dimensions of 
synthetic membranes (>10 nm) exceeds the dimensions of membrane 
proteins, functional incorporation in the membrane is feasible.  
Membrane proteins, such as the aquaporin Z (AqpZ), LamB, TsX or 
complex 1, are specific transporters,66,67,69,70 while OmpF or FhuA form 
unspecific channels.68,71 The membrane proteins can tune the 
permeability of the membrane in a selective manner when specific 
transporters are inserted. In this thesis, the membrane protein OmpF and 
the ion-channel gramicidin were used to render the polymersome 
membrane permeable for substrates or trigger factors. 
 
Fig.  5 Top view of OmpF. Figure generated from the protein database: 
http://www.rcsb.org. 
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OmpF 
The outer membrane protein F (OmpF) is isolated from E. coli cultures 
in quantities of tens of mg/mL cultures72 and is stable in conditions of up 
to 70 °C in 2% sodium dodecyl sulphate.73 Dissolving OmpF in ethanol, 
for example for membrane incorporation, has no influence on its activity 
or stability. OmpF (Fig.  5) allows the passage of molecules up to a 
molecular weight of 600 Daltons (Da).74 It has a beta-barrel structure, as 
most of the channel proteins,74 which secondary structure has increased 
stability compared to α-helical membrane proteins. 
Functional incorporation of OmpF in PMOXA-PDMS-PMOXA 
copolymer membranes was realised by Meier et al.75 As shown in Fig.  5, 
OmpF is composed of three identical subunits, whereby the monomers 
are mainly build by a 16-stranded antiparallel β-sheet barrel.76 
Gramicidin 
In contrast to OmpF, which unspecifically allows the passage of 
molecules, gramicidin is an ion-channel, specific for monovalent cations. 
Gramicidin is a polypeptide antibiotic, which is produced by Bacillus 
brevis. It consists of 15 hydrophobic amino acids that are neither charged 
nor polar with the common following sequence: formyl-L-val-gly-L-ala-o-
leu-L-ala-o-val-L-val-o-val-L-trp-o-leu-L-xxx-D-leu-L-trp-D-Ieu-L-trp-
ethanolamine, where xxx is tryptophan in gramicidin A, phenylalanine in 
gramicidin B, and tyrosine in gramicidin C.77  
Consequently, gramicidin is almost insoluble in water, but is soluble in 
many apolar solvents, phospholipids and alcohols. 
Due to its small size, gramicidin can adopt a variety of different 
conformations. The two main conformations were determined as a helical 
dimer or a double helical structure (Fig.  6).77 The helical dimer consists of 
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two monomeric gramicidin helices, which are associated with each other 
N-terminus to N-terminus. 
 
Fig.  6 Two main conformations of gramicidin pores are (A) a helical dimer (this 
form leads to channel formation) or (B) a double helical structure (pore formation). 
Reprinted with permission from Ref. 77 Copyright 1990 by Annual Reviews Inc. 
 
The association between the two monomer- helices is stabilised by six 
H-bonds. The dimer formation (this conformation is around 25 Å in length) 
is crucial to cross a membrane (e.g. a lipid- bilayer) because one 
gramicidin molecule alone would be too short to span the membrane.77 
The channel, which is formed by the gramicidin helical dimer, is pervious 
for monovalent cations such as H+ and K+ and has a diameter of 4 Å. In 
nature, gramicidin serves as a defending mechanism against other 
microorganisms. It has the ability to incorporate into lipid membranes, 
rendering them permeable for ions thereby destroying the electrochemical 
gradient, which is necessary for ATP production.  
1.4.4.  Engineering artificial organelles as cell implants based on nanoreactors 
Due to the inherent advantageous properties of nanoreactors, their 
development is highly directed towards applications inside the body. This 
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could be either in the blood stream or in a bio-inspired approach by 
mimicking cell organelles.2,47,61,62,78 Such an approach of developing "cell 
implants" has large potential in the repair of cell dysfunctions directly at 
the source, responsible of many disease such as Parkinson`s disease, 
amyotrophic lateral sclerosis (ALS), Alzheimer, cancer, etc. This new 
strategy will have an enormous impact on personalised medicine and in 
the design of artificial cells to build more complex synthetic systems. To 
date, only few examples of nanoreactors used as artificial organelles are 
known, which can be explained by the complex requirements for their 
design and preparation. Nevertheless, until now, the few claimed artificial 
organelles even do not perform a biologically relevant task. Nanoreactors 
must have appropriate sizes or are tagged with cell-targeting moieties for 
enhanced cell-uptake. In addition, the activity of entrapped/encapsulated 
enzymes must be maintained in situ and the nanoreactor must be stable 
in order not to break under different environmental conditions, such as 
low pH as present in lysosomes. 
1.5.  Concept of nanocarriers for drug/protein delivery based on amphiphilic 
block copolymers 
The concept of nanocarriers based on polymersomes emerged from 
the desire to deliver active components such as drugs at high dosage to 
specific locations. This was realised by the encapsulation (in the aqueous 
cavity) and/or entrapment (in the membrane) of payloads (drugs,79,80 
DNA,81 proteins,82,83 or RNA84) in the compartments and its directed 
release. 
Encapsulation efficiency plays a crucial role in the efficacy of the 
payloads, especially when high dosages of drugs were needed. Different 
attempts to increase the encapsulation efficiency, for example by 
complexation of the encapsulated compounds85 or by optimisation of the 
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copolymer block lengths46 were performed. In addition, it is also important 
that the nanocarriers can "detect" the target location for payload release. 
This is achieved by a targeting approach, which in combination with 
triggers, such as pH, temperature or light can efficiently control the 
release of the active components. Nevertheless it is still challenging to 
precisely control the release over time and it is unknown that payloads 
are released in the right place of action. 
1.6.  Relevance of reactive oxygen species (ROS) in oxidative stress 
In certain pathologies, the regulation of reactive oxygen species 
(ROS), which include the superoxide radical anion (O2
-•), peroxynitrite 
(ONOO–), the hydroxyl radical (OH-•) and hydrogen peroxide (H2O2) is 
disordered. ROS are highly reactive molecules due to their unpaired 
electrons. They are generated during the oxygen metabolism as a by-
product and play an important role in cell signalling and homeostasis.86,87 
Oxidative stress occurs when the metabolic status of an aerobic organism 
is imbalanced with ROS by overwhelming the cellular antioxidant defence 
mechanisms to the disadvantage of the organism`s antioxidant defence 
mechanism. Oxidative stress has been shown to contribute to aging88 and 
to play a significant role in many disease including arthritis, Parkinson`s 
disease, amyotrophic lateral sclerosis (ALS), cancer and AIDS.89-92 There 
are different sources, where ROS are produced as shown in Fig.  7.  
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Fig.  7 Overview of the source of reactive oxygen species and its impact on 
biomolecules and biological processes. 
 
Exogenous agents such as smog, ozone, pesticides, ionizing 
radiation, xenobiotics etc. and a variety of endogenous processes, such 
as the mitochondrial respiration, cytochrome P-450 detoxification 
reactions, xanthine oxidase oxidation, phagocytic oxidative bursts, and 
peroxisomal leakage can generate significant amount of ROS. This leads 
to damage, inactivation and modulation of biological molecules, such as 
proteins, carbohydrates, lipids, and nucleic acids and of cellular events 
due to the activity of ROS (Fig.  7). 
Dramatic effect on suitable adaption of metabolic processes had to 
occur due to the availability of oxygen in the course of evolution. Amongst 
others, the development of antioxidant defence mechanisms to regulated 
ROS was essential for survival.  
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1.6.1.  Natural defence mechanism 
Superoxide radicals and related hydrogen peroxide are continuously 
produced during the mitochondrial respiratory as a result of univalent 
oxygen reduction by Complex I.93 But also in peroxisomes, where the 
fatty acid α-oxidation, the β-oxidation of very long chain fatty acids, the 
catabolism of purines, and the biosynthesis of glycerolipids and bile acids 
occurs, reactive oxygen species can be formed.94 The natural defence 
mechanisms are able to reduce reactive oxygen species to tolerable, non-
toxic amounts due to their toxic effect at concentration above the 
threshold produced during the metabolism or necessary for signal 
transduction. Antioxidant substances are part of the defence mechanism, 
which are able to minimise or prevent substrate oxidation. These can be 
for example enzymes such as superoxide dismutase (SOD), catalase 
(CAT), both found in peroxisomes, peroxidases (e.g. lactoperoxidase or 
horseradish peroxidase), glutathione peroxidase and transferases, 
quinone reductases or small molecular weight substances such as 
glutathione, ascorbic acid, vitamin C and E, uric acid, carotenoids, etc. 
able to act as antioxidants.  
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Fig.  8 Schematic overview of ROS homeostasis occurring in peroxisomes. Specific 
transporters (e.g. ABCD1) transport various peroxisomal metabolites such as 
VLCFA across the membrane and most of the peroxisomal matrix proteins are 
imported in a PTS1/Pex5p-dependent manner. Peroxisomal oxidases (light purple) 
are responsible to break down the substrates so that the hydrogen extracted from 
the substrate is directly transferred to O2. Peroxisomal antioxidant enzymes (light 
blue) convert the generated H2O2 to H2O and O2. A by-product of the xanthine 
oxidase (XO) activity is O2
•–
, which is immediately reduced by manganese 
superoxide dismutase (MnSOD) and copper-zinc-superoxide dismutase 
(Cu/ZnSOD). Others, such as Mpv17 and M-LP (dark blue) are involved in the 
regulation of peroxisomal ROS metabolism, even though it is not clear if they are 
localized in the peroxisome. Reprinted with permission from Ref. 94. Copyright 
2009 WILEY-VCH Verlag GmbH & Co. KGaA. 
 
The importance of ROS detoxification is illustrated in the schematic 
overview of ROS homeostasis occurring in peroxisomes, as shown in Fig.  
8.94 It proceeds as a cascade reaction, where SOD detoxifies the O2
•– 
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radicals to hydrogen peroxide, shown in equation 2.  
        
    
                 (2) 
The toxic character of H2O2 implies its further decomposition to 
harmless products, water and O2, which is made either by CAT, 
glutathione peroxidase, peroxiredoxin or PMP20, which also belongs to 
the peroxiredoxin family.95 CAT detoxifies H2O2 in a catalactic reaction 
(equation 3). 
                (3) 
The mechanism, where glutathione peroxidase is involved, removes 
H2O2 by the oxidation of glutathione (GSH) to its oxidised form, 
glutathione disulphide (GSSG) (equation 4). 
                          (4) 
The peroxiredoxin (PRX) system uses thioredoxin (TRX) to detoxify 
H2O2. The following reaction mechanism is proposed: (equation 5) 
         
     (       )              (        )       (5) 
Due to the inactivity of PRX (oxidised), it needs to be restored to its 
reduced form by TRX, shown in equation 6. 
    (        )       (       )        (       )     (        ) (6) 
TRX is a polypeptide especially occurring in the endoplasmic reticulum 
and in mitochondria. It contains a dithiol-disulfide active site. Its reduced 
state is obtained by flavoenzyme thioredoxin reductase.  
1.6.2.  Antioxidant therapy 
The aim of the antioxidant therapy is to counteract the functional 
failure or the overcharge of natural antioxidant mechanisms by providing 
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antioxidants. These are able to reduce the harmful effects of ROS and 
thus prevent or cure oxidative stress and related diseases. Early 
antioxidant therapies made use of antioxidants known from the natural 
defence mechanism, such as SOD or CAT.96 But also vitamins, such as 
vitamin A, vitamin C, or vitamin E were used to reduce the amount of 
ROS.97 Nevertheless, the short half-life in blood plasma and difficulty for 
efficient cellular uptake of antioxidant substances lower the efficacy of an 
antioxidant therapy. For example it is known that SOD and CAT were 
inadequately delivered to targeted cells.98,99 A strategy to increase uptake 
behaviour was for example by conjugation of antioxidant enzymes with 
antibodies to improve their biocompatibility.99,100 The risk is that 
conjugation of enzymes with other molecules can dramatically lower the 
activity of the enzymes.101  
Nevertheless, both the use of antioxidant enzymes, as well as the use 
of vitamins in order to efficiently treat conditions of oxidative in vivo did 
not yield convincing benefits yet. 
1.7.  Concept of molecular recognition 
Molecular recognition allows specific biological interactions by non-
covalent bonds such as hydrogen bonds, hydrophobic interactions, metal 
coordination etc. and supports instant response in different processes. 
Molecular recognition is distinguished between static molecular 
recognition and dynamic recognition. Static molecular recognition can be 
described as a key-lock system (Fig.  9A), where the key exactly fits into 
the lock. Dynamic molecular recognition implies on the contrary that a 
binding of a first guest molecule to the host allows a second molecule via 
a conformation change to fit (induced fit) (Fig.  9B). Hence, in a positive 
allosteric system, the binding of the first guest molecules increases the 
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binding affinity towards the second guest, while in a negative allosteric 
system, the first guest molecule decreases the binding affinity towards the 
second guest. 
 
Fig.  9 Different models of substrate binding to enzymes: A) In the lock-key model, 
the correctly sized and shaped substrate binds to the active site of an enzyme in 
order to undergo an enzymatic reaction. B) In the induced fit model, the substrate 
determines the correct shape of the active site of the enzyme, in order to process the 
substrate to the product. 
 
Technical realisation of the molecular recognition concept resulted in 
the principle of key-lock systems or the use of affinity tags and is widely 
applied in the purification102,103 and immobilisation20,23,104,105 of 
biomolecules, protein labelling,106,107 targeting approaches,108 etc. 
1.7.1.  Molecular recognition strategies in nature 
Molecular recognition in biological systems helps molecules to self-
assemble, organise, recognise or communicate and to achieve biological 
function. Natural recognition models are for example the 
antigen−antibody,109,110 receptor−ligand systems (the nicotinic 
acetylcholine receptor or the folate receptor),111 DNA−protein 
assemblies,112 or RNA –ribosomes. 
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1.7.2.  Targeting strategies 
In order to specifically target nanocarriers or nanoreactors, the natural 
principle of molecular recognition, which allows identification of patterns 
to be recognised by each other, can be applied to synthetic systems. It is 
achieved by functionalisation of the polymersome surface to build specific 
recognition points, which is presented in the following section.  
Metal-functionalised polymer membranes 
Functionalisation of amphiphilic diblock copolymers with metal-based 
recognition sites that can self-assemble to polymersomes allow 
production of metal-functionalised polymer membranes. In these 
supramolecular assemblies, the free coordination points of the metal 
centre interacts with biomolecules by replacing the solvent molecules and 
rearranging its geometry.55 Prominent ligands that are able to be 
recognised by peptides and proteins when complexed with metals such 
as copper or nickel are iminodiacetato (IDA), bis(2-pyridylmethyl)amine 
(BPA), diethylenetriamine (DIEN), nitrilotriacetic acid (NTA) or tris 
nitrilotriacetic acid (trisNTA), tris(2-pyridylmethyl)amine (TPA), and tri(2-
aminoethyl)amine (TREN).55,113 This approach finds application in the 
selective binding of biological molecules for functional and oriented 
immobilisation,114 and can be successfully used for 2D and 3D protein 
immobilisation. Polymersomes, functionalised with specific molecular 
moieties on the outer surface, such as biotin, antibodies, or metal 
complexes,21,23 allow for cellular uptake, protein binding or can be used to 
be immobilised on solid supports.52 
1.7.3.  Metal-chelation: NTA and trisNTA 
Metal-chelation describes the ability of molecules or ions to bind to 
metal sites and implies that the binding of a polydentate ligand to the 
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metal centre consists of at least two coordination bonds. The metal 
complexes formed with these ligands have a coordination sphere that 
consists of strongly binding atoms of the ligand and weak binding solvent 
molecules. The biomolecule interacts with the metal ion as it replaces the 
solvent molecules and rearranges the geometry. This binding mechanism 
confers the advantage of stable immobilisation of the biomolecule, 
similarly to nature.115 In this respect, NTA- and IDA-metal complexes 
have been used to design synthetic receptors that bind peptides or 
proteins under physiological conditions.113,116 The NTA ligand is widely 
applied in immobilised-metal affinity chromatography.117 It coordinates for 
example the Ni2+ with four valences as shown Fig.  10. 
 
Fig.  10 Model of the interaction between residues in the His-tag and the metal ion in 
tetra-pentadentate NTA ligand. Reprinted with permission form Ref. 117. 
Copyright 2009 Elsevier Inc. 
 
In this molecular configuration, two additional valences are available to 
be coordinated to the imidazole rings of histidine residues. In a further 
development, increased binding capability was achieved by using trisNTA 
moieties for protein immobilisation studies. The trisNTA molecules (Fig.  
11b, here complexed with CuII) feature three NTA (Fig.  11a) moieties, all 
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complexed with a metal ion, which are simultaneously involved in the 
ligand-binding process. 
 
Fig.  11 Schematic formula of a) Cu
II−NTA complex and b) CuII− trisNTA. X 
represents solvent molecules or external binding atoms of other molecules. 
Reprinted with permission from Ref. 55. Copyright 2012 American Chemical 
Society. 
 
1.7.3.  His-tags and His-tagged molecules 
His-tagged molecules can be used not only for immobilisation or 
purification purpose of proteins but also in order to study molecular 
recognition interactions. These molecules most commonly consist of a tag 
moiety with at least six consecutive histidines covalently bound. Other 
reported His-tag sequences were summarised in a review of immobilised-
metal affinity chromatography.117 The tag moiety has been shown to 
specifically bind to metal binding sites by a shift of the 
association/dissociation equilibrium constant to the site of association as 
a result of the known affinity of histidines to transition metals, such as 
Zn2+, Cu2+, Ni2+, or Co2+.115 There, typical dissociation rates of different 
systems were determined to range between 10-6 and 10-9 M. The 
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system`s properties, such as the used medium, buffer solution, pH, ligand 
density or concentration or accessibility can have an influence on the 
binding behaviour. As an example, the oligohistidine sequence consisting 
of six histidines efficiently interacts with NiII−NTA complexes with a 
binding affinity in the subnanomolar range.107,118,119 When the number of 
histidines on each tag was increased, for example, 10 histidines instead 
of 6 histidines) a decreased metal binding affinity was observed.115 His6-
tag affinity to different transition-metal ions was predicted by molecular 
dynamic simulations, including Cu2+, Fe3+, Ni2+, and K+ ions,. The results 
indicated that the His6-tag exhibits the strongest binding affinity for Ni
2+ 
and Cu2+ ions.120  
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2.  Combat superoxide anion radicals by antioxidant nanoreactors 
A key challenge in life and nano-sciences is to fuse biological entities, 
such as enzymes, with synthetic materials, for example block copolymers 
in order to create new, complex synthetic biological devices. Combination 
of specificity and efficiency of biological molecules with robustness and 
possibility of tailoring of polymeric materials allows the design of efficient 
mimics of living entities, or of electronic-inspired systems, on the nano-
scale domain. These out-perform conventional chemical or biological 
approaches to generate revolutionary, highly-specific communicating or 
processing systems, such as biosensors, signal amplifiers, electron-
transfer devices, or nanoreactors.1,25,121 Enzymatic activity can be 
improved and enzymatic pathways customised by combining synthetic 
with biological materials, as has been shown by trypsin encapsulation in 
PS-b-PAA block copolymers122 or by reconstitution of ubiquinone 
oxidoreductase in copolymer membranes.69 However, a real challenge is 
related to the preservation of the enzyme activity as well as its integrity 
when combined with polymeric systems. This renders the situation more 
complex than in bulk conditions, and requires mild procedures of 
generating the hybrid systems, as well as to establish the polymer/protein 
interactions, and their effect on enzyme structure and activity. 
Recently such bio-synthetic materials were successfully applied for 
local bio-conversion on surfaces,53 and inside living cells.61 Here we plan 
to extend these concepts to the detoxification of reactive oxygen species 
(ROS), including the superoxide radical anion (O2
•-), peroxynitrite, 
hydroxyl radical, and hydrogen peroxide, those natural production is 
dramatically increased during oxidative stress.123 Oxidative stress has 
been reported to play an important role both related to the toxicology of 
inorganic nanoparticles,124 and in the pathogenesis of many diseases, 
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such as arthritis, Parkinson’s disease, amyotrophic lateral sclerosis, 
cancer, or AIDS.89,90,125 
 
2.1.  Motivation and concept 
Many attempts to detoxify ROS by direct antioxidant enzyme 
administration were undertaken, but no conclusive data was obtained. 
SOD, for example, was quickly eliminated from the blood stream.98 In 
addition, attempts to modify SOD in order to improve delivery were tried. 
To this end, SOD was covalently modified with poly(ethylene glycol) 
(PEG)126 or encapsulated in liposomes127,128 and in polymeric 
microspheres.129 But none of these attempts could improve SOD delivery 
significantly. 
A promising attempt was the design of antioxidant nanoreactors 
encapsulating SOD inside oxygen permeable polymeric vesicles. The 
enzyme efficiently catalysed the reaction of superoxide radicals to 
generate hydrogen peroxide.51 However, hydrogen peroxide as a final 
product is well known to still contribute to oxidative damage.130 Therefore, 
in order to detoxify superoxide radicals and related harmful hydrogen 
peroxide, similar to cellular antioxidant mechanisms, an intricate system 
must be engineered. 
Here, we use this concept in order to engineer advanced nanoreactors 
based on the encapsulation of two different antioxidant enzymes, 
superoxide dismutase (SOD) and lactoperoxidase (LPO) or catalase 
(CAT), in polymersomes for detection and detoxification of reactive 
oxygen species (ROS). The encapsulated antioxidant enzymes act 
simultaneously in situ while protected from proteolytic attack.15,41  
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Fig.  12 a) Specialised enzymatic cascade reaction inside polymeric nanovesicles for 
detection and detoxification of superoxide radicals. Two different types of enzymes 
act inside the polymersome in a cascade reaction with substrates (D) and products 
(F) to detoxify reactive oxygen species (A). Substrates, products, and reactive 
oxygen species penetrate the polymeric membrane due to the insertion of protein 
channels (B); b) Schematic illustration of the reaction mechanism of the SOD/LPO 
cascade reaction inside a polymersome; c) Chemical reactions allowing the detection 
and detoxification of superoxide radicals: 1) generation of O2
-•
; 2) reactions 
involving SOD; 3) reactions involving LPO. Adapted with permission from Ref. 56. 
Copyright 2011 Wiley-VCH Verlag GmbH & Co. KGaA. 
 
The selected enzymes catalyse the same reaction in nature. 
Superoxide radicals can diffuse through the polymer membrane and 
reach the enzymes, where they were reduced in a cascade reaction to 
harmless reaction products H2O and molecular oxygen (Fig.  12b). 
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In order to observe the detoxification process, i. e. the detection of 
superoxide radicals and testing the antioxidant activity inside cells, 
membrane proteins were needed in order to allow the passage of 
substrates and products of LPO through the polymer membrane, which is 
highly impermeable to small molecules.56 This was realised by the 
incorporation of the outer membrane protein F (OmpF) in the vesicle 
membrane to permit passive diffusion of molecules of sizes smaller than 
600 Da.74 OmpF allowed that a second substrate for LPO, amplex red, 
was able to penetrate the aqueous cavity of the vesicles, which was 
converted in situ to a fluorescent product, resorufin, so that the activity of 
the enzymes could directly be observed.  
2.2.  Design of an enzymatic cascade reaction to fight oxidative stress 
The cascade reaction is initialised by SOD, which catalyses the 
reduction of superoxide radicals, generated for test purpose in the initial 
reaction by xanthine/xanthine oxidase (Fig.  12c), to hydrogen peroxide at 
high efficiency. The reaction rate remains unchanged at physiological pH, 
the condition used here, and appears not to be affected by pH variation in 
range between pH 6 and 9.131 In the second step of the cascade reaction, 
hydrogen peroxide is decomposed by LPO or CAT in presence of one of 
its specific substrate, amplex red, which is converted to a fluorescent 
product resorufin that can easily be detected (Fig.  12c). LPO was chosen 
as a second enzyme due to its high activity at physiological pH – 80% of 
its activity is preserved,132 which makes it compatible to SOD. In addition, 
the ability to use a second substrate for LPO to generate a fluorescent 
product in the end of the cascade reaction allows detailed 
characterisation of the enzyme kinetics in bulk, in the nanoreactor and 
when used as artificial organelle. 
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In order to further optimise the cascade reaction, the use of CAT 
instead of LPO as the second enzyme was considered. CAT plays an 
important role in the ROS homeostasis of peroxisomes and is therefore a 
promising enzyme in order to detoxify hydrogen peroxide. 
2.3.  Design and characterisation of antioxidant nanoreactors 
We engineered antioxidant nanoreactors comprising of membrane 
protein gated polymersomes, which are able to detoxify superoxide anion 
radicals in the aqueous cavity via a cascade reaction. The cascade 
reaction is based on the activity of Cu/Zn-SOD, which is the first enzyme, 
and LPO or catalase (CAT) as the second enzyme. 
To provide the reaction cavity, polymersome superstructures were 
generated from the amphiphilic triblock copolymer poly(2-
methyloxazoline)-b-poly(dimethylsiloxane)-b-poly(2-methyloxazoline) 
(PMOXA-PDMS-PMOXA) by self-assembly in aqueous solution at 
physiological condition. The generated vesicles were mechanically very 
stable,133 and do not comprise of structural defects as known from 
liposomes. The used polymer membrane is highly permeable to 
superoxide anion radicals, but impermeable to higher molecular weight 
molecules such as saccharide ions or water.67 The functional 
incorporation of OmpF in the polymersome membrane allows only a 
passive diffusion of molecules up to 600 Da74 and thus is appropriate for 
the use with a second substrate for LPO, amplex red, which is converted 
in the presence of hydrogen peroxide, to a fluorescent product, resorufin. 
This in turn simplifies the detection of the superoxide anion radical and 
hydrogen peroxide detoxification process. 
Based on the chemical nature and the hydrophobic-to-hydrophilic ratio 
of the used PMOXA12-PDMS55-PMOXA12 copolymer, polymersome 
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preparation was made using the direct dissolution method. This method 
provides mild conditions so that the integrity and activity of different 
enzymes encapsulated in nanoreactors were preserved.56,63  
 
Fig.  13 A) TEM micrograph of empty PMOXA-PDMS-PMOXA polymersomes. 
Scale bar = 200 nm; Light scattering of empty polymersomes: B) First order fit of 
DLS data; C) Guinier plot representation of SLS data. Reprinted with permission 
from Ref. 78. Copyright 2013 American Chemical Society. 
 
Via this preparation method, homogeneous, empty PMOXA-PDMS-
PMOXA polymer vesicles with a diameter of 200 ± 40 nm were formed in 
PBS buffer, as confirmed by TEM (Fig.  13A) and dynamic and static light 
scattering (Fig.  13B and C). 
Membrane permeability was adjusted according to an increase of 
permeability while keeping the polymersomes intact. An OmpF 
concentration of 50 µg/mL proved optimal for membrane permeability, 
and did not affect membrane stability.70  
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2.3.1.  Optimised encapsulation of individual enzymes in polymersomes 
In order to work the best condition out to engineer efficient co-
encapsulated antioxidant nanoreactors, characterisation and optimisation 
of each encapsulated enzyme type must be evaluated individually. In this 
respect, individual encapsulation efficiencies needed to be assessed – 
taking care not to induce vesicle aggregation or to disturb the vesicle self-
assembly process.  
 
Fig.  14 A) TEM micrograph of SOD-encapsulated PMOXA-PDMS-PMOXA 
polymersomes. Scale bar = 200 nm; Light scattering of SOD-encapsulated 
polymersomes: B) Second order fit of DLS data; C) Guinier plot representation of 
SLS data. Reprinted with permission from Ref. 78. Copyright 2013 American 
Chemical Society. 
 
The different concentrations used for polymersome preparation did not 
affect their morphology or size of the nanoreactors, as established by a 
combination of light scattering and TEM for: SOD (Fig.  14), LPO (Fig.  
15), and CAT (Fig.  16). 
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Fig.  15 A) TEM micrograph of LPO-encapsulated PMOXA-PDMS-PMOXA 
polymersomes. Scale bar = 200 nm; Light scattering of LPO-encapsulated 
polymersomes: B) Second order fit of DLS data; C) Guinier plot representation of 
SLS data. Reprinted with permission from Ref. 78. Copyright 2013 American 
Chemical Society. 
 
In order to measure and quantify the number of encapsulated 
enzymes and to increase the encapsulation efficiency of enzymes per 
polymersome, the enzymes were labelled with different fluorescent dyes 
− AlexaFluor-488 for SOD, AlexaFluor-633 or dylight-633 for LPO, and 
dylight-488 for CAT − and the efficiency was determined by a combination 
of fluorescence correlation spectroscopy and fluorescence brightness 
measurements. 
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Fig.  16 TEM micrograph of CAT-encapsulated polymersomes. Scale bar = 200 nm. 
Reprinted with permission from Ref. 78. Copyright 2013 American Chemical 
Society. 
 
Upon labelling SOD with AlexaFluor-488, a labelling efficiency of three 
AlexaFluor-488 molecules per SOD was obtained, which was considered 
for the calculation of the encapsulation efficiency. Furthermore, one 
AlexaFluor-633 molecule or 2.7 dylight-633 molecules per LPO, and 1 
dylight-488 molecule per CAT was achieved.  
The molecular brightness of the enzyme-containing polymersomes, 
recorded as counts per molecules (CPM), was divided by the CPM of 
freely-diffusing labelled enzymes to determine the number of enzymes 
per vesicle. This number was then used to calculate the encapsulation 
efficiency in vesicles (EEv) based on the initial enzyme concentration by 
dividing the number of enzyme molecules per polymersome by the 
maximum number, which could be theoretically encapsulated inside a 
vesicle via a statistical, self-assembly process of encapsulation. The 
detailed encapsulation efficiency (EEv) calculation is shown in the 
Appendix. 
When SOD-AlexaFluor-488 was encapsulated in polymersomes, the 
diffusion time D changed from 109 s, which corresponds to the free 
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SOD-AlexaFluor-488, to a value of 3.5 ± 1 ms, which indicates that the 
enzyme was encapsulated in vesicles (Fig.  17A). 
 
Fig.  17 A) FCS autocorrelation curves and the simulation of: a) free AlexaFluor-
488; b) SOD-AlexaFluor-488; c) SOD-AlexaFluor-488-containing vesicles; B) 
Comparison of the theoretical and experimental amount of enzymes encapsulated in 
a polymer vesicle as a function of initial enzyme concentration: Theoretical 
(squares) and experimental (dots) number of SOD encapsulated in 75 nm radius-
sized polymersomes. Reprinted with permission from Ref. 78. Copyright 2013 
American Chemical Society. 
 
Preparing polymersomes with different initial amounts of SOD-
AlexaFluor-488 from 0.1 mg/mL to 0.5 mg/mL allowed the optimisation of 
a maximum encapsulation efficiency of EEv of 25 ± 10% at an initial 
concentration of 0.25 mg/mL (Fig.  17B). To rule unspecific binding of the 
enzyme or of the labelled enzyme out, which would affect the calculated 
number of encapsulated enzymes, control measurements using empty 
polymersomes incubated with dye-labelled enzymes or with only the dye 
were performed. In this case, no change of diffusion time was observed, 
proving that neither AlexaFluor-488 nor SOD-AlexaFluor-488 interact to 
empty polymersomes. Increasing the SOD concentration used for 
encapsulation to 0.9 mg/mL caused solubility problems of SOD being the 
limiting factor of further increase. The resulting high encapsulation 
efficiency of SOD together with the high reaction kinetics 
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(kcat ≈ 10
-9 M-1 s-1)131 were basic pre-requisites for efficient antioxidant 
properties. 
Similarly, encapsulation of LPO-AlexaFluor-633 in polymersomes was 
characterised by a change in the diffusion time from 320 s, 
corresponding to the free LPO-AlexaFluor-633, to 8.5 ± 1 ms, showing 
successful enzyme encapsulation (Fig.  18A). In order to optimise LPO 
encapsulation efficiency, differently concentrated enzyme solutions from 
0.1 mg/mL to 0.5 mg/mL were used. The optimum EEv of 66 ± 33% was 
reached with an initial LPO concentration of 0.25 mg/mL (Fig.  18B). 
 
Fig.  18 A) FCS autocorrelation curves and the simulation of: a) free AlexaFluor-
633; b) LPO-AlexaFluor-633; c) LPO-AlexaFluor-633-containing polymersomes; B) 
Comparison of the theoretical and experimental amount of enzymes encapsulated in 
a polymer vesicle as a function of initial enzyme concentration: Theoretical 
(squares) and experimental (dots) number of LPO encapsulated in 75 nm radius-
sized polymersomes. Reprinted with permission from Ref. 78. Copyright 2013 
American Chemical Society. 
 
Further increase of the concentration of LPO-AlexaFluor-633 used for 
the encapsulation to 0.83 mg/mL led to the formation of aggregates 
during the self-assembly process, characterised by FCS with diffusion 
times of >30 ms and confirmed by TEM (Fig.  19A and B).  
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Fig.  19 A) FCS autocorrelation curves and the simulation of: a) free AlexaFluor-
633 (50 nM) and b) LPO-AlexaFluor-633-containing aggregates (0.83 mg/mL); B) 
TEM micrograph of LPO-AlexaFluor-633 containing aggregates. Scale bar = 2 μm. 
Reprinted with permission from Ref. 78. Copyright 2013 American Chemical 
Society. 
 
The reason for aggregate formation is the unspecific binding, ob-
served, when free AlexaFluor-633 was incubated with empty polymer-
somes, which increased the diffusion time to 7 ms. When a high, initial 
LPO-AlexaFluor-633 concentration was used for encapsulation, non-en-
capsulated labelled enzymes served as aggregation points on the outer 
vesicle surface and induced aggregate formation. When LPO was 
labelled with dylight-633 using the same high initial concentration, the 
formation of aggregates could be avoided (Fig.  20). 
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Fig.  20 Fluorescence autocorrelation curves: FCS autocorrelation curves (line) and 
the simulation (dashed line) of a) free dylight-633 (50 nM); b) dylight-633-labelled 
LPO (50 nM) and c) empty ABA polymersomes incubated with dylight-633. Re-
printed with permission from Ref. 78. Copyright 2013 American Chemical Society. 
 
Nevertheless, aggregate formation is not a limiting factor of the optimi-
sation of the encapsulation efficiency, because the optimum EEv was ob-
tained at significantly lower concentration. Therefore, all further experi-
ments were conducted with LPO-AlexaFluor-633 for nanoreactor-, and 
later artificial peroxisome-characterisation. 
The modular build-up of nanoreactors allows to exchange enzymes for 
further adaption to specific functions. Instead of LPO, we used CAT as a 
second enzyme to test, if the nanoreactor activity could be further 
increased. CAT is differed from LPO, it detoxifies H2O2 in a catalactic 
reaction without the necessity of additional co-substrates and it has a 
higher molecular weight of 250 kDa.134 When CAT-dylight-488 was 
encapsulated, FCS measurements resulted in diffusion times of 4 ± 1 ms, 
which can be attributed to CAT-dylight-488-containing polymersomes 
(Fig.  21c). On the other hand, a diffusion time of 340 s was 
characteristic of the free, labelled-enzyme (Fig.  21a), whereas the 
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diffusion time for the free dye was 44 s. No aggregates were formed for 
all different CAT concentrations used during vesicle formation. 
 
Fig.  21 Normalized FCS autocorrelation curves (lines) and the simulation (dashed 
lines) of a) free dylight-488; b) CAT-dylight-488 and c) CAT-dylight-488-containing 
PMOXA12-PDMS55-PMOXA12 vesicles. Reprinted with permission from Ref. 78. 
Copyright 2013 American Chemical Society. 
 
A maximal EEv of 16 ± 9% was calculated based on brightness 
measurements, which is lower compared to LPO. This can be explained 
by the higher molecular weight of CAT compared to LPO, which creates 
problems for efficient encapsulation, as shown before with lipid 
vesicles.135  
2.3.2.  Activity assay of individual enzyme species in solution and in 
polymersomes 
LPO activity of the free enzyme in solution and encapsulated in 
polymersomes was determined by using an activity assay comprising of 
amplex red, which is converted by LPO in presence of hydrogen peroxide 
to resorufin, shown in Fig.  22A and B, respectively. 
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Fig.  22 A) Activity assay for LPO in free conditions with different concentrations of 
amplex red: a) 3.75 µM; b) 1.88 µM; c) 0.94 µM and d) 0.47 µM. B) Activity assay 
of: a) empty polymersomes (amplex red 0.5 µM); b) LPO encapsulated in 
polymersomes without channel proteins (amplex red 0.5 µM) and LPO encapsulated 
in polymersomes with channel proteins and with gradient of amplex red: c) 0.18 
µM; d) 0.37 µM; e) 0.5 µM and f) 1 µM. Reprinted with permission from Ref. 56. 
Copyright 2011 Wiley-VCH Verlag GmbH & Co. KGaA. 
 
In order to measure enzyme kinetics, different substrate 
concentrations of amplex red were used. As expected, polymersomes 
containing LPO without OmpF gated membranes produced no resorufin 
signal. On the other hand, LPO containing vesicles with gated 
membranes clearly converted amplex red to resorufin in proportion to the 
initial substrate concentration. This demonstrates that OmpF allows 
substrates diffusing through the membrane. 
Calculation of the kinetic constants for the LPO enzymatic reaction (KM 
and Vmax) in free conditions compared to encapsulated conditions using 
the Lineweaver-Burk equation136 gave information about the preservation 
of enzyme activity. This showed that substrate affinity to LPO in 
nanovesicles is slightly higher (KM value of 2.9 ± 0.1 µM) compared to 
free conditions (KM value of 9.4 ± 0.3 µM). Higher substrate affinities in 
encapsulated condition have already been reported,122 which results from 
higher collision frequencies, due to the location of both enzyme and 
substrate at the same interface. Comparison of the maximal reaction 
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rates Vmax of the encapsulated enzyme (37.1 ± 7.1 µMs
-1) with the 
enzyme in free condition (132.3 ± 75.9 µMs-1) shows that it is lower in the 
encapsulated condition, but still comparable to the free condition. 
 
Fig.  23 LPO activity over time, when a) encapsulated in polymersomes and b) in 
free condition. Reprinted with permission from Ref. 56. Copyright 2011 Wiley-VCH 
Verlag GmbH & Co. KGaA. 
 
The stability of encapsulated LPO was also compared to free LPO 
over a time period of 60 days (Fig.  23); both systems were stored in dark 
at 4 °C. After 60 days, LPO activity inside the polymersomes was still 
approximately 70%, while the activity of LPO free in solution decreased to 
40%, which could be a result of possible contamination with small 
amounts of proteases of the free enzyme containing solution. This further 
confirms that the aqueous cavity of the polymersomes provides 
advantageous conditions for the enzyme in means of protection, which 
was also reported for SOD containing polymersomes.51  
During the optimisation of the antioxidant nanoreactor, we also 
compared the enzyme kinetics of LPO-containing polymersomes to that 
of CAT-containing polymersomes according to the activity assay 
presented in Scheme 1. At comparable concentrations of LPO and CAT 
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in free condition adjusted to the concentration range expected to be 
present in polymersomes, CAT activity was comparable to the activity of 
LPO (Fig.  24A). CAT activity was also measured in CAT-encapsulated 
polymer vesicles. The successful incorporation of the channel protein 
OmpF, which allows passage of H2O2 and amplex red through the 
membrane, led to a clear decrease in the fluorescence signal (Fig.  24B 
b) compared to the condition in which no CAT-encapsulated polymer 
vesicles were present (Fig.  24B a). Thus, CAT was encapsulated in an 
active form. 
 
Fig.  24 A) CAT activity assay based on an assay containing LPO (50 nM), H2O2 
(3 µM) and amplex red (0.5 µM) to monitor CAT activity in free conditions using 
different CAT concentrations: a) 0 nM; b) 10 nM; c) 50 nM; d) 100 nM.  B) CAT 
activity assay based on an assay containing LPO (10 nM), H2O2 (0.6 µM) and 
amplex red (0.1 µM) to monitor CAT activity: a) without nanovesicles; b) in 
nanovesicles with incorporated OmpF channel membrane.  [CR] = count rate. 
Reprinted with permission from Ref. 78. Copyright 2013 American Chemical 
Society. 
 
Similar kinetics between peroxidases and CAT at low substrate 
concentrations and under physiological conditions have already been 
reported.137 But the result of the lower encapsulation efficiency of CAT 
compared to LPO makes hydrogen peroxide degradation by CAT-
containing polymersomes less effective. The determinant of the enzyme 
activity is in this case the encapsulation efficiency and not the specificity 
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of the enzyme. Therefore, further experiments were performed using only 
LPO as second enzyme. 
2.3.3.  Optimised co-encapsulation of SOD and LPO in polymersomes 
Superoxide radical detoxification by the antioxidant nanoreactors 
needs successful co-encapsulation of both enzyme types, SOD and LPO, 
in polymersomes. 
 
Fig.  25 Turbid solution containing SOD/LPO-co-encapsulated polymersomes. 
(Sample after size-exclusion- and dye separation (dialysis) process.) Reprinted with 
permission from Ref. 78. Copyright 2013 American Chemical Society. 
 
The simultaneous co-encapsulation, using the optimised condition of 
each individual enzyme type and self-assembly of the block copolymer 
produced a turbid solution (Fig.  25). Co-encapsulation did not affect the 
morphology or the size of the vesicles, as shown by TEM and light 
scattering (Fig.  26A, B and C). 
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Fig.  26 A) TEM micrograph of SOD/LPO co-encapsulated polymersomes; Light 
scattering data for SOD/LPO-co-encapsulated vesicles: B) Second order fits of DLS 
data; C) Guinier plot representation of SLS data. Adapted with permission from 
Ref. 78. Copyright 2013 American Chemical Society. 
 
In order to relate the ROS detoxification efficacy with the quantity of 
co-encapsulated enzymes, fluorescence cross-correlation spectroscopy 
(FCCS) was used. Because the encapsulation of the enzymes inside 
polymersomes is based on a probabilistic process due to the unspecific 
inclusion of molecules during the self-assembly process in vesicles, the 
encapsulation of two different types of enzymes can produce the following 
scenario. Either only one type of enzyme is encapsulated, none of them 
were encapsulated, or both types of enzymes were simultaneously 
encapsulated. In order to quantify the co-encapsulation, FCCS is used, 
which is based on monitoring the fluorescence intensity fluctuation of two 
fluorescent species in overlaying confocal volumes. If the two species are 
moving in a simultaneous way, e.g. when located inside the same 
confinement, a cross-correlation can be calculated, which is proportional 
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to the degree of simultaneous movement. This technique allows to 
determine the degree of co-localisation of the fluorescently labelled 
enzymes SOD and LPO in the same polymersome.  
 
Fig.  27 FCS and FCCS of SOD/LPO co-encapsulated polymersomes: a) 
autocorrelation curves of vesicles containing SOD-AlexaFluor-488; b) 
autocorrelation curves of vesicles containing LPO-AlexaFluor-633, and c) Cross-
correlation curves of SOD-AlexaFluor-488 and LPO-AlexaFluor-633 co-
encapsulated in the polymersomes. Dotted lines are experimental curves. Reprinted 
with permission from Ref. 78. Copyright 2013 American Chemical Society. 
 
Successful co-encapsulation was obtained, as shown in the positive 
cross-correlation curve of the FCCS measurement (Fig.  27c). Qualitative 
analysis of the fluorescence brightness measured in each channel (Fig.  
27a and b) of the FCS measurement revealed that an enzyme ratio of 
SOD:LPO of 1:2 was present inside the polymersomes. Fluorescence 
from the first species detected in the second channel and vice versa, also 
known as cross-talk, was negligible (<0.5 kHz) in the FCCS experiment, 
due to the well-separated fluorescence emission spectra of AlexaFluor-
488 and AlexaFluor-633. Calculation of the relative amplitude of the 
cross-correlation curve in relation to the amplitude of the auto-correlation 
curve allows calculating that approximately 22 ± 10% of the 
polymersomes contained simultaneously both enzymes. This is close to 
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the value of a theoretical calculation, based on the self-assembly process 
of vesicle formation during individual enzyme encapsulation. 
2.3.4.  Multi-enzyme kinetics in a solution that simulates polymersome conditions 
In order to carry out complex reaction as efficiently and in accordance 
with nature, specific enzyme functionality in multi-enzyme systems needs 
to be maintained. Based on the result of the FCS/FCCS quantitative 
analysis, activity tests of the SOD/LPO cascade reaction in solution under 
conditions simulating the concentration ranges of enzymes encapsulated 
in polymersomes were performed.  
 
Fig.  28 A) Cascade reaction in free conditions (xanthine (XA): 25 µM; xanthine 
oxidase (XO): 0.17 U/mL; LPO: 16 nM): without SOD a), and with SOD (205 nM) 
b). Both curves were smoothed via adjacent-averaging. B) Cascade reaction in free 
conditions (XA: 25 µM; XO: 0.17 U/mL; LPO: 1.6 nM; SOD: 205 nM) for a 
gradient of amplex red: a) 12.5 µM; b) 8.4 µM; c) 5.6 µM; d) 3.3 µM and e) 1.7 µM. 
Reprinted with permission from Ref. 56. Copyright 2011 Wiley-VCH Verlag GmbH 
& Co. KGaA. 
 
In the SOD/LPO cascade reaction, the slope is increased in the 
presence of SOD (Fig.  28A b) showing that the reaction completely 
detoxifies superoxide radicals via hydrogen peroxide to water and 
molecular oxygen. In comparison, when SOD is absent (Fig.  28A a), the 
signal intensity is clearly reduced, which was taken into account as 
background signal together with amplex red autooxidation. Because 
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these effects can be neglected for other activity tests at high enzyme 
concentration, the kinetics of encapsulated enzymes (Fig.  28B) will only 
be compared to that of free enzymes in solution providing similar 
concentration conditions as observed in nanovesicles. 
2.3.5.  Multi-enzyme kinetics in situ inside polymersomes 
Optimisation of the co-encapsulation by the selection of optimal 
enzyme concentrations and ratios allows a very efficient cascade 
reaction, taking place in situ in the polymersome cavity, where superoxide 
radicals were successfully reduced to molecular oxygen and water (Fig.  
29A a). Resorufin, the product generated in the step by LPO in presence 
of hydrogen peroxide was detected by fluorescent measurements. The 
FCS set-up was used in these measurements due to its high sensitivity 
and the requirement of only low sample volume. 
 
Fig.  29 A) Cascade reaction of: a) SOD-LPO-loaded nanocontainers with OmpF 
inserted inside the polymer membrane; b) SOD-LPO-loaded nanocontainers 
without OmpF inserted inside the polymer membrane; c) LPO-containing vesicles 
with OmpF inserted inside polymer membrane and d) empty polymer vesicles in the 
presence of amplex red. B) Cascade reaction of SOD-LPO-loaded nanocontainers 
with OmpF inserted inside the polymer membrane with added amplex red gradient 
(XA: 25 µM; XO: 0.17 U/mL): a) 16.7 µM; b) 8.3 µM; c) 4.16 µM; d) 1.7 µM. 
Adapted with permission from Ref. 56. Copyright 2011 Wiley-VCH Verlag GmbH 
& Co. KGaA. 
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SOD/LPO co-encapsulated polymersomes without OmpF (Fig.  29A b) 
showed low resorufin formation, which can be attributed to non-
encapsulated LPO, which is still present in low amount after polymersome 
purification and is able to oxidise amplex red in presence of H2O2 
generated by xanthine/xanthine oxidase (XA/XO) as a by-product. 
Similarly, LPO-encapsulated polymersomes with OmpF, but lacking of 
SOD also showed low resorufin formation, which was detected due to the 
generation of H2O2 generated by XA/XO (Fig.  29A c). The used triblock 
copolymer did not induce amplex red autoxidation (Fig.  29A d). In 
contrast, SOD/LPO containing polymersomes with OmpF reconstituted 
channels were able to generate a considerable amount of resorufin (Fig.  
29A a), which is characteristic for a complete cascade reaction. In direct 
comparison to SOD/LPO containing polymersomes without reconstituted 
OmpF (Fig.  29A b), resorufin intensity was clearly decreased. These 
results are in agreement with FCCS measurements, which already 
proved successful co-encapsulation. 
SOD/LPO containing polymersomes with reconstituted OmpF could 
statistically co-exist with polymersomes without OmpF. Based on the 
OmpF concentration employed, approximately 14 OmpF molecules are 
embedded in one polymersome. Due to this high amount of channels per 
polymersome and the statistical distribution of channels, the probability 
that a polymersome contains no channels should be small. 
In order to qualitatively analyse this cascade reaction, the Michaelis-
Menten kinetic approach has shown to be a suitable model, e. g. in 
characterising HRP in the glucose oxidase/horseradish peroxidase 
tandem reaction.138 Even if the signal to noise ratio is at the detection limit 
due to being close to the single molecule level, Michaelis-Menten kinetics 
provided reliable results.139 Therefore, we applied the Michaelis-Menten 
kinetic to extract the kinetic parameters of the SOD/LPO cascade reaction 
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in free condition (for single molecules) and inside polymersomes (in bulk: 
Fig.  28B and in polymersome condition: Fig.  29B). 
Calculation of the Michaelis-Menten constant KM revealed a value of 
1.1 ± 0.1 µM in free condition, which is lower compared to the value of 
7.3 ± 0.4 µM for the SOD/LPO containing nanoreactors, because the co-
encapsulation is limited by the encapsulation efficiencies of the individual 
enzymes as confirmed by FCCS. The individual enzymes containing 
polymersomes also contribute to the overall cascade reaction, but this 
reaction pathway is less effective than the pathway occurring in the co-
encapsulated polymersomes, because the hydrogen peroxide, converted 
by SOD containing polymersomes, needs to exit the polymersome and 
need to get in contact with polymersomes containing either SOD/LPO or 
only LPO. However, the condition of excess of H2O2 is fulfilled due to the 
extremely high SOD reaction speed and the presence of OmpF, which 
allows good accessibility of the enzymes so that Michael-Menten kinetics 
can be simulated. 
With respect to Vmax, a value of 11.1 µMs
-1 for enzymes in bulk 
compared to the value of 0.02 µMs-1 shows the same trend as for single 
enzyme encapsulation, where the conversion rate of the enzyme is higher 
in bulk condition, because the substrate needs to pass through the 
membrane proteins in order to reach the reaction volume inside the 
polymersomes. 
2.4.  Combating superoxide anion radicals in cells by artificial peroxisomes 
Polymersomes are qualified for the use inside cells due to their 
intrinsic properties such as high stability and their limited miscibility with 
phospholipids.140 Artificial organelles can be designed by the successful 
uptake of polymersomes containing the desired enzymes in cells, 
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providing that the enzymatic activity inside the polymersomes is 
preserved under cellular conditions. The combination of the naturally 
occurring enzymes SOD and LPO in synthetic polymersomes generates a 
hybrid system, which shares the functionality and properties of 
peroxisomes (morphology and size from 200 nm to 1.1 µm)141 when 
implanted in cells. 
 
Fig.  30 A) Schematic view of a cell showing various organelles. B) Peroxisomes are 
spherical, cell organelles of sizes in the nanometre range that play a significant role 
in the regulation of ROS. C) An artificial peroxisome (AP) is based on the 
simultaneous encapsulation of a set of antioxidant enzymes in a polymer vesicle, 
with a membrane equipped with channel proteins. The APs serve for ROS 
detoxification inside cells. D) Schematic enzymatic cascade reaction occurring inside 
the AP and serving to detoxify superoxide radicals and related H2O2. Reprinted 
with permission from Ref. 78. Copyright 2013 American Chemical Society. 
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The aim is to combat reactive oxygen species (ROS) in cells (Fig.  30). 
Thus, designing efficient artificial peroxisomes (AP) (Fig.  30C) requires 
an understanding of their integration into cells and the influence of their 
properties on cellular interactions. Cell integration and preservation of 
function needs that toxicity, cell-uptake of the polymersomes, intracellular 
trafficking and translocation and functionality in intra-cellular conditions 
must be studied. 
2.4.1.  Integration of artificial peroxisomes in cells 
The first requirement of the compatibility to use artificial peroxisomes 
(APs) in living systems is to assess possible toxic effect to cells. The 
toxicity of APs was evaluated by a MTS assay in the HeLa cell line. APs 
exhibit minimal in vitro cytotoxicity in HeLa cells for a period of up to 48 
hours (Fig.  31A).  
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Fig.  31 A) Viability in HeLa cells after incubation with different concentrations of 
APs (MTS assay). Blue bars: incubation time 24 h, red bars: incubation time 48 h. 
B) CLSM images of HeLa cells incubated with APs containing SOD-AlexaFluor-488 
and LPO-AlexaFluor-633 for 24 h (Scale bar = 20 µm). C) CLSM images of HeLa 
cells incubated with APs containing SOD and LPO-AlexaFluor-633 for different 
incubation times. (Scale bar = 20 µm). D) Flow cytometry analysis of APs in HeLa 
cells for different incubation times (0-, 2-, 4-, 8-, 18-, 24 h). Reprinted with 
permission from Ref. 78. Copyright 2013 American Chemical Society. 
This is in agreement with the reported non-toxicity of PMOXA-PDMS-
PMOXA-based copolymers with different block lengths studied in other 
cell lines.57,62  
The first interaction of an AP with a cell is the interaction with the cell 
membrane, which determines a possible uptake in the following step. To 
this end, we studied the uptake behaviour into HeLa cells of AP co-
encapsulated with SOD-AlexaFluor-488 and LPO-AlexaFluor-633. By the 
use of a dual channel confocal fluorescence microscope, co-localisation 
of a fluorescence signal coming from SOD-AlexaFluor-488 and of a signal 
from LPO-AlexaFluor-633 showed that both enzymes were uptaken in 
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cells (Fig.  31B). This is the first time that two different types of enzymes 
capable of working in tandem in polymersomes are uptaken in cells. 
Although two different enzymes were loaded in polymer vesicles 
earlier by us and others,56,142 here we demonstrate for the first time the 
presence of nanoreactors containing both enzymes in cellular system. 
Further, we directly evidenced the effect of initial concentration dependent 
co-encapsulation efficiencies of SOD-LPO enzymes inside nanoreactors 
in intra-cellular conditions (Fig.  32). The concentration of SOD inside 
nanoreactors (number of enzymes) can be increased to only a certain 
extent, probably due to solubility. This effect was demonstrated by FCS 
measurements used to determine the number of SOD per vesicle as a 
function of SOD concentration (Fig.  17). However, we observed reduced 
SOD fluorescence intensity, due to the interaction of LPO AlexaFluor-633 
with the copolymer, which suppresses SOD encapsulation efficiency 
during the co-encapsulation process. FCS and FCCS experiments 
corroborated well with cellular uptake studies. 
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Fig.  32 Confocal image of HeLa cells incubated with SOD-LPO co-encapsulated in 
PMOXA12-PDMS55-PMOXA12 polymersomes prepared with different initial 
concentrations. a) Control cells b) initial concentration of SOD (0.25 mg/mL) and 
LPO (0.1 mg/mL) c) initial concentration of SOD (0.5 mg/mL) and LPO 
(0.2 mg/mL) d) initial concentration of SOD (0.25 mg/mL) and LPO (0.5 mg/mL). 
Reprinted with permission from Ref. 78. Copyright 2013 American Chemical 
Society. 
 
However, for detailed uptake kinetics experiments, we used APs only 
encapsulated with AlexaFluor-633 labelled LPO to simplify the 
measurements. Cellular uptake was increased with time from 2h to 18h 
indicating time dependent internalisation of APs (Fig.  31C). Fluorescence 
intensity varied from cell to cell, suggesting the number of internalised 
APs in individual cells is different due to non-specific interactions and 
miscellaneous level of direct contact to the cells at the close proximity.  
In general, cellular uptake is directly related to the concentration of 
nanoparticles. However, aggregation can dramatically influence the dose 
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of nanoparticle exposed to a cell, changing the exposed concentration 
compared to the initial bulk concentration.143 Aggregation behaviour will 
not only affect the concentration of APs exposed to a cell surface, but 
also change the properties of the APs by having some enzymes outside 
which may mislead to inaccurate activity assessments. To test this 
hypothesis, we studied the uptake kinetics of APs containing two different 
initial concentrations of LPO-AlexaFluor-633 (0.25 mg/mL and 
0.83 mg/mL). As we studied the effect of initial enzyme concentration on 
encapsulation efficiency and aggregation (FCS experiments), we carefully 
choose those two different initial concentrations. At low concentration 
(0.25 mg/mL), no aggregation is observed (Fig.  18A), while the higher 
concentrated system (0.83 mg/mL) allows to study aggregation behaviour 
that was characterised by FCS (Fig.  19A). The rate of uptake was 
quantified by using flow cytometry based on the mean cell fluorescence 
corresponding to overall cell population. APs containing LPO-AlexaFluor-
633 (0.25 mg/mL) showed minimal uptake of around 10% after 2 h. 
Uptake linearly increased over time and reached a plateau at 85% after 
18h: cells were saturated with the uptake of APs after 18h under the used 
experimental conditions. This saturation might be due to a depletion of 
APs for the uptake or saturation of the storage capacity of cells.144,145 APs 
containing LPO-AlexaFluor-633 at a concentration of 0.83 mg/mL forming 
aggregates as observed by TEM and FCS showed a dramatic change in 
the uptake reaching 60% after 2 h incubation time compared to APs 
containing LPO-AlexaFluor-633 (0.25 mg/mL). This indicates that 
aggregation can dramatically influence the dose of APs in cellular uptake 
as well as the internalisation kinetics. 
The uptake kinetics can also depend on the mechanism of the 
internalisation pathway.146 The effects of several membrane entry 
inhibitors on nanoreactor uptake were examined by first incubating the 
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HeLa cells for 1 h at 37 °C with chloropromazine (10 μg/mL) in order to 
inhibit the formation of clathrin vesicles, filipin III (1 μg/mL) to inhibit 
caveolae, or amiloride (50 μM) to inhibit macropinocytosis, and then 
treating the cells with nanoreactors (100 μg/mL) for an additional 24 h. 
Next, the cells were washed twice with PBS (pH 7.2) and analysed with 
flow cytometry.  
Nanoreactors are generally internalised by cells through various 
endocytotic pathways. Understanding the route of entry into cells for 
nanoreactors is important because it determines intracellular fate and 
therapeutic efficacy. Uptake kinetics can also depend on the mechanism 
of the internalisation pathway. Preliminary experiments to detect the 
mechanism of internalisation by using specific endocytosis pathway 
inhibitors were analysed in flow cytometry (Fig.  33). The quantified data 
suggest that at least two different pathways were involved in nanoreactor 
uptake; clathrin-mediated endocytosis and macropinocytosis. Cellular 
uptake of APs is dramatically hampered by amiloride, an inhibitor of 
macropinocytosis (70%). Thus, macropinocytosis is one of the dominant 
uptake pathways and is known for non-specific uptake; therefore, 
aggregation strongly affects cellular uptake kinetics based on the route of 
entry mechanism. Often more than one endocytotic pathway is involved in 
the uptake of polymeric nanoparticles and particularly so in the case of 
non-specific uptake.147  
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Fig.  33 Flow cytometry analysis of LPO encapsulated in PMOXA12-PDMS55-
PMOXA12 vesicles in HeLa cells with different endocytotic pathway inhibitors (red: 
non-treated cells, green: cells treated with nanoreactors without inhibitors yellow: 
cells treated in advance with nanoreactors and with chlorpromazine, blue: cells 
treated in advance with nanoreactors and with dimethyl amiloride, light blue: cells 
treated in advance with nanoreactors and with filipin III). Reprinted with 
permission from Ref. 78. Copyright 2013 American Chemical Society. 
 
When nanoreactors serve as APs inside cells, endosomal escape is a 
critical requirement. To evaluate whether APs escape endosomes or are 
trafficked for degradation, we used an endo-lysosome marker, pH-rodo, 
and visualised cells by confocal laser-scanning microscopy (CLSM). The 
majority of APs were located in intracellular regions, particularly in the 
peri-nuclear region, and only few were stayed in endo-lysosome 
compartments (Fig.  34A). Based on the fluorescent signals from the peri-
nuclear region, it can be concluded that APs escaped from endosomes. 
Co-localisation signals of endo-lysosome compartments and APs imply 
that APs were transported through endocytosis. By visualisation of the 
intracellular localisation of APs with TEM, further insight into endosomal 
escape was gained. TEM micrography proved the presence of structurally 
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intact APs in peri-nuclear regions, with only a few collapsed APs (Fig.  
34B). In endosome-like compartments, the APs were present in clearly 
reduced number (Fig.  34C). Intact APs escaped from endosomes and 
were allocated in the cytoplasm, which is in agreement with the CLSM co-
localisation studies. Escape from endosomes by PMOXA-PDMS-PMOXA 
vesicles has already been reported in THP-1 cells.62  
 
Fig.  34 A) CLSM image of HeLa cells incubated for 24 h with APs (blue: nucleus 
stained with Hoechst, green: endosome/lysosome stained with pH-rodo, red: 
artificial peroxisomes) (Scale bar = 5 µm).  B) TEM images of the peri-nuclear 
region of HeLa cells incubated with APs for 12 h (Scale bar = 200 nm). C) TEM 
images of endosome-like compartments in HeLa cells incubated with APs for 12 h 
(Scale bar = 200 nm). D) Protective effect of APs against paraquat by flow 
cytometry analysis: viability of untreated cells considered as 100%, (cells), viability 
of cells after treatment with paraquat (PQ) and viability of cells pre-treated with 
APs for 24 h, and sequentially treated with paraquat for a further 24 h (PQ-APs). E) 
Real time ROS detoxification kinetics of APs in: a) cells treated with pyocyanin, and 
b) cells pre-treated with APs (8 h) followed by treatment with pyocyanin. Reprinted 
with permission from Ref. 78. Copyright 2013 American Chemical Society. 
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 It is noteworthy that similar block copolymer was studied for polymer-
lipid interactions to understand interfacial effects of the tri-block 
copolymer with cell membrane. It has been demonstrated that smaller 
amounts of the tri-block copolymer system was sufficient to force the lipid 
membranes to phase separate and form domains.140 Additionally we have 
shown in earlier studies that similar tri-block copolymer based 
polymersomes escape the endosomes in THP-1 cells.62 Therefore, it is 
clear that APs escape the endosomes possibly due to the ability to force 
the endosomal membrane to phase separate thereby causing endosomal 
escape.  
To assess the APs antioxidant functionality, oxidative injury was 
induced by paraquat in HeLa cells, known to induce toxicity involving 
production of ROS.148 Since ROS serve as important intracellular 
signalling molecules that affect cell viability, this viability in turn is 
modulated by the intracellular production of ROS. The viability of the cells 
was quantified by staining them with propodium iodide (PI), a fluorescent 
and intercalating agent, and subsequent analysis using flow cytometry. 
Cells pre-treated with APs provided an around 26% protective effect 
against the oxidative stress caused by paraquat, although the number of 
enzymes inside APs was low (Fig.  34D). Indeed, the efficient cascade 
reaction inside the APs explains that the increased viability corresponds 
to protective effect exclusively by APs. In order to determine the 
involvement of APs in the ROS detoxification directly in cells, it is 
important to be able to monitor ROS generation in intact, living cells. Such 
detection is difficult due to the low concentration and high reactivity of 
ROS. The short half-life of the ROS requires an immediate and real time 
monitoring in the live cells. Live cell analysis of ROS detoxification 
kinetics of APs was monitored in real time using highly sensitive ROS 
fluorescent probes. We optimised the concentration of pyocyanin to 
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stimulate the ROS in cells without causing cell death and cell suspension 
over a period of 30 min, which shows continuous production of ROS.  
Stimulated cells treated with APs detoxified the ROS under oxidative 
stress in live cells (Fig.  34E). As expected, cell populations demonstrate 
significant heterogeneity in rate of ROS generations upon stimulation to 
pyocyanin. Thus, individual cells within a population may exhibit different 
kinetics of ROS production as well as different detoxification kinetics. 
2.5.  Conclusion 
We engineered artificial peroxisomes by the combination of natural 
occurring antioxidant enzymes with synthetic block copolymers, which 
form polymersomes, aiding the cellular antioxidant defence mechanism in 
case of oxidative stress. Similar to nature, these APs contain SOD and 
LPO or CAT, which detoxifies superoxide radicals in situ via hydrogen 
peroxide to the harmless products water and molecular oxygen. The 
generation of functional nanoreactors, which are able to be cell uptaken 
and function as an artificial organelle, represent a milestone in the 
development of in vivo cell implants and will open new frontiers in medical 
therapy. The main advantage over previous attempts to reduce reactive 
oxygen species is that the APs are not limited for example in uncontrolled 
release of enzymes. They carry out the function of a cell organelle 
permanently. The polymersome properties were optimised by means of 
high encapsulation efficiency to allow an enhanced cascade reaction and 
to mimic the morphology and function of a natural peroxisome. Enzymatic 
activity over time is preserved even longer than in solution, making this 
hybrid system not only suitable for therapeutic applications but also for 
technical applications such as biosensors. For the therapy of oxidative 
stress, we were able to show that the APs escaped in intact form from 
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endo-lysosomes and were distributed within the cytoplasm, important for 
proper functioning. In addition, viability measurements revealed that the 
APs were non-toxic. Concluding the high efficacy of the APs in cells in 
detoxification of superoxide radicals, the APs are a significant innovation 
in the treatment of cellular ROS and the repair of disturbed cell functions. 
This is of particular importance, because disturbed cell functions are 
mainly responsible in the development of disease such as Parkinson`s 
disease, arterial sclerosis, cancer and many more.  
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3.  Design of pH-triggered nanoreactors 
The design of pH-triggered nanoreactors is based on the 
encapsulation of environment-sensitive molecules in polymersomes and 
their remote control via specific and functional ion-channels incorporated 
in the polymersome membrane. Feasibility of this concept was proven 
using lipid vesicles encapsulating pyranine (a pH dependent fluorescent 
molecule) and a channel was formed in the lipid membrane with the ion-
channel forming molecule gramicidin A.149 Because lipid vesicles are very 
fragile and short-lived, the further goal was to use polymersomes in order 
to design stable and pH-triggerable nanoreactors. 
 
Fig.  35 Procedure to prove functional gramicidin channel formation: a) Pyranine 
encapsulated vesicles show high fluorescence at pH = 8.3. b) Upon lowering the pH 
of the vesicle solution to pH = 5, the fluorescence of non-encapsulated pyranine 
drops immediately. c) Upon addition of gramicidin, functional channel formation 
lead to a permeabilisation of the vesicles and d) thus to a reduction of fluorescence 
of the encapsulated pyranine. e) and f) Pyranine encapsulated vesicles preserve their 
fluorescence activity, when no gramicidin was added. 
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3.1.  Motivation and concept 
Specific functions under biological conditions of polymersomes can be 
induced by external trigger factors, such as pH, light or temperature. This 
is especially useful for therapeutic applications when unwanted side 
reactions need to be avoided. A possible strategy to develop responsive 
nanoreactors is by combining specific pores, such as gramicidin in the 
membrane of polymersomes. Gramicidin incorporation in liposomes was 
already reported.150 The proof of functionality of gramicidin in the 
membrane was realised by encapsulating a pH-sensitive dye, pyranine, in 
the aqueous cavity of liposomes. Upon lowering the pH of the liposome 
solution, the quenching of pyranine molecules was directly monitored. In 
this case, due to the protective character of the vesicles, encapsulated 
pyranine molecules were not quenched and still yielded high fluorescence 
intensity. In the next step, upon addition of the gramicidin ion-channels to 
the vesicle solution, the pore forming capabilities were proven by direct 
observation of the quenching of the dye encapsulated in the vesicles. The 
conceptual steps of functional gramicidin incorporation are illustrated in 
Fig.  35. After the successful realisation of this technique with liposomes, 
the same preparation procedure and execution of the experiments were 
performed using polymersomes. 
3.2.  Evidence of functional ion-channel incorporation in liposomes 
Gramicidin appears in different conformations when dissolved in 
different solvents151 and not every solvent provides functional pore 
formation. First a suitable solvent had to be identified, which allows ideal 
pore formation and would not destroy the vesicles. The different solvents 
for gramicidin, dimethyl sulphoxide (DMSO), trifluoroethanol (TFE), 
dioxane, pyridine, isoporpanol, decane and the mixtures DMSO:ethanol 
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(DMSO:EtOH) in the ratio 1:1 and the mixture TFE:DMSO:EtOH (2:1:1) 
were first tested on lipid pyranine-encapsulated vesicles. Fluorescence 
spectroscopy results for liposomes were shown in Fig.  36. 
 
Fig.  36 Fluorescence spectrometry: Time driven fluorescence measurement of the 
fluorescence emission of pyranine encapsulated in lipid vesicles after lowering pH 
from 8.3 to 5 (each measurement around time point of 75 s) and subsequent addition 
of gramicidin (in different solvents) after around 160 s. 
 
As expected (due to the pH dependent fluorescence intensity of 
pyranine), a decrease in fluorescence intensity occurred after adding HCl 
solution. Subsequently, gramicidin in different solvents was added. A 
further decrease of fluorescence intensity in liposomes was only 
observed, when gramicidin dissolved in DMSO, TFE, pyridine, decane, 
DMSO:EtOH (1:1), or isopropanol was added after around 160 s to the 
liposome solution, shown in Fig.  36. This indicates that functional ion-
channels were reconstituted in the membrane of the liposomes. In 
addition, these used solvents were not able per se to 
permeabilise/weaken the liposome membranes, because no change of 
signal intensity was observed after the treatment with the solvent. 
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3.3.  Evidence of functional ion-channel incorporation in polymersomes 
The solvents that allowed gramicidin to build a functional pore into the 
liposome membrane were then tested with pyranine encapsulated 
PMOXA14-PDMS65 polymersomes. 
 
Fig.  37 Fluorescence spectrometry: Time driven fluorescence measurement of the 
fluorescence emission of pyranine encapsulated in PMOXA14-PDMS65  vesicles after 
lowering pH from 8.3 to 5 (after 65 s) and subsequent addition of gramicidin (in 
TFE:DMSO:EtOH (2:1:1)) after 110s. Addition of gramicidin (red); addition of 
solvent (TFE:DMSO:EtOH (2:1:1)) (black). 
  
HCl was added after 50 s to 80 s and the solvents (with and without 
gramicidin) were added after 110 s to 130 s. Only gramicidin dissolved in 
TFE:DMSO:EtOH (2:1:1) added to the vesicles lead to a reduction of 
fluorescence intensity, without destroying/destabilising the membrane by 
the solvent alone (Fig.  37). Note that we observed a permeabilisation of 
the membrane, when solely TFE was used. Interestingly, this behaviour 
was not observed when liposomes were used. 
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In order to prove structural integrity of the polymersomes after different 
steps, preliminary TEM measurements and light scattering experiments 
were performed before, after lowering pH and after addition of the 
gramicidin dissolved in TFE:DMSO:EtOH (2:1:1). In the first step, TEM 
micrographs showed the formation of pyranine-encapsulated 
polymersomes in pH 8.3 (Fig.  38A). After lowering the pH of the 
polymersome solution from 8.3 to 5, TEM micrography revealed structural 
defect vesicles (Fig.  38B). 
P. Tanner 
 
76 
 
Fig.  38 TEM micrographs of A) AB polymersomes containing pyranine. pH inside 
and outside of polymersomes = 8.3; B) AB polymersomes containing pyranine. 
Image was taken after pH of the solution was reduced to pH = 5; C) AB 
polymersomes containing pyranine. Image was taken after pH was reduced to pH = 
5 and subsequent addition of gramicidin. 
Engineering artificial organelles  
 
77 
 
Considering that the fluorescence intensity during fluorometric 
experiments did not vanish completely when the pH was lowered, the 
TEM results suggest that a high proton pressure induced a polymersome 
collapse during harsh TEM sample preparation. This explanation is 
further supported by TEM micrographs showing intact polymersomes 
(Fig.  38C), when the pH of the polymersome solution was decreased, 
while gramicidin was incorporated into the polymersome membrane. 
Under these conditions, the high proton gradient induced by the pH 
change is immediately equalized inside the polymersomes by functional 
pore formation. 
In addition, gramicidin incorporation also shows no membrane 
destabilisation effects. These results further underline preliminary light 
scattering experiments (Fig.  39A - C), where the hydrodynamic radii did 
not change between the different steps of the experimental procedure; i. 
e. A) non-treated polymersomes, B) measurement after lowering pH, C) 
measurement after lowering pH and subsequent addition of gramicidin. In 
this last step, an additional small peak in the size range of 10 nm 
appeared, which can be contributed to the formation of micelles induced 
by the solvent of gramicidin. 
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Fig.  39 Preliminary dynamic light scattering experiments of A) AB polymersomes 
containing pyranine. pH inside and outside of polymersomes = 8.3; B) AB 
polymersomes containing pyranine after the pH of the solution was reduced to pH = 
5; C) AB polymersomes containing pyranine after the pH was reduced to pH = 5 
and subsequent addition of gramicidin. 
 
3.3.1.  Ion-channel formation (H
+
 kinetics) as a function of gramicidin 
concentration in polymersome membranes 
Different gramicidin concentrations were used to study H+ influx rate 
as a function of gramicidin concentration in the membrane of 
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polymersomes. Already at a gramicidin concentration of 65 nM (Fig.  40, 
red line), H+ influx can be observed, showing that already a low number of 
gramicidin is sufficient for proton trafficking. This is in agreement with the 
high monovalent cation conductance of gramicidin.151 A two-fold increase 
of the gramicidin concentration to 130 nM showed no significant increase 
in the H+ influx rate (Fig.  40, blue line), while at a gramicidin 
concentration of 32 nM no pore formation was detected (Fig.  40, black 
line). 
 
Fig.  40 Fluorescence spectrometry: Time driven fluorescence measurement of the 
fluorescence emission of pyranine encapsulated in PMOXA14-PDMS65  
polymersomes after lowering pH from 8.3 to 5 (after 125 s) and subsequent addition 
of gramicidin (after 300 s) (in TFE:DMSO:EtOH (2:1:1)) at different  gramicidin 
concentrations (dark line: 32 nM; red line: 65 nM; blue line: 130 nM). 
3.4.  pH-triggered nanoreactors 
Gramicidin incorporation in PMOXA14-PDMS65 polymersomes forms 
the basis to engineer pH-triggered nanoreactors, which are composed of 
a model pH-sensitive enzyme, acid phosphatase. In order to visualise 
enzymatic activity, a suitable substrate need to be co-encapsulated with 
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the enzyme. Here the enzyme substrate ELF97 was used, which is 
converted into a fluorescent product, upon activation of the enzyme (Fig.  
41). 
 
Fig.  41 Schematic view of acid phosphatase and ELF97 co-encapsulated vesicles. 
Upon lowering pH to around pH = 5 and subsequent addition of gramicidin in order 
to permeabilise the vesicle membrane, the resulting pH condition inside the vesicle 
activates acid phosphatase, which produces a fluorescent product from the ELF97 
substrate. 
 
In order to prove the concept, acid phosphatase together with ELF97 
was co-encapsulated in liposomes. Inside the liposomes, activation of 
acid phosphatase by a change of pH to either pH 6 (Fig.  42 blue line) or 
pH 5 (Fig.  42 dark line) led to the formation of fluorescent ELF97 product, 
when gramicidin formed ion-channels in the vesicle membrane. Under 
these conditions, the successful lowering of the pH in the vesicles allowed 
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to activate the enzyme. In contrast, no fluorescent product was formed in 
absence of gramicidin (Fig.  42 red line). 
 
Fig.  42 Time dependent fluorescence emission of ELF97 product encapsulated in 
acid phosphatase co-encapsulated liposomes: black line) Adjusting pH to around 6 
and subsequent addition of gramicidin led to the formation of the fluorescent 
ELF97 product; red line) Adjusting pH to around 6 in absence of gramicidin did not 
induce product formation; blue line) Adjusting the pH to 5 and subsequent addition 
of gramicidin led to an increased formation of the fluorescent ELF97 product. 
 
When the same reaction was performed using vesicles made from 
PMOXA14-PDMS65 copolymer, no increase of fluorescence was observed. 
Thus, we were not able to generated pH-sensitive polymer nanoreactors. 
The reason for this result might be that a low encapsulation efficiency of 
the enzyme does not allow for simultaneous co-encapsulation of the 
substrate, necessary to detect the enzymatic functionality. To solve this 
problem, further optimisation of the individual encapsulation of the 
enzyme and substrate is needed in order to allow co-encapsulation. 
Another possibility could be the switch to a new enzyme/substrate 
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system, which is distinguished with improved properties such as 
increased encapsulation behaviour and assay sensitivity. 
3.5.  Conclusion 
The diblock copolymer used here formed vesicles in the diameter of 
approximately 200 nanometres and was able to encapsulate a pH 
sensitive dye, pyranine. This was used in order to prove the incorporation 
of gramicidin in the membrane of polymersomes. This achievement is an 
important step towards the design of pH-triggerable nanoreactor, in order 
to activate or deactivate the nanoreactor activity upon request via specific 
ion-channels. Up to now, encapsulation of a pH sensitive enzyme, acid 
phosphatase, together with its substrate is only possible in case of 
liposomes generating only a low detection signal. In case of 
polymersomes, no signal could be generated, indicating no simultaneous 
co-encapsulation of the enzyme and its substrate. Further investigation to 
improve encapsulation efficiency of the enzyme and the substrate to 
achieve pH-sensitive nanoreactor are on-going. It is also considered to 
exchange the enzymatic system in order to improve the system’s 
performance and thus to engineer functional pH-switchable nanoreactors. 
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4.  Metal-functionalised polymersomes for molecular recognition 
The specificity exhibited by molecular recognition assemblies is based 
on a perfect structural match between biological entities, which results in 
minimisation of energy, allowing the energy barrier to be by-passed and 
to fulfil a biological role. The fact that molecular recognition is based on 
highly selective moieties, their application is discussed in industrial and 
medical context, such as the purification102,103 and immobilisation21,23,104,105 
of biomolecules, labelling of proteins,106,107 2D-crystallisation23,104 and 
biosensing.152,153 Molecular recognition also plays an important role in the 
development of nanocarriers for drug/protein delivery or nanoreactors due 
to the potential decrease of dosages and improved localisation in a 
desired biological compartment. In this respect, these carriers need to be 
functionalised with a specific affinity tag to enable molecular recognition. 
4.1.  Motivation and concept 
In a molecular recognition process, solvent molecules are specifically 
replaced by ligands. During this process, a change of geometry can occur 
at the binding site, which allows specific recognition. Even though the 
principle is widely applied in technology, the change of geometry and the 
exact mechanism are in many cases poorly understood. 
Here, we characterise in detail the conformation change of the 
coordination sphere of CuII-trisNTA centres, which were used to 
functionalise poly(butadiene)-b-poly(ethylene oxide) (PB-b-PEO) diblock 
copolymers. These metal-functionalised block-copolymers are able to 
form polymersomes in aqueous solution with metal centres exposed at 
the inner and outer surface (Fig.  43A), while only the outer exposed 
metal centres were used for binding studies. We used trisNTA (Fig.  43E) 
for functionalisation, because its binding affinity is higher than NTA (Fig.  
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43C). His6-tags with optional labelling can be used to bind to these 
molecular architectures (Fig.  43D).  The use of His6-tags is regarded to 
be a simplified model of His6-proteins, which were used to bind to metal 
sites of the polymersomes` surface. This simplification of using short His6-
tags allows better understanding of the docking mechanism, which is 
essential for biological, technical and medical applications. Compared to 
Ni2+ ions, which are used in many NTA-based systems that have an 
octahedral coordination sphere, different coordination geometries exists 
for Cu(II).154 The different arrangements of Cu(II) are induced by its 
stereochemistry and allows us to use copper as the metal-coordination for 
His6-tags and to gain a deep insight into the rearrangement of the metal 
centre upon binding of a tagged molecule. 
The high affinity of different His-tagged proteins to metal-NTA 
functionalised liposomes and PB-b-PEO diblock copolymer 
polymersomes is widely known.21,23,104 Because the dissociation constant 
of His-tagged proteins is more or less independent of the surface where 
the metal centre is bound, the local environment of the metal is crucial 
during the binding process. 
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Fig.  43 A) Schematic representation of Cu
II
-functionalised PB-b-PEO vesicles. The 
metal centres available for binding are located on the outer vesicle surface that can 
be recognised by fluorescently labelled His6-tags; B) Detailed view of A); C) 
Schematic formula of Cu
II
-NTA complex and D) fluorescently labelled 
(sulphorhodamine B-His6-tags; E) Cu
II
-trisNTA. X represents solvent molecules or 
external binding atoms of other molecules. The red star represents 
sulphorhodamine B. Reprinted with permission from Ref. 55. Copyright 2012 
American Chemical Society. 
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4.2.  Formation of Cu(II)-trisNTA functionalised polymersomes 
Using the diblock copolymer PB39-PEO36-SA-OH-containing 10% PB39-
PEO36-SA-trisNTA.d-Cu
2+ and applying the film rehydration method led to 
the self-assembly of polymersomes. In order to reduce the polydispersity 
of polymersome sizes, ranging from giant vesicles to nanovesicles, the 
sample solutions were extruded through a 1 µm, 400 nm and 200 nm 
pore-sized filter membrane in descending order. The use of copper 
instead of nickel has the advantage of studying the copper 
stereochemistry and to determine the final structural changes in the 
metal-coordination environment by EPR while a high binding affinity is 
provided by Cu(II). 
 
Fig.  44 A) Dynamic light scattering representation. Data extrapolated to zero 
concentration and zero angle of vesicles made from 10% Cu
II
-functionalised PB39-
PEO36 block copolymer; B) Guinier plot representation of static light scattering 
data of vesicles made from 10% Cu
II
-functionalised PB39-PEO36 block copolymer. 
The data is extrapolated to zero concentration and zero angle. Reprinted with 
permission from Ref. 55. Copyright 2012 American Chemical Society. 
 
Dynamic light scattering155 was used to characterise the polymersome 
hydrodynamic radius to a value of Rh = 107 ± 12 nm (Fig.  44A), 
comparable to NiII-functionalised trisNTA-PB-b-PEO vesicles.23 Static light 
scattering experiments (Fig.  44B) allow to calculate the radius of gyration 
(RG) and the ratio of RG/Rh was determined subsequently as 0.96, which 
indicates a  hollow-sphere morphology.155  
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As expected, size and morphology of the polymersomes were not 
affected by using similar copper concentration compared to nickel inside 
the NTA moieties.23 This also indicates that the metal ions are complexed 
in the NTA pockets of the trisNTA and do not affect the polymer 
membrane. Further, static light scattering characterisation provided the 
weight average molecular weight of a vesicle (Mw) to be 8 x 10
7 ± 3 x 106 
gmol-1 and the second virial coefficient A2 to be close to zero, ruling out 
any long-range interactions between the vesicles in the investigated 
concentration range. In addition, the polymersomes preserved their size 
and shape over several months at room temperature. 
Another characteristic of polymersome formation is the aggregation 
number, which is obtained by dividing the weight average molecular 
weight of a vesicle by the weight average molecular weight of the diblock 
copolymer. The value calculated for this system is 20,000, which is typical 
for nanometre-sized polymersomes.24  
This aggregation number can be used to qualitatively analyse the 
number of functional metal ions on the outer polymersome surface. There 
is a 50% probability that the used Cu-trisNTA-functionalised diblock 
copolymers protrude at the outer surface. Further, it has to be considered 
that only 10% of polymers used were functionalised, which, in addition, 
decreases the percentage of active available functional groups. 
Therefore, based on the assumption that only 10% of block copolymers 
was rehydrated during the film hydration process, we estimated that a 
polymersome contains approximately 300 metal ions, which corresponds 
to 20 copper ions per 100 nm2 of polymersome surface (nanometre-sized 
polymersomes). 
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4.3.  His6-tags binding to Cu
II
-trisNTA polymersomes 
When His6-tags bound to the nanometre-sized Cu
II-trisNTA 
polymersomes, no change in morphology or structure was observed, 
demonstrating the high stability after the recognition process (Fig.  45). 
Also, no aggregate formation was induced upon binding of the tag-
molecules, which could affect cellular-uptake behaviour for potential 
therapeutic applications. This was shown by TEM micrographs of 10% 
copper-functionalised polymersomes, before and after the addition of 
His6-tags (Fig.  45A and B). In both cases, the size of the polymersomes 
is consistent with the values measured with light scattering. Contrast 
differences in the TEM micrographs of non-bound Cu-trisNTA-
functionalised polymersomes compared to the same polymersomes with 
attached His6-tags are likely due to different capillary effects.  
 
Fig.  45 TEM micrograph of 10% copper-functionalised polymersomes. A) Cu
II
-
trisNTA-functionalised PB-b-PEO polymersomes; B) His6-tag bound to Cu
II
-
trisNTA-functionalised PB-b-PEO polymersomes. Reprinted with permission from 
Ref. 55. Copyright 2012 American Chemical Society. 
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To visualise His-tag binding with confocal laser-scanning microscopy, 
we generated giant CuII-trisNTA-functionalised PB-b-PEO polymersomes 
and incubated them with fluorescently labelled-His6-tags (s-His6-tags). To 
reduce the background fluorescence intensity of the images, non-bound 
peptide (in a small amount) was removed by dialysis. In the laser-
scanning micrographs, polymersomes specifically bound with s-His6-tags 
appear as bright fluorescent coronas (Fig.  46A). Because the PB-b-PEO 
polymersome membrane is highly impermeable to small molecules, the 
fluorescent s-His6-tags were not able to penetrate the membrane. The 
hollow vesicular structure of the peptide bound polymersomes could be 
clearly rendered by the composition of fluorescent z-stack images taken 
in different layers of the sample (Fig.  46B). 
 
Fig.  46 Confocal fluorescence microscopy image of fluorescently labelled His6-tags 
bound to the outer surface of PB39-PEO36-SA-/ 10%-PB39-PEO36-SA-trisNTA.d-Cu
2+
 
(800 µM) vesicles incubated with s-His6-tags in bidistilled water. A) Two-
dimensional cut, focused on the mid-plane of the selected vesicles; B) three-
dimensional image produced by merging two-dimensional layers measured at 
different heights. Reprinted with permission from Ref. 55. Copyright 2012 
American Chemical Society. 
 
Fluorescence correlation spectroscopy (FCS) is widely used to 
investigate molecular interactions of fluorescent molecules, such as green 
fluorescent protein interaction to an antibody.156 Here, this technique is 
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used to study the binding of fluorescently labelled His6-tags to nanometre-
sized polymersomes, based on the change of diffusion times, which is 
different from small molecules (for example fluorescently labelled His6-
tags) compared to big entities, for example nanovesicles. CuII-
functionalised polymersomes (at a concentration of 8 µM) incubated with 
s-His6-tags (initial concentration of 50 nM) showed two populations. A 
small portion (< 5%) of a population with a diffusion time of 56 µs 
represents free peptides still present in solution. The other population, to 
a portion of more than 95%, has a characteristic diffusion time of 7.5 ms, 
which can be attributed to s-His6-tags bound to vesicles (Fig.  47A). 
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Fig.  47 A) FCS autocorrelation curves and the simulation of a) sulphorhodamine B 
acid chloride labelled His6-tags; b) sulphorhodamine B acid chloride labelled His6-
tags bound to vesicles; B) Fraction of bound s-His6-tags as a function of the Cu
II
 
content of PB39-PEO36-SA-OH/ 10%PB39-PEO36-SA-trisNTA-Cu
2+
 vesicles 
generated in bidistilled water. (Initial concentration of His6-tag: 50 nM, and initial 
concentration of Cu-trisNTA functionalised vesicles: 8 µM). Reprinted with 
permission from Ref. 55. Copyright 2012 American Chemical Society. 
 Similar experiments of His6-red fluorescent protein to Ni
II-
functionalised PB-b-PEO polymersomes exhibited a similar binding 
behaviour, proving that our His6-tag model system can be used to check 
binding properties of much larger His-tagged proteins. The small size of 
the model peptides should also cause less interference with the vesicle 
surface, which in turn allows faster and stronger binding behaviour. 
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FCS results are in agreement with the observations from confocal 
microscopy, where the majority of s-His6-tags are bound to the metal-
functionalised polymersomes (Fig.  47A and B). From the diffusion time 
obtained by FCS, the hydrodynamic radius Rh can be determined via the 
Stokes-Einstein equation to be 90 nm − comparable to both values 
obtained from light scattering and TEM. 
The dissociation constant of s-His6-tags bound to Cu
2+-functionalised 
polymersomes was determined by a titration of the s-His6-tags (50 nM) 
with increasing amounts of polymersomes (Fig.  47B). The Cu2+ of the 
vesicle was varied from 2 to 8 M. The corresponding curve was fitted by 
a Langmuir isotherm21,157 (equation 7) and the binding constant was 
determined. 
  
   
   
     
   (7) 
 
F corresponds to the corrected fraction of His6-tags-bound vesicles 
and P is the metal concentration of the related samples. K stands for the 
binding constant. A dissociation constant KD of s-His6-tags was calculated 
to a value of 0.6 ± 0.2 µM. In comparison to other KD of similar systems 
shown in Table 1, this value is lower, which stands for increased binding. 
 
Table 1 Different KD-values in polymersomes and liposomes using different His-
tagged ligands. 
Vesicle system Ligand 
KD [µM] (FCS-
based) 
Ref. 
PB60-b-PEO34-SA/PB60-b-PEO34-SA-NTA.d-Ni
2+ His6-EGFP 12.0 ± 0.8 
21 
PB39-b-PEO36-SA/PB39-b-PEO36-SA-trisNTA.d-Ni
2+ His6-RFP 2.0 ± 0.4 
23 
PB39-b-PEO36-SA/PB39-b-PEO36-SA-trisNTA.d-Ni
2+ 
His10-MBP-
FITC 
7.0 ± 1.2 21 
PB39-b-PEO36-SA/PB39-b-PEO36-SA-trisNTA.d-Ni
2+ His6-EGFP 12.3 ± 1.2 
21 
Ni2+-NTA-NBD-lipid His6-peptide 4.3 ± 0.8 
157 
PB39-b-PEO36-SA/PB39-b-PEO36-SA-trisNTA.d-Cu
2+ His6-tag 0.6 ± 0.2 
this work 
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In Table 1, nickel-functionalised vesicles were used for protein binding 
for comparison with our copper-functionalised systems. It was shown by 
molecular dynamics simulations that NiII and CuII have a similar affinity 
towards a His6-tag.
120 Nevertheless it was shown that copper binds His-
tags more strongly than nickel, providing a high binding capacity, but a 
poorer specificity. 
Comparing the His6-tags binding of our copper-functionalised 
polymersomes with His6-RFP binding to PB39-PEO36-trisNTA.d-Ni
2+ 
vesicles, a much greater binding affinity can be stated. We assume that in 
addition to the different binding affinity as explained before, the small 
peptide molecules interfere less with the flexible PEO chains at the 
polymersome surface, so that improved binding conditions were provided. 
Polymersomes containing no metal-functionalised block copolymers 
showed less than 3% His6-tag binding measured under the same 
conditions. This low unspecific binding of the His6-tag is in agreement with 
the protein repellent character of PEO chains at the vesicle surface.22 
Also non-functionalised vesicles did not bound s-His-tags after addition of 
Cu(OTf)2, clearly defining that copper complexed in the NTA pocket is the 
recognition point of His-tag proteins.  
FCS can be also used to quantify the number of bound s-His6-tag per 
polymersome by performing brightness measurements. The molecular 
brightness of peptide-bound polymersomes recorded as counts per 
molecule (CPM) must be divided by the CPM of freely diffusing s-His6-
tags, taking the fluorescence quantum yield into account. This calculation 
resulted on average in 210 ± 36 molecules per polymersome. Compared 
to the value of reported His6-RFP binding to vesicles, s-His6-tags bound 
an order of magnitude higher to the polymersomes of similar nature. 
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When the small size of the used labelled His6-tags compared to the size 
of a fluorescent protein is considered, we can hypothesise that more 
metal-trisNTA moieties can be more easily occupied with small peptides, 
which explains the small KD value (Fig.  43A and B). Furthermore, the 
calculated number of His6-tags per polymersomes is in agreement with 
the available metal ions/polymersomes calculated from the aggregation 
number determined by light scattering. 
4.4.  Structure of the coordination sphere of Cu
II
 in His6-tag-Cu
II
-trisNTA 
polymersomes in comparison to model systems 
In order to gain more insight inside the coordination sphere of Cu(II) 
before and after the binding process of the His-tag molecules, electron 
paramagnetic resonance spectroscopy (EPR) was applied. EPR can be 
used to characterise structural information of paramagnetic species, e. g. 
transition metals or radicals.  The observed X-band CW-EPR spectrum of 
polymersomes (Fig.  48a) produces only a broad signal with a low 
intensity, which can be ascribed to a high local copper concentration 
coming from the high number of metal ions per polymersome as 
calculated from light scattering data. In this case, the resulting strong 
dipolar interactions of the CuII centres are potentially responsible of 
broadening of the EPR spectrum to the detection limit. On the other hand, 
EPR measurements of CuII-functionalised PB39-PEO36-SA-trisNTA.d.
21 
provided clear spectra. The CW-EPR spectrum of the functionalised 
polymersomes (Fig.  48a) is different from the simulated spectrum, where 
the reported EPR parameters of the latter building blocks were used for 
the polymersomes (Fig.  48b). Because the spectrum in polymersomes 
(Fig.  48a) exhibits spectral features, which were characteristic of strong 
dipolar interactions between CuII sites, it cannot be simulated using a 
single species. 
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Fig.  48 (a) X-band CW-EPR spectrum of a frozen solution of Cu
II
-trisNTA 
functionalised vesicles in bidistilled water taken at 100 K. (b) Simulation of the CW-
EPR spectrum of the PB39-PEO36-SA-trisNTA.d using the parameters reported in 
Ref. 
20
. (c) Experimental X-band CW-EPR spectrum of a frozen solution of Cu
II
-
trisNTA functionalised vesicles incubated with the His6-peptide in a 1:50 ratio taken 
at 10 K. (d) Simulation of (c) using the parameters in Table 1. (e) and (f) individual 
contributions to the simulation (d). All presented spectra are normalised for clarity. 
The spectral intensity of (a) is more than a factor 10 lower than that of (c). 
Reprinted with permission from Ref. 55. Copyright 2012 American Chemical 
Society. 
 
When we incubated the polymersomes with His6-RFP, His6-EGFP or 
with His6-tags, only the addition of His6-tags, at an initial concentration of 
2 mM, led to a change in the EPR spectra compared to the non-bound 
condition, observable in an increased CW-EPR signal. This behaviour is 
caused by the lower concentration of His6-proteins used, which is limited 
by their commercial availability and the function of the peptide to act as a 
spacer between the different CuII sites. In Fig.  48c, the X-band CW-EPR 
spectrum together with its simulation (Fig.  48d) of His6-peptide incubated 
polymersomes is shown. Two contributions can be discerned (EPR 
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parameters are given in Table 2), although the signal is poorly resolved. 
The EPR parameters are typical of type II copper centres.158 The 
vesicle:His6 system is in agreement with the situation where Cu
II is 
equatorially ligated either to four oxygen atoms (4O) or to one nitrogen 
and three oxygen atoms (1N3O) as the first EPR parameters. The second 
types imply that either two nitrogen atoms and two oxygen atoms (2N2O), 
three nitrogen atoms and one oxygen atom (3N1O), or four nitrogen 
atoms (4N) are coordinated with CuII, whereas the last set supports 
histidine binding. In this case, high values for the z-component of the 
copper hyperfine have been reported.159-163 The third contribution caused 
by the copper sites located on the inner vesicle surface will be present at 
considerably lower intensity, which is in agreement with the spectrum in 
Fig.  48a. 
Different model systems have been studied to interpret the above 
findings: a) a mixture of Cu-triflate (Cu(OTf)2) with NTA, b) a mixture of 
Cu(OTf)2 with His6-peptide and c) a mixture of Cu(OTf)2 with His6-tags 
and NTA. The obtained EPR parameters are presented in Table 2. It is 
evident that the His6-tags cannot bind to free Cu
II ions under the given 
conditions. This possibility was excluded by the fact that the spectral 
changes did not occur (Fig.  48), when peptide was added to non-
functionalised vesicles containing free CuII ions in the solution. Moreover, 
EPR experiments made with different mixtures of Cu(OTf)2, NTA and the 
His6-peptide showed that both NTA and the peptide ligate to the Cu(II) 
ion. Also, it became obvious that more CuII centres are linked with 
increasing His6-tag concentration. 
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Table 2 Principal g and copper hyperfine values of Cu
II
-trisNTA functionalised 
polymersomes compared with different model systems. The hyperfine values are 
given for the 
63
Cu nucleus. 
 gx, gy gz |Ax|,|Ay|/MHz |Az|/MHz 
CuII vesicles with His6  
2.035 (± 0.004) 
2.066 (±  0.005) 
2.230 (± 0.001) 
2.215 (± 0.001) 
5 (± 20) 
5 (± 20) 
570 (± 1) 
590 (± 2) 
Cu(OTf)2:NTA (1:5)  2.061 (±  0.005) 2.302 (± 0.001) 45 (± 20) 512 (± 2) 
Cu(OTF)2:His6 (1:5)  2.074 (±  0.005) 2.375 (± 0.001) 21 (± 20) 450 (± 2) 
Cu(OTf)2:NTA:His6 (1:5:5)  2.058 (±  0.005) 2.282 (± 0.001) 10 (± 20) 510 (± 2) 
PB39PEO36-SA-trisNTA.d 2.052 2.253 91 517 
Cu(His) solution at pH 7.3  
(Ref. 162) 
2.058 2.24 37 561 
Cu(His) solution at pH 3.8 
(Ref. 159) 
2.06 2.31 - 507 
 
A hexacoordination of the metal site is typically assumed (Fig.  43C) 
for aqueous transition-metal complexes of NTA, which involves the 
ligation of three carboxyl groups, an amine group and two water 
molecules. Although no structural data are available, a similar binding 
mode is proposed for the interaction between a polyhistidine tag and 
metal-NTA chelates. The crystal structure of a bisimidazole complexed to 
CuII and NTA shows a five-coordinate square pyramidal structure, with 
one protonated carboxyl group, two imidazoles and two carboxy groups of 
NTA equatorially ligated, and a weak axial coordination of the NTA amine 
group.23 Therefore pulsed EPR experiments were performed to verify this 
structure. The low-frequency area of the HYSCORE spectrum of a 
Cu(OTf)2:NTA (1:5) mixture exhibits no cross peaks from a weakly 
coupled 14N nucleus as expected when amine nitrogen atoms binds 
axially to copper. The Mims ENDOR spectra (Fig.  49) and the 1H 
HYSCORE spectra, taken at different magnetic field positions, show 
maximum 1H hyperfine couplings of 7 to 9 MHz.  
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Fig.  49 Mims-ENDOR of Cu(OTf)2:NTA mixture of 1:5 ratio in frozen water 
solution recorded (a) at B0 = 344.8 mT (observer position corresponding to g ≈ gx,y), 
and (b) at B0 = 303.0 mT (observer position corresponding to g = gz, MI = -1/2). 
Reprinted with permission from Ref. 55. Copyright 2012 American Chemical 
Society. 
 
This is in accordance with the findings for [Cu(H2O)6]
2+ in frozen 
water164 and in Mg(NH4)2(SO2)4.6H2O crystals
165 and corroborate with the 
equatorial water ligation in the CuII-NTA complex. The large proton 
coupling is not likely to be caused by the NTA protons, as their far 
distance from the copper site would result in smaller hyperfine couplings. 
Davies ENDOR spectroscopy was used to probe the interactions with 
directly coordinated nitrogen atoms. A value of ~25 MHz for the z-
component of the hyperfine interaction of the amine nitrogen was 
obtained, confirming an equatorial ligation of this amine. 
A low-frequency HYSCORE spectrum was obtained by adding His6-
tags to a Cu(OTf)2:NTA mixture, which shows contributions of a weakly 
coupled 14N nucleus (Fig.  50A) simulated by using the data in Table 3 
(Fig.  50B). The obtained parameters resemble the reported values for 
the remote imidazole nitrogen in CuII-bound imidazole complexes166 and 
CuII-bound histidine complexes.159,161,167,168 This underlines the His6-
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peptides binding, seen in CW-EPR measurements. Furthermore, the 
Mims ENDOR and HYSCORE spectra indicate a maximum proton 
coupling of 5.8 MHz (Fig.  51). This corresponds to the known proton 
hyperfine coupling value for the Hε proton of an equatorially ligated 
histidine imidazole to be max. 5.4 MHz.162 Therefore, the water, 
equatorially ligated to copper centre, is substituted with His residues. 
 
Fig.  50 A) X-band HYSCORE spectrum of a frozen solution of 
Cu(OTf)2:NTA:His6-peptide mixture at a 1:5:50 ratio taken at 5 K; B) Simulation of 
A) using the parameters from Table 3. The observer position is 335.0 mT, τ = 104 
ns. Reprinted with permission from Ref. 55. Copyright 2012 American Chemical 
Society. 
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Table 3 Comparison between the experimental 
14
N spin Hamiltonian parameters 
derived from the HYSCORE spectra for His6-tag ligation and the Cu
II
-NTA 
functionalised vesicles and the Cu
II
-NTA complexes. 
 A/MHz e2qQ/h/MHz h 
CuII vesicles with 
His6  
± 1.9 (± 0.3) ± 1.5 (± 0.1) 0.95 (± 0.10) 
Cu(OTf)2:NTA:His6 
(1:5:50)  
± 1.7 (± 0.3) ± 1.5 (± 0.1) 0.90 (± 0.10) 
Cu(His) (Ref. 107) 1.4 -1.43 0.95 
 
The pulsed EPR analysis described here allowed to assess the effect 
of His6-tag addition to Cu
II-NTA functionalised polymersomes. Only a 
weak spin echo signal of a frozen solution containing the polymersomes 
without peptide was obtained and no pulsed EPR experiments could be 
performed in agreement with the CW-EPR spectrum (Fig.  48a).  
 
Fig.  51 
1
H Mims-ENDOR spectrum of a frozen solution of Cu(OTf)2 with NTA and 
His6-peptide mixture taken at 5 K at the field position B0 = 334.0 mT, τ = 120 ns. A 
maximum 
1
H hyperfine coupling of 5.8 MHz is observed. Reprinted with permission 
from Ref. 55. Copyright 2012 American Chemical Society. 
 
After the addition of the His6-peptide, the echo intensity improved, 
which could be explained by the peptide acting as a spacer between the 
CuII sites on the polymersome surface, thereby reducing the dipolar 
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interaction between these sites. Nevertheless, a low echo intensity was 
still observed so that ESEEM or ENDOR experiments could only be 
performed at the position of highest echo intensity (corresponding to the 
observer position g = gx,y). This is shown in the 
14N HYSCORE spectrum 
(Fig.  52A) with its corresponding simulation (Fig.  52B) using the given 
data in Table 3. The data confirms a binding of the His6-tags to the copper 
site, as the parameters match with data, which is expected for the remote 
nitrogen of a His ligand. In addition, Mims-ENDOR experiments arrived to 
the same conclusion and are against an equatorial H2O ligation. 
 
Fig.  52 A) X-band HYSCORE spectrum of a frozen solution of Cu
II
-NTA-
functionalised vesicles with His6-peptide at a 1:50 ratio taken at 5 K; B) Simulation 
of a) using the parameters from Table 3. The observer position is 338.8 mT, τ = 120 
ns. Reprinted with permission from Ref. 55. Copyright 2012 American Chemical 
Society. 
 
Combining all data, EPR analysis of the aqueous CuII-NTA- and the 
CuII-NTA-His6 complexes clearly shows the existence of type-II copper 
complexes. Pulsed EPR and ENDOR data clarified that the copper ion is 
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equatorially bound to at least one water molecule and to the NTA amine 
nitrogen. This is different from the observation of the X-ray structure of 
copper(II)-nitrilotriacetic acid-bis(N-methylimidazol-2-yl)ketone ternary 
complexes where the NTA amine is in an axial position.169 In this case, it 
is reasonable that a flat bis-imidazole complex may be the cause of this 
different configuration. 
Upon addition of His6-tags to copper-trisNTA functionalised 
polymersomes, the equatorial water is replaced by His residues, as 
clearly shown by HYSCORE and ENDOR data. This is further 
corroborated by pulsed EPR data, which confirms an equatorial ligation of 
the imidazole(s) of His6-tags attached to the Cu
II-NTA moieties on the 
surface of polymeric vesicles. 
Incubation of His6-tags to the polymersomes provoked the formation of 
two different type-II copper sites (Table 2) as established from CW-EPR. 
Their principal g and copper hyperfine values significantly differ from 
those observed for the Cu(OTf)2:NTA:His6-peptide mixture. This could 
suggest that the surrounding structure influenced the local copper 
complex structure. Hence, the gz value of Cu
II-PB39-PEO36-SA-trisNTA.d 
is also lower than that observed for the aqueous copper NTA complex. 
The EPR parameters of the vesicle/His6-tag mixture resemble the values 
obtained for copper histidine complexes at neutral pH,162 while the 
parameters of the Cu(OTf)2:NTA:His6-peptide mixture were comparable to 
those of the copper-histidine complexes at pH 3.82.102 The copper-
histidine ligation difference at different pH values originates form the 
number of His residues and corresponding amine groups ligating to the 
copper centre. 
DFT computations complemented these observations. While it is 
known that DFT cannot exactly reproduce EPR parameters of transition-
metal complexes in means of underestimated g values and dissatisfying 
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transition-metal hyperfine values yet, the computations can be still used 
to estimate general trends and hyperfine values of the ligand nuclei.170 
Therefore, the EPR parameters of three models were computed using 
DFT (Fig.  53A, B and C). The effect of the exchange of water by His 
residues was simulated and the impact of the overall charge of the 
complex on the EPR parameters was evaluated. In model A, one NTA 
and two water molecules are ligated to the copper site, while models B 
and C includes the ligation of one NTA and a bis-imidazole molecule with 
a peptide-like linker. While in model C all carboxy groups are 
deprotonated, models A and B have one protonated carboxy group. All 
structures were optimised in terms of their overall lowest energy state via 
geometry optimisation using different starting geometries. The 
corresponding coordinates of the models are given in the Appendix. The 
DFT results are presented in Table 4 and the corresponding spin density 
distributions (Fig. 54 – Fig. 56) are shown in the Appendix. The computed 
parameters of models A and B reproduce different experimentally 
observed trends: Both typically have a quasi-axial g tensor, characteristic 
of type-II complexes with the copper in a dx2-y2 ground state. The 
computations confirm for model A, the aqueous CuII-NTA model, the 
experimental observation of the NTA amine nitrogen located in the 
equatorial plane (i.e. plane determined by dx2-y2) located NTA amine 
nitrogen and bearing a considerable amount of spin density. The 
computed z-component of this hyperfine interaction (27 MHz) resembles 
to the experimental value (25 MHz). Also, the computed maximum 
hyperfine interactions (absolute value) of equatorially ligated water 
protons (10.7 MHz) is in the same order of magnitude as the experimental 
values (9 MHz). 
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Fig.  53 DFT-optimised structures of the three models. Model A: 
[Cu(N(CH2COO)2(CH2COOH))(H2O)2]; Model B: 
[Cu(N(CH2COO)2(CH2COOH))(C11H15N5O)]; Model C: 
[Cu(N(CH2COO)3)(C11H15N5O)]
-
. Reprinted with permission from Ref. 55. 
Copyright 2012 American Chemical Society.   
 
Following the experimental trend of computed maximum proton 
hyperfine couplings, the value for model B (His residues) are smaller (6.4 
MHz). Indeed, the hyperfine values of the remote nitrogen atoms are 
around 1.5 – 2.2 MHz. In agreement to the experimental results, gz 
decreases upon attachment of the His residues and the copper |Az| 
values are similar for both models A and B. To conclude, these results 
agree with the experimental trends and confirm the EPR parameters, 
which indicates that addition of His6-tags to Cu(OTf)2:NTA is entirely due 
to the replacement of the equatorial water by His residues. 
In a next step, protonation effects of the NTA carboxyl groups are 
studied by comparing model B (one protonated carboxyl group) and 
model C (no protonation of the carboxyl groups). Deprotonation of the 
third carboxyl group caused an increase of the gz value and the g tensor 
to become rhombic. The copper |Az| value and the NTA amine nitrogen 
hyperfine coupling are reduced considerably, while the rest of the ligand 
hyperfine values are less affected ranging in the order of the experimental 
errors. Thus protonation could play a role in the different EPR parameters 
of the Cu(OTf)2-NTA-His6 mixture and the polymersome-His6 systems. 
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Similar hyperfine values were found in both systems for the protons and 
the remote nitrogens of the His residues, which were also computed for 
both models B and C. Lower gz (higher |Az| values) were seen for the 
polymersome system compared to the Cu(OTf)2-NTA-His6 mixture. 
Additionally, the copper |Az| values differ more between the two His6-
ligated systems than between Cu(OTf)2-NTA and Cu(OTf)2-NTA-His6. A 
similar trend is also observed for a higher copper |Az| value difference 
between models B and C compared to models A and B. These results 
suggest that the NTA carboxy groups on the polymersome system are 
protonated, probably induced by polymersome surface properties. The 
presence of two different copper complexes in the polymersome system 
could result from changes in the number or orientation of the His ligands. 
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Table 4 Computed principal g and hyperfine values for models A-C (Fig.  53). 
  gx gy gz 
Model A  2.067 2.075 2.210 
Model B  2.059 2.061 2.193 
Model C  2.038 2.099 2.202 
 nucleus Ax [MHz] Ay [MHz] Az [MHz] 
Model A Cu 
N(NTA) 
H (H2O)
a
 
69 
27 
-10.8 
77 
45 
6.2 
-522 
27 
-5.4 
Model B Cu 
N(NTA) 
N1(His)
b
 
N2(His)
c
 
H (His)
a
 
49 
27 
44 
1.7 
6.4 
76 
41 
36 
2.3 
-0.4 
-533 
27 
35 
1.6 
0.1 
Model C Cu 
N(NTA) 
N1(His)
b
 
N2(His)
c
 
H (His)
a
 
173 
20 
42 
1.6 
5.9 
-3 
33 
34 
2.2 
-0.3 
-495 
20 
33 
1.6 
0.2 
aData for the proton with the largest hyperfine coupling (in absolute value), bAverage of 
computed hyperfine values of copper bound His nitrogens; cAverage of computed hyperfine 
values for remote His nitrogen atoms. 
4.5.  Conclusion 
The CuII-trisNTA-functionalised PB-b-PEO polymersomes are well 
suited to study molecular recognition process of peptide binding. As 
peptides, we used a model system of an oligohistidine sequence 
consisting of six histidines – a His6-tag – to study their binding to copper 
centres on the polymersome surface. Upon binding, a detailed structural 
view of the rearrangement of the metal coordination sphere was obtained. 
Qualitative binding analysis revealed that more than 200 fluorescently 
labelled His6-tags were bound to one polymersome. This was visualised 
by fluorescence laser-scanning microscopy as a highly intense 
fluorescent corona surrounding the metal-functionalised polymersomes. 
FCS measurements revealed that this system has a high binding affinity, 
which was found to be higher than of similar systems using His-tagged 
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proteins.21,23 Different EPR and ENDOR methods were used to 
investigate the electronic and geometric change of the copper centre 
complexed in the NTA pocket upon binding of the model His6-tags. His6-
tag binding was demonstrated via the typical HYSCORE signature of the 
remote nitrogen of the imidazole ligand of the residue, and by the 
reduction of the proton hyperfine coupling using EPR and DFT data from 
model systems. As expected from other experiments, these findings 
confirmed the strong and selective binding. The highly specific binding 
capacity of the copper-functionalised PB-b-PEO polymersomes together 
with a simple preparation procedure and inherent high structural stability 
make the system very suited for a wide range of applications such as 
protein crystallisation, targeting approaches or immobilisation on solid 
supports.  
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5.  Overall conclusion 
We designed and developed protein-polymer assemblies to engineer 
artificial organelles. The development required to study three key aspects 
in order to increase the overall efficacy of the artificial organelles: i) 
increased efficacy by means of optimised building blocks, ii) introduction 
of specific membrane permeability by the use of selective ion-channels 
and iii) applying specific recognition points by the use of a molecular 
recognition strategy: 
i) Combination of natural occurring antioxidant enzymes with synthetic 
block copolymers, which are able to self-assemble into polymersomes, 
allowed engineering of artificial peroxisomes (APs). They can support 
natural peroxisomes and help the cellular antioxidant defence mechanism 
in general to combat oxidative stress. As active compounds, SOD and 
LPO or CAT were used in complex, optimised conditions, which detoxify 
in tandem superoxide radicals in situ via hydrogen peroxide to harmless 
products. These APs were able to be taken up by cells and function as 
specific artificial organelles, opening a new direction in medical therapy. 
The polymersome properties were optimised by means of high 
encapsulation efficiency in order to allow enhanced cascade reactions 
and to mimic the morphology and functions of natural peroxisomes. 
Enzymatic activity is preserved over time even longer than in solution, 
making this hybrid system not only suitable for therapeutic applications, 
but also for technical applications such as biosensors. For the therapy of 
oxidative stress, we were able to show that the APs escaped intact from 
endo-lysosomes and were distributed within the cytoplasm, which is 
important for properly functioning. In addition, viability measurements 
revealed that the APs were non-toxic. 
ii) In order to address the polymersome membrane permeability in 
more detail, in addition to the incorporation of OmpF in triblock copolymer 
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vesicles, diblock copolymer vesicles of 200 nanometres in diameter were 
produced to encapsulate a pH sensitive dye, pyranine. This system was 
used in order to prove the membrane incorporation of gramicidin. The 
successful accomplishment of the ion-channel incorporation is an 
important step towards the design of pH-triggerable nanoreactors and 
artificial organelles, where the activity of the protected active compounds  
can be activated or deactivated via specific ion-channels “on demand”. 
iii) Next to the controlled activity, the site specific action of the active 
compound is also important. To address this challenge, CuII-trisNTA-
functionalised PB-b-PEO polymersomes were used to study molecular 
recognition process of specific peptide binding. A model system of an 
oligohistidine sequence consisting of six histidines – a His6-tag – was 
used to study their binding to copper centres on the polymersome 
surface. Upon binding, a detailed structural view of the rearrangement of 
the metal coordination sphere was obtained. More than 200 fluorescently 
labelled His6-tags were bound to one polymersome, proving efficient 
binding. The system was also characterised by a high binding affinity. 
Different EPR and ENDOR methods were used to investigate the 
electronic and geometric change of the copper centre complexed in the 
NTA pocket upon binding of the model His6-tags. These experiments, as 
well as DFT computations, confirmed strong and specific binding. This 
detailed knowledge about the molecular recognition behaviour of the 
system and the simple preparation procedure allows to further engineer 
specific artificial organelles with site-specific action capabilities. 
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6.  Experimental section 
Materials 
Cu/Zn-superoxide dismutase (Cu/Zn-SOD) from bovine erythrocytes 
(>3,000 U/mg), lactoperoxidase (LPO) from bovine milk (>200 U/mg), 
catalase (CAT) from bovine liver (≥10,000 units/mg), xanthine oxidase 
(XO) (microbial, 7 U/mg), xanthine (XA), sodium phosphate buffer (DPBS 
1 x Dulbecco`s salts without calcium chloride and magnesium chloride, 
pH 7.3), hydrogen peroxide, 30% (w/w)) and dimethyl sulphoxide (DMSO) 
(>99.5%),were purchased from Sigma Aldrich and were used without any 
further treatment. 10-acetyl-3,7-dihydroxyphenoxazine (amplex red), 
AlexaFluor 488 carboxylic acid succinimidyl ester, and AlexaFluor-633 
carboxylic acid succinimidyl ester were obtained from Molecular Probes 
(Invitrogen) (Eugene, OR, USA) and were used as received. Dylight-488 
carboxylic acid succinimidyl ester and dylight-633 carboxylic acid 
succinimidyl ester were purchased from Thermo Fisher Scientific Inc. 
(Rockford, IL, USA) and were used without further purification. Amplex 
red stock solutions were prepared in DMSO (50 mM) and stored at -20 
C°. N-Octyl-oligo-oxyethylene (OPOE) was purchased from Enzo Life 
Sciences (Lausen, Switzerland). Hoechst and propidium iodide were 
purchased from Invitrogen. An ROS detection kit from Enzolife, 
polycarbonate membrane filters (Millipore), and sepharose 2B (Sigma 
Aldrich) were used. RPMI-1640 cell culture medium (GIBCO), fetal calf 
serum (FCS), penicillin and streptomycin (Sigma Aldrich) and PBS 
(GIBCO) were used in the cell experiments. L-α-phosphatidylcholine, 
gramicidin from bacillus brevis (a mixture of gramicidin A, B, C and D), 
pyranine (8-Hydroxypyrene-1,3,6-trisulfonic acid trisodium salt), and acid 
phosphatase were purchased from Sigma-Aldrich and used without 
further purification. ELF97 phosphatase substrate was purchased from 
Invitrogen. 2-(6-chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium 
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hexafluorophosphate (HCTU) and rink amide AM resin (0.61mmol/g) 
were purchased from IRIS Biotech GmbH, Marktredwitz, Germany. The 
amino acids (N-α-t.-Boc-L-histidine) were obtained from Novabiochem, 
Läufelfingen, Switzerland. Sulphorhodamie B acid chloride (λex: 560 nm, 
λem: 580 nm) and copper(II)triflate was purchased from Sigma-Aldrich, 
Buchs, Switzerland. Dichlormethane was provided by Brenntag 
Schweizerhall AG, Basel, Switzerland, dimethylformamide (DMF) by J. T. 
Baker and acetonitrile (ACN) by Fischer Scientific. DMF was treated with 
aluminium oxide to reduce the concentration of free amines prior to 
application in peptide synthesis. 
Methods used for the design of antioxidant nanoreactors/artificial 
peroxisomes 
Outer membrane protein F production 
OmpF expression was carried out in E. coli (BL21 (DE3)omp8)72 
according to a previously optimised protocol53 and the product was stored 
at 700 µg/mL with 3 wt% OPOE stock solution at 4 C°. 
Fluorescence labelling of SOD, LPO and CAT 
SOD was labelled with AlexaFluor-488 carboxylic acid succinimidyl 
ester, LPO was labelled with AlexaFluor-633 or dylight-633 carboxylic 
acid succinimidyl ester and CAT was labelled with dylight-488 carboxylic 
acid succinimidyl ester following the protocol provided by Invitrogen 
(www.invitrogen.com). The solutions containing labelled enzyme were 
filtered through a 0.22 μm Millex low protein-binding Durapore membrane 
(Millipore, Billerica, MA, USA) and separated by fast protein liquid 
chromatography (FPLC) on a Sephadex G25 (Aldrich) column 
equilibrated with phosphate-buffered saline buffer (PBS). The 
concentration of labelled enzyme and the degree of labelling was 
determined by dual wavelength FPLC (Äkta FPLC, GE Healthcare 
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Europe GmbH, Glattbrugg, Switzerland) or by UV/VIS. After the labelling 
and purification procedure, 209.56 µM of labelled SOD, 4.45 µM of 
labelled LPO and 20 µM of labelled CAT were obtained.  
PMOXA-PDMS-PMOXA vesicles preparation 
Synthesis and characterisation of ABA triblock copolymer PMOXAn-
PDMSm-PMOXAn (n = 12 and m = 55) has been described previously.
53 
Vesicles were prepared at room temperature by drop-wise addition of 
PBS to ABA copolymer under continuous stirring, obtaining a 5 mg/mL 
polymer concentration. The aqueous polymer solution was extruded with 
an Avanti mini-extruder (Avanti Polar Lipids, Alabama, USA) through a 
400 nm diameter pore-size polycarbonate (PC) membrane (one time), 
and through a 200 nm pore-size PC membrane (11 times) in order to 
reduce size polydispersity of the vesicles.  
Preparation of nanovesicles containing individual enzyme types and 
SOD/LPO (or SOD/CAT) containing artificial peroxisomes 
To encapsulate an individual enzyme type in vesicles, a solution of 
SOD, LPO or CAT (in concentrations between 0.1 – 0.83 mg/mL) were 
mixed with a solution of ABA block copolymer, followed by the 
preparation steps described above. A mixture of SOD and LPO at 
different ratios in PBS was added drop-wise to the ABA polymer solution 
to encapsulate both enzymes simultaneously. When required, channel 
protein68 was simultaneously incorporated by drop-wise addition of the 
OmpF porin stock solution to the enzyme(s)-ABA copolymer mixture with 
continuous stirring to reach a final concentration of 50 µg/mL OmpF. Non-
encapsulated enzymes were separated from vesicles by 48 hour dialysis 
(Spectrapore dialysis tube, mean width cut-off size: 300 kDa, Spectrum 
Laboratories Inc.), exchanging dialysis PBS buffer after 24 hours. 
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Transmission electron microscopy (TEM) 
Empty vesicles, vesicles containing a single-enzyme constituent, SOD-
AlexaFluor-488, LPO-AlexaFluor-633 or CAT-dylight-488, vesicles 
containing co-encapsulated SOD-AlexaFluor-488 and LPO-AlexaFluor-
633 and cell-samples were negatively stained with 2% uranyl acetate 
solution and deposited on carbon-coated copper grids. Vesicle samples 
were studied using a transmission electron microscope (Philips Morgagni 
268D) at 293 K.  
Light scattering (LS) 
Dynamic (DLS) and static (SLS) light-scattering experiments were 
performed on an ALV (Langen, Germany) goniometer, equipped with an 
ALV He-Ne laser (JDS Uniphase, wavelength λ = 632.8 nm). Vesicles 
dispersions were prepared by serial dilution to polymer concentrations 
ranging from 2.5 to 0.05 g/L. Light scattering was measured in 10 mm 
cylindrical quartz cells at angles of 40 − 150° at 293 ± 0.5 K. The 
refractive index increment ∂n/∂C of the vesicle dispersions was 
determined to 0.16  0.02 mL/g at 632.8 nm with an ALV-DR1 differential 
refractometer. The photon intensity auto-correlation function g2(t) was 
determined with an ALV-5000E correlator (scattering angles between 40° 
and 150°). DLS data were analysed via non-linear decay-time analysis 
supported by regularized inverse Laplace transform of g2(t) (CONTIN 
algorithm). The angle-dependent apparent diffusion coefficient was 
extrapolated to zero momentum transfer (q²) using ALV Correlator 
software static and dynamic FIT and PLOT 4.31. Angle and 
concentration-dependent SLS data were analysed using a Guinier plots 
approach. 
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Fluorescence correlation spectroscopy (FCS) and fluorescence cross-
correlation spectroscopy (FCCS)  
FCS and FCCS measurements were performed at room temperature 
on a Zeiss LSM 510-META/Confcor2 laser-scanning microscope 
equipped with an argon2-laser (488 nm), a helium/neon laser (633 nm) 
and a 40× water-immersion objective (Zeiss C/Apochromat 40X, NA 1.2) 
or a 63x water emulsion lens (Olympus). The pinhole was adjusted to 70 
µm, and 90 µm, respectively. For each measurement, 10 μL of sample 
solution, containing either free dye AlexaFluor-488 or AlexaFluor-633 or 
dylight-488 or dylight-633, each concentrated to 50 nM, or containing an 
enzyme- (or combined enzyme-) encapsulated vesicle solution used 
directly after the purification step, were placed in special, chambered 
quartz glass holders (Lab-Tek; 8-well, NUNC A/S). For FCS, spectra were 
recorded over 30 s, and each measurement was repeated 10 times. 
Excitation power of the argon2 laser was PL = 15 mW, and the excitation 
transmission at 488 nm was 5%. Excitation power of the helium/neon 
laser was PL = 5 mW, and excitation transmission at 633 nm was 1%. 
Diffusion times for free dye (AlexaFluor-488, AlexaFluor-633, dylight-488 
and dylight-633) as well as for labelled SOD, labelled LPO and labelled 
CAT were independently determined and fixed in the fitting procedure. 
The results were presented as a mean value of three independent 
measurements. For the fitting of the autocorrelation function according to 
a two-component model, the following equation 8 was used:  
(8) 
where, 
 N: number of fluorescent particles 
 S: structural parameter 
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 τD1: diffusion time of the component 1 in the assay. 
 1-Y: fraction of particles with diffusion time τD1 
 τD2: diffusion time of component 2 in the assay. 
 Y: fraction of particles with diffusion time τD2 
 f(T): function used for fitting the tripled characteristics τT and % 
τT of the fluorescent label within the assay. 
By means of an iterative least-square method, the values calculated 
by the algorithm are compared repeatedly to the experimentally 
generated autocorrelation curve and approximated until the difference 
between the two curves is minimised. 
FCCS measurements were performed on the same instrument in the 
FCCS mode. Overlap of the confocal volumes was ensured in each 
channel by optimising pinhole settings in each measurement channel and 
performing calibration measurements. Cross-talk was measured 
independently in each detection channel to exclude false-positive cross-
correlation.171 The fraction of co-encapsulated enzymes (R) can be 
estimated by the formula (equation 9): 
  
    
     
   
  (9) 
 
where Rg is the relative autocorrelation amplitude of the green channel, 
Rr: relative autocorrelation amplitude of the red channel, and 
Rcc: the relative amplitude of the cross-correlation. 
 
 
The theoretical fraction of co-encapsulated enzymes, P, in the 
hypothesis of independent event probabilities p1 (fraction of encapsulated 
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SOD) and p2 (fraction of encapsulated LPO) can be estimated by the 
formula (equation 10): 
  
                                                            (10) 
Individual enzyme types activity assay 
LPO and CAT kinetics in solution or in nanovesicles were studied with 
a PerkinElmer LS55 fluorescence spectrometer (Waltham, 
Massachusetts, USA) at ambient temperature. Free LPO kinetics was 
tracked using a gradient of H2O2 and amplex red as follows: 
concentrations from 0.3 μM to 2.4 µM H2O2, 5 nM LPO solution in PBS 
buffer and concentrations from 0.47 M to 3.75 μM amplex red. The 
kinetics of LPO in nanovesicles were followed immediately after mixing 
H2O2 (1.09 – 5.86 μM) with a 50-fold diluted LPO-containing nanovesicle 
solution and the addition of amplex red (0.18 – 1 M).  
The solutions were mixed in a quartz cuvette and the fluorescence 
intensity of resorufin (ex = 530 nm, em = 580 nm), as the reaction 
product, was recorded. 
CAT activity was compared to LPO activity by a competition reaction 
as presented in Scheme 1. 
Scheme 1 CAT activity assay. Reprinted with permission from Ref. 78. Copyright 
2013 American Chemical Society. 
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Multi-enzyme activity assay 
The cascade reaction of SOD and LPO in tandem was followed in free 
solution or in nanovesicles by fluorescence spectroscopy using the set-up 
of FCS. Activity tests of free SOD and LPO in sequence were performed 
by mixing SOD (0.2 nM - 66 µM) with LPO (0.016 - 1µM) in different 
concentration domains and in the presence of amplex red (9 µM) with 
various amounts of xanthine (2 µM – 25 μM). The cascade reaction was 
started by the addition of xanthine oxidase (0.002 − 0.17 U/mL), with the 
concentrations adjusted to not short circuit SOD due to generation of 
H2O2 by the xanthine-xanthine oxidase system. Resorufin formation was 
followed as count rate (kHz).  
Activity tests of SOD/LPO co-encapsulated vesicles were carried out 
by mixing 10 µL SOD-LPO-containing nanovesicle solution with amplex 
red (23.8 µM), and xanthine (35.71 µM) to a final volume of 210 μL. The 
cascade reaction was started by the addition of xanthine oxidase 
(0.24 U/mL). 
Cell experiments  
HeLa cells were cultured and maintained in Modified Eagle's Medium 
(DMEM) supplemented with high glucose, 10% fetal calf serum,  1% 
penicillin (10`000 units/mL) and streptomycin (10`000 mg/mL) (purchased 
from Sigma Aldrich), 2 mM L-glutamine and 1 mM pyruvate. Cells were 
grown in a humidified incubator (HERA Cell 150, Thermo Scientific, 
Germany) at 37 °C in a 5% CO2 atmosphere until a confluence of 60 –
 80% was achieved, and then harvested by trypsin-EDTA. 
Cytotoxicity of the vesicles and APs 
Cells were cultured in a 96-well plate at a density of 2 x 104 cells/well, 
and incubated with 100 µL of DMEM growth medium per well for 24 h. 
Different concentrations of empty polymer vesicles and enzyme-loaded 
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polymer vesicles were added to different wells and incubated with cells 
for a period of time (24 and 48 h). Subsequently, 20 µL of CellTiter® 96 
Aqueous One Solution Cell Proliferation Assay (MTS) reagent (Promega) 
were added to each well and then incubated for a further 2 h. The 
absorbance of each well mixture was measured with a Spectromax M5e 
microplate reader (Molecular Devices) at 490 nm.  
Cell uptake of APs 
HeLa cells were cultured in a 6-well plate at different densities of cells 
per well (1 x 105 for CLSM, 2 x 105 for flow cytometry analysis, and 1 x 
106 for TEM) in DMEM medium and incubated with enzyme-loaded 
polymer vesicle solution at different time intervals (2-, 4-, 8-, 18-, 24 h) at 
37 °C in a humidified CO2 incubator. For flow cytometry analysis, cells 
incubated with a solution of enzyme-loaded polymer vesicles were 
washed with PBS to remove free enzyme-containing vesicles and 
quantitatively analysed for rate of uptake of enzyme-containing vesicles 
with a flow cytometry set-up (CYAN, BD biosciences). A total of 10,000 
events were analysed for each condition. 
Study of APs escape from endosome  
HeLa cells pre-incubated with a polymer vesicle solution containing co-
encapsulated SOD and LPO were fixed with a solution of 3% 
paraformaldehyde in PBS, and 0.5% glutaraldehyde in PBS containing 
1.5% saccharose (pH 7.3), and then post-fixed in 0.5% aqueous osmium 
tetroxide. The samples were then dehydrated using a graded series of 
ethanol solutions, block-stained in 6% of uranyl acetate and embedded in 
LR white resin (Sigma Aldrich). Ultra-thin sections were contrasted with 
0.3% lead citrate and imaged with TEM. 
For CLSM visualisation, the HeLa cell culture was first treated with 
enzyme-loaded polymer vesicles (100 μg/mL) for 4 h, followed by 
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treatment with pH-rodo™ Red dextran (20 μg/mL) for a further 20 min at 
37 °C following the supplier's protocol. The cells were rapidly washed with 
PBS and prepared for imaging. 
Cellular ROS detoxification by APs 
HeLa cells were treated with paraquat to induce oxidative stress and 
analysed by flow cytometry (CYAN, BD Biosciences). HeLa cells at a 
density of 1 x 105 plated in a 6-well plate were first incubated with 
enzyme-loaded polymer vesicles (500 µg/mL) for 24 h, and subsequently 
with paraquat (2 mM) for a further 24 h at 37 °C in a 5% CO2 atmosphere. 
Cells were washed with PBS buffer and stained with propidium iodide (PI, 
50 mg/mL) to determine cell viability. A total of 10,000 events were 
analysed for each condition. To analyse the ROS detoxification kinetics of 
artificial peroxisomes in live cells, HeLa cells were seeded at 4 x 103 
cells/well in a 96-well plate incubated overnight for cell attachment, 
followed by incubation with APs vesicles for 8 h. Afterwards, cells were 
treated with ROS/superoxide detection mix from Enzolife’s 
ROS/superoxide detection kit for 1 h. Cells were then incubated with 
pyocyanin (300 µM) to induce ROS generation in the cells. ROS 
detoxification kinetics was measured with a Spectromax M5e microplate 
reader (Molecular Devices) in the kinetic mode with a 550/620 nm filter 
set. 
Methods used for the design of pH-triggered nanoreactors 
 
PMOXA-PDMS and L-α-phosphatidylcholine vesicles preparation and 
encapsulation of the pH-sensitive dye (pyranine) 
PMOXA14-PDMS65 was used to prepare vesicles at room temperature 
by using the film hydration method obtaining a 5 mg/mL polymer 
concentration. The direct dissolution method was used for the preparation 
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of vesicles based on L-α-phosphatidylcholine. In order to encapsulate the 
pH-sensitive dye pyranine, the polymer film or the lipids were hydrated 
using pyranine dissolved in PBS at a concentration of 50 mM. The 
aqueous polymer solution and liposome solution were extruded with an 
Avanti mini-extruder (Avanti Polar Lipids, Alabama, USA) through a 
400 nm diameter pore-size polycarbonate (PC) membrane (one time), 
and through a 200 nm pore-size PC membrane (11 times) in order to 
reduce size polydispersity of the vesicles.  
Measurements of gramicidin incorporation by monitoring pH change inside 
vesicles and design of pH-sensitive nanoreactors 
Functional gramicidin ion-channel formation in the liposome or 
polymersome membrane was measured by using a PerkinElmer 
fluorescence spectrometer LS55 (Waltham, Massachusetts, USA) in the 
time driven mode. Pyranine encapsulated polymersomes were diluted 
1:300. A pH change was monitored during addition of HCL to lower the 
pH from pH 8.3 to 5. The effect of subsequent addition of a low amounts 
of gramicidin (dissolved in different suitable solvents such as dimethyl 
sulphoxide (DMSO), trifluoroethanol (TFE), dioxane, pyridine, 
isoporpanol, decane and the mixtures DMSO:ethanol (DMSO:EtOH) in 
the ratio 1:1 and the mixture TFE:DMSO:EtOH (2:1:1)) to yield 
concentrations between 30 nM and 130 nM was compared in means of 
the change of the fluorescence intensity of pyranine inside the vesicles to 
the condition when the same amount of solvent was added and when no 
further components were added. In order to characterise pH-sensitive 
nanoreactors, simultaneously acid phosphatase (10 μM) and ELF97 (12.5 
μM) were added during the vesicle formation process and purified as 
described above. pH-dependent activity of acid phosphatase inside the 
vesicles was measured using also the LS55 fluorescence spectrometer in 
the time driven mode. 
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Transmission electron microscopy (TEM) 
Pyranine-encapsulated vesicles in condition of pHinside = pHoutside, 
pHinside < pHoutside and after addition of gramicidin were negatively stained 
with 2% uranyl acetate solution and deposited on carbon-coated copper 
grids. Vesicle samples were studied using a transmission electron 
microscope (Philips Morgagni 268D) at 293 K.  
Light scattering (LS) 
Dynamic (DLS) experiments were performed on an ALV (Langen, 
Germany) goniometer, equipped with an ALV He-Ne laser (JDS 
Uniphase, wavelength λ = 632.8 nm). Light scattering was measured in 
10 mm cylindrical quartz cells at a fixed angle of 90° at 293 ± 0.5 K for 
comparison of the effects of pH change and gramicidin incorporation in 
the polymersome membrane. The photon intensity auto-correlation 
function g2(t) was determined with an ALV-5000E correlator. DLS data 
were analysed via non-linear decay-time analysis supported by 
regularized inverse Laplace transform of g2(t) (CONTIN algorithm).  
Methods used for study molecular interaction of metal-functionalised 
polymersomes with His-tags 
Polymers  
Synthesis and characterisation of the diblock copolymer PB39-b-PEO36 
was described previously.21 A mixture of PB39-b-PEO36-SA-OH containing 
10% PB39-b-PEO36-SA-trisNTA.d-Cu
2+ was used for all experiments. The 
diblock copolymer is functionalised with trisNTA a variant of NTA and 
complexed with Cu2+ ions. The non-functionalised diblock copolymer was 
characterised at a molecular mass of 3530 g/mol, which increased to 
3690 g/mol upon functionalisation with trisNTA. Both block copolymers 
have a low polydispersity index.
21
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Peptide synthesis and fluorescent labelling 
The peptides were synthesised on a Syro I Peptide Synthesiser 
(MulitSynTech GmbH, Witten, Germany) using solid phase synthesis with 
an Fmoc-strategy. HCTU as the coupling reagent, with N-ethyldi-
isopropylamine (DIPEA) dissolved in N-methyl-2-pyrrolidone (NMP) and 
used as the base to couple a-N-Fmoc-protected amino acids to the rink 
amide resin. For elongation, Fmoc-His-OH (0.5 mol/L, 4 equiv.), HCTU 
(0.5 mol/L, 4 equiv.) dissolved in DMF, and DIPEA (12 equiv.) were 
added to the resin. The mixture was agitated for 1 h and washed with 
DMF (3 x 3 mL). Fmoc deprotection was performed with 20% piperidine in 
DMF followed by 3 min agitation, draining, and repetition of deprotection 
for 10 min. Resin was subsequently washed with DMF (5x3 mL). 
Acetylation of unreacted amine groups was performed following each 
coupling with a solution of acetic anhydride/DIPEA (3 mol/L, 5 equiv.) in 
DMF. After synthesis, the peptide resin was alternately washed with DMF 
(3 x 6 mL), isopropanol (3 x 6 mL), and dichloromethane (3 x 6 mL), and 
then dried under vacuum. 
The coupling of the dye to the N-terminus was performed on peptide 
still bound to the solid phase. A DMF solution of carboxylic-acid-
succinimidyl-ester-activated dye (sulphorhodamine B) was added to the 
peptide. Uncoupled dye was washed away alternating with DMF (3 x 
6 mL), isopropanol (3 x 6 mL), and dichloromethane (3 x 6 mL). 
Cleavage of the peptide from the resin and removal of its protective 
groups was performed with a mixture of 95% trifluoroacetic acid (TFA), 
2.5% tri-isopropylsilane, and 2.5% H2O. The resin was additionally 
washed two times with this mixture (2 mL) and the peptide was 
precipitated in 40 mL cold di-isopropylether (IPE). The precipitated 
peptide was washed three times with cold IPE by centrifugation and 
decantation, before being dried under vacuum. 
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Peptide purification and characterisation 
Purification and analysis of the peptides were performed by HPLC 
(Shimadzu Prominence 20A, Japan) on reverse phase (RP) columns 
(Merck Chromolith, RP-18e, 100 mm x 10 mm and 100 mm x 4.6 mm). 
The separation of the unlabelled peptide from labelled peptide yielded 
sample purities higher than 95%. This was detected by absorption at 
280 nm and 560 nm. Linear gradients of solvent A (ACN) and solvent B 
(0.1% TFA, or 2% acetic acid in bidistilled water) were used.  
The eluted sample was collected in fixed volume fractions, which were 
subsequently analysed for purity and molecular weight using HPLC and 
matrix-assisted laser desorption/ionisation time-of-flight mass 
spectroscopy (MALDI-TOF-MS). MALDI-TOF-MS was performed for 
mass confirmation with a Voyager-DETM System (Applied Biosystems, 
USA) in positive reflector mode, an accelerating voltage of 25 kV, grid 
voltage of 75% and 100 − 300 ns extraction delay time. Matrix (α-cyano-
4-hydroxycinnamic acid) sample mixtures were prepared using a solution 
of ACN/0.1% TFA in bidistilled water on a 100-well gold plate. Fractions 
with matching mass and exceeding 95% purity were pooled with 
ammonia before neutralisation and then lyophilised. Products were stored 
under argon at -18 °C.  
PB-b-PEO vesicle preparation and His6-tag binding.  
PB-b-PEO vesicles were prepared (800 µM) according to the film 
rehydration method and contained 10% CuII-trisNTA functionalised PB-b-
PEO copolymer.21 His6-tags or sulphorhodamine B acid chloride labelled 
His6-tags (s-His6-tags) were added to the vesicle solution at different 
concentrations depending on the used measurement technique (see 
below). The solutions were extruded with an Avanti mini-extruder (Avanti 
Polar Lipids, Alabama, USA) through a 400 nm diameter pore-size 
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polycarbonate (PC) membrane (one time), and through a 200 nm pore-
size PC membrane (11 times) in order to minimize nanovesicle size 
distribution. 
Dynamic and Static Light Scattering (DLS and SLS) 
Light scattering experiments were performed on an ALV (Langen, 
Germany) goniometer, equipped with an ALV He-Ne laser (JDS 
Uniphase, wavelength  = 632.8 nm). Vesicle dispersions were prepared 
by serial dilution to polymer concentrations ranging from 0.7 to 0.1 g/L. 
Light scattering was measured in 10 mm cylindrical quartz cells at angles 
of 30 – 150° at 293 K ± 0.5 K. The photon intensity auto-correlation 
function g(t) was determined with an ALV-5000E correlator (scattering 
angles between 30° and 150°). DLS data were analysed via non-linear 
decay-time analysis supported by regularized inverse Laplace transform 
of g(t) (CONTIN algorithm). The angle-dependent apparent diffusion 
coefficient was extrapolated to zero momentum transfer (q²) using ALV 
Correlator software static and dynamic FIT and PLOT 4.31. 
Transmission electron microscopy (TEM) 
TEM images were taken using a transmission electron microscope 
(Philips Morgagni 268D) operated at 80 keV. The vesicle samples diluted 
to a final polymer concentration of 8 µM were negatively stained with 2% 
uranyl acetate solution for 10 s and deposited on carbon-coated copper 
grids in order to perform the measurement. 
Confocal laser-scanning micorscopy (CLSM)  
PB-b-PEO vesicles were prepared (800 µM) as mentioned above and 
were incubated with fluorescently labelled His6-tags (s-His6-tags) (1 µM) 
for 5 min at room temperature. The solution was dialyzed for 24 h with a 
Spectrapore dialysis tube (mean width cut-off size: 300 kDa, Spectrum 
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Laboratories Inc.) to separate non-bound s-His6-tags from vesicles. This 
solution was investigated at room temperature in special chambered 
quartz glass holders with a confocal laser-scanning microscope (Zeiss 
LSM 510-META/Confcor2), in LSM mode, using a Helium/Neon laser 
(543 nm) and a 63× water-immersion objective (Zeiss C/Apochromat 
63X, NA 1.2). HeNe laser excitation power was PL = 1 mW, and 
excitation transmission at 543 nm was 20%.  
Fluorescence Correlation Spectroscopy (FCS) 
For FCS measurements, PB-b-PEO vesicle solutions with different CuII-
functionalised PB-b-PEO concentrations (ranging from 2 µM to 8 µM) 
were prepared as mentioned above. The vesicle solutions containing 
different amounts of copper were incubated with 50 nM s-His6-tags and 
were immediately measured without dialyzing. FCS measurements were 
performed at room temperature in special chambered quartz glass 
holders (Lab-Tek; 8-well, NUNC A/S), on the Zeiss LSM 510-
META/Confcor2 laser-scanning microscope equipped with a HeNe laser 
(543 nm) and a 40× water-immersion objective (Zeiss C/Apochromat 40X, 
NA 1.2), with pinhole adjusted to 78 µm. Spectra were recorded over 
30 s, and each measurement was repeated 10-times. The excitation 
power of the HeNe laser was PL =1 mW, and the excitation transmission 
at 543 nm was 10%. The structural parameter and diffusion times of the 
free dye (sulforhodamine B acid chloride) and of the dye-labelled His6-
tags were independently determined and fixed in the fitting procedure. 
These parameters were used to fit the autocorrelation curve of s-His6-tags 
bound PB-b-PEO vesicles. The fluorescence signal was measured in real 
time and the autocorrelation function was calculated by a software 
correlator (LSM 510 META - ConfoCor 2 System). The results were 
presented as a mean value of three independent measurements. 
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X-band CW-EPR 
Samples for X-band CW-EPR measurements were prepared similar to 
FCS with the exception that an 800 µM vesicle solution was incubated 
with 2.0 mM s-His6-tags. X-band CW-EPR measurements (microwave 
(MW) frequency of about 9.44 GHz) were performed on a Bruker ESP 
300E instrument, equipped with a liquid Helium cryostat (Oxford Inc.). A 
MW power of 10 mW, a modulation frequency of 100 kHz and a 
modulation amplitude of 0.5 mT were applied. All spectra were taken at 
100 K and 10 K. The EasySpin program was utilized to simulate the CW-
EPR spectra.172 
X-band pulsed EPR experiments were performed on a Bruker Elexsys 
spectrometer (9.76 GHz), equipped with a helium-gas flow cryostat 
(Oxford Inc.). The measurements were done at 4 K, with a repetition rate 
of 1 kHz.  
ENDOR experiments  
The ENDOR experiments were performed using the MW pulse 
sequence π – T – π/2 – – π – – echo, whereby a π radio-frequency (rf) 
pulse is applied during time T. The following parameters were used: tπ = 
48 (96) ns, tπ/2 = 24 (48) ns, T = 15 µs, trf = 13 µs and  = 200 ns. The 
Mims ENDOR experiments were performed with the MW pulse sequence 
 – π/2 – τ – π/2 – T – π/2 – τ – echo. The parameters used were: tπ/2 = 
16 ns, T = 15 µs, trf = 13 µs. The spectra were recorded at  = 104 ns. 
HYSCORE 
The standard HYSCORE experiments were performed using the π/2 – τ 
– π/2 – t1 – π  –t2 – π/2 – τ – echo sequence of pulses with tπ/2 = 16 ns 
and tπ = 16 ns. The time intervals t1 and t2 were varied in steps of 16 ns. 
In order to eliminate unwanted echoes, a four-step phase cycle was 
applied. The time-domain HYSCORE spectra were base-line corrected 
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with a third-order polynomial, apodized with a Hamming window and zero 
filled. The absolute-value spectra, obtained after two-dimensional Fourier 
transformation, were added to different τ values (104 ns, 120 ns, 176 ns) 
to reduce the blind-spot effects. The HYSCORE spectra were simulated 
using a program developed at ETH Zurich.173  
DFT computations 
Spin-restricted DFT computations were performed with the ORCA 
package174-177 on different models for aqueous CuII-NTA and CuII-NTA-
His6-tag binding (see results and discussion sections). Geometry 
optimisations were performed with the BP86 functional with an Ahlrich 
split-valence plus polarization (SVP) basis set for all other atoms except 
copper, for which a more polarized triple zeta valence basis set (TZVPP) 
is used. The geometry optimisations were tested for different starting 
geometries and the most stable geometry overall was chosen for further 
computation of the EPR parameters. For the latter, the B3LYP functional 
was taken, combined with the EPR-II basis set for nitrogen and hydrogen, 
the ORCA basis set “Core Properties” (CP(PPP)) and SVP for all other 
atoms. A dielectric surrounding with the dielectric constant of water was 
simulated assuming the COSMO model in all computations. 
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7.  Appendix 
Calculation of the encapsulation efficiency: 
To determine maximum enzyme encapsulation efficiency based on the 
number of encapsulated enzymes per vesicle, following equations were 
used:  
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Where, in equation 11, c is the enzyme concentration [gmol-1] used for 
encapsulation and NA the Avogadro number. The reciprocal value of 
equation 11 gives the apparent volume per particle Vapparent (equation 12). 
The number of particles N*enzymes is derived by dividing the volume of the 
polymer vesicles Vvesicle by the volume of apparent volume Vapparent, 
representing the theoretical encapsulation of enzymes by one polymer 
vesicle (equation 13). To calculate the encapsulation efficiency, EEv (%), 
the number of particles determined by FCS brightness measurements, 
N*exp, is divided by the theoretical value (equation 14). 
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Coordinates of the used models for DFT and spin density distributions: 
Model A: [Cu(N(CH2COO)2(CH2COOH))(H2O)2] 
 
 
Fig.   54 Calculated spin density of model A. The contour levels are set at 0.0017 and 
-0.0017, respectively. Blue represents positive spin density, while red represents 
negative spin density. 
 
Model A: Coordinates (in Å) 
  H       1.986319     -3.766505     -0.002538 
  H       1.048407     -5.276164     -0.082316 
  C       0.954631     -4.173606      0.006035 
  C       0.363875     -3.792742      1.372461 
  O      -0.360862     -2.715521      1.387576 
  H       1.911532     -3.810738     -2.437720 
  H       0.545170     -2.868100     -3.101400 
  H      -1.136889     -4.164111     -2.675405 
  H      -0.208779     -5.532695     -1.986454 
  N       0.206808     -3.604295     -1.148356 
  Cu     -0.780084     -1.904933     -0.339569 
  O      -1.742134     -1.379114     -2.071862 
  O      -1.564094     -0.255161      0.566701 
  C      -0.729385     -4.584561     -1.732349 
  C       1.130284     -3.063877     -2.179103 
  C       1.798449     -1.725157     -1.756243 
  O       2.872735     -1.424390     -2.313065 
  O       1.144457     -1.027523     -0.904697 
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  C      -1.943043     -4.877461     -0.858495 
  H      -3.145692     -6.276150     -0.421447 
  O      -2.310240     -6.163282     -0.933767 
  O      -2.542502     -4.026354     -0.216120 
  O       0.638868     -4.455462      2.380576 
  H      -2.597000     -0.945433     -1.865298 
  H      -1.557722     -0.397582      1.537494 
  H      -1.227656     -0.678462     -2.526009 
  H      -0.959451      0.506383      0.438370 
 
Model B: [Cu(N(CH2COO)2(CH2COOH))(C11H15N5O)] 
 
Fig.   55 Calculated spin density of model B. The contour levels are set at 0.0017 and 
-0.0017, respectively. Blue represents positive spin density, while red represents 
negative spin density. 
 
Model B: Coordinates (in Å) 
  O       0.602432     -4.366001      2.366477 
  C       0.350746     -3.697671      1.351770 
  O       1.322347     -1.035162     -1.016393 
  C       1.913262     -1.808572     -1.848316 
  H      -4.370836      2.857339     -1.736942 
  H      -4.326905      2.165665     -3.798643 
  O      -0.303207     -2.579311      1.353159 
  H      -1.394634      1.904801     -4.778039 
  H      -2.787056      1.154668     -5.602032 
  C      -2.401450      1.473803     -4.610637 
  H      -0.173716      0.207722     -2.900534 
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  H      -0.104274      1.294144     -0.635806 
  C      -0.986255      1.165798     -0.000845 
  C      -2.900475     -1.442676     -2.439612 
  Cu     -0.678248     -1.780782     -0.419280 
  N      -1.608280     -1.242648     -2.165215 
  N      -1.393501     -0.085058      0.424616 
  C      -1.199137     -0.172971     -2.944475 
  C      -2.264897      0.291787     -3.699694 
  N      -3.324982     -0.540675     -3.361746 
  H      -4.270859     -0.505503     -3.752520 
  H      -3.546140     -2.202240     -1.985470 
  C      -2.478165      0.098388      1.179757 
  N      -2.777760      1.424239      1.244256 
  C      -1.846837      2.132198      0.494726 
  H      -3.062747     -0.681864      1.679489 
  H      -3.558600      1.821479      1.774000 
  C      -3.328439      2.578944     -4.049666 
  C      -2.718276      3.329173     -2.860547 
  N      -3.476061      3.350105     -1.727732 
  C      -3.131937      4.107925     -0.528749 
  C      -1.882071      3.605736      0.240401 
  H      -4.022616      4.086288      0.128643 
  H      -2.954803      5.170926     -0.800015 
  H      -3.490140      3.335766     -4.846359 
  O      -1.618273      3.897314     -2.942389 
  H      -1.825320      4.179835      1.190601 
  H      -0.979793      3.857812     -0.348261 
  C       1.154341     -3.114166     -2.228934 
  N       0.202492     -3.572055     -1.184932 
  O       3.001551     -1.603611     -2.426269 
  H       0.575332     -2.895652     -3.149794 
  C      -0.782080     -4.516595     -1.745364 
  H      -1.160684     -4.103560     -2.703868 
  H      -0.316056     -5.500125     -1.970811 
  C       0.912737     -4.150743     -0.010429 
  H       1.886217     -3.913216     -2.477798 
  C      -2.013151     -4.720475     -0.869047 
  O      -2.579433     -3.831286     -0.248680 
  O      -2.442060     -5.990694     -0.915201 
  H      -3.283128     -6.049242     -0.403119 
  H       0.940642     -5.259686     -0.063526 
  H       1.967184     -3.806616     -0.030207 
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Model C: [Cu(N(CH2COO)3)(C11H15N5O)]
-
 
 
Fig.  56. Calculated spin density of model C. The contour levels are set at 0.0017 and 
-0.0017, respectively. Blue represents positive spin density, while red represents 
negative spin density. 
 
Model C: Coordinates (in Å) 
  O       0.926091     -4.315926      2.321426 
  C       0.558879     -3.679574      1.316592 
  O       1.263008     -1.006906     -1.041422 
  C       1.838176     -1.749821     -1.904118 
  H      -4.327253      2.837797     -1.746011 
  H      -4.291118      2.170098     -3.818731 
  O      -0.125606     -2.583357      1.359648 
  H      -1.350400      1.875660     -4.758340 
  H      -2.737551      1.131332     -5.595999 
  C      -2.363172      1.454281     -4.601453 
  H      -0.202956      0.239622     -2.765101 
  H      -0.072479      1.178235     -0.422051 
  C      -1.014227      1.088705      0.129711 
  C      -2.912779     -1.466237     -2.445785 
  Cu     -0.802761     -1.886316     -0.363633 
  N      -1.643377     -1.235327     -2.106224 
  N      -1.492393     -0.146972      0.523713 
  C      -1.216786     -0.160207     -2.865571 
  C      -2.250859      0.278299     -3.679181 
  N      -3.310202     -0.575318     -3.392913 
  H      -4.236075     -0.557271     -3.829340 
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  H      -3.551224     -2.241888     -2.009024 
  C      -2.641561      0.075919      1.161082 
  N      -2.914065      1.411203      1.184595 
  C      -1.894395      2.085042      0.524156 
  H      -3.298664     -0.682647      1.601380 
  H      -3.733103      1.834538      1.629047 
  C      -3.287239      2.573842     -4.063300 
  C      -2.682454      3.326981     -2.873982 
  N      -3.439690      3.343427     -1.740875 
  C      -3.090379      4.095822     -0.540404 
  C      -1.872386      3.556720      0.253649 
  H      -3.992548      4.110910      0.101781 
  H      -2.873153      5.149525     -0.817587 
  H      -3.431829      3.325748     -4.867958 
  O      -1.586170      3.902764     -2.954894 
  H      -1.812098      4.140558      1.198383 
  H      -0.950427      3.771309     -0.319655 
  C       1.117492     -3.082877     -2.274411 
  N       0.238591     -3.607442     -1.212457 
  O       2.897574     -1.501980     -2.529977 
  H       0.490583     -2.869658     -3.165252 
  C      -0.796413     -4.541126     -1.689452 
  H      -1.120777     -4.206244     -2.697008 
  H      -0.393004     -5.573851     -1.796641 
  C       1.010544     -4.159346     -0.076019 
  H       1.883745     -3.830852     -2.582332 
  C      -2.091358     -4.602167     -0.821057 
  O      -2.434265     -3.524442     -0.230012 
  O      -2.724058     -5.685285     -0.838941 
  H       1.015169     -5.271075     -0.095836 
  H       2.070530     -3.841981     -0.169094 
 
  
Engineering artificial organelles  
 
135 
8.  References 
(1) Borisov, S. M.; Wolfbeis, O. S.: Optical Biosensors. Chem. 
 Rev. (Washington, DC, U. S.) 2008, 108, 423-461. 
(2) Tanner, P.; Egli, S.; Balasubramanian, V.; Onaca, O.; Palivan, C. 
 G.; Meier, W.: Can polymeric vesicles that confine enzymatic 
 reactions act as simplified organelles? FEBS Lett. 2011, 585, 
 1699-1706. 
(3) Immordino, M. L.; Dosio, F.; Cattel, L.: Stealth liposomes: review 
 of the basic science, rationale, and clinical applications, existing 
 and potential. Int. J. Nanomed. 2006, 1, 297- 315. 
(4) Baumann, P.; Tanner, P.; Onaca, O.; Palivan, C. G.: Bio-Decorated 
 Polymer Membranes: A New Approach in Diagnostics and 
 Therapeutics. Polymers 2011, 3, 173-192. 
(5) Fu, Z.; Ochsner, M. A.; de Hoog, H.-P. M.; Tomczak, N.; Nallani, 
 M.: Multicompartmentalized polymersomes for selective 
 encapsulation of biomacromolecules. Chem. Commun. 2011, 47, 
 2862-2864. 
(6) Palivan, C. G.; Vebert, C.; Axthelm, F.; Meier, W.: Responsive 
 self-assembled nanostructures. CRC Press LLC, 2007, 32/1-
 32/26. 
(7) Dziubla, T. D.; Karim, A.; Muzykantov, V. R.: Polymer 
 nanocarriers protecting active enzyme cargo against proteolysis. 
 J. Control. Release 2005, 102, 427-439. 
(8) Wu, J.; Eisenberg, A.: Proton Diffusion across Membranes of 
 Vesicles of Poly(styrene-b-acrylic Acid) Diblock Copolymers. 
 J. Am. Chem. Soc. 2006, 128, 2880-2884. 
(9) de Hoog, H. M.; Nallani, M.; Cornelissen, J. J. L. M.; Rowan, A. 
 E.; Nolte, R. J. M.; Arends, I. W. C. E.: Biocatalytic oxidation by 
 chloroperoxidase from Caldariomyces fumago in polymersome 
 nanoreactors. Org. Biomol. Chem. 2009, 7, 4604-4610. 
(10) Palivan, C. G.; Fischer-Onaca, O.; Delcea, M.; Itel, F.; Meier, W.: 
 Protein-polymer nanoreactors for medical applications. Chem. Soc. 
 Rev. 2011, 41, 2800-2823. 
(11) Tanner, P.; Baumann, P.; Enea, R.; Onaca, O.; Palivan, C.; Meier, 
 W.: Polymeric Vesicles: From Drug Carriers to Nanoreactors and 
 Artificial Organelles. ACR 2011, 44, 1039-1049. 
(12) Bolinger, P.-Y.; Stamou, D.; Vogel, H.: An Integrated Self-
 Assembled Nanofluidic System for Controlled Biological 
 Chemistries. Angew. Chem. Int. Edit. 2008, 47, 5544-5549. 
P. Tanner 
 
136 
(13) Graff, A.; Winterhalter, M.; Meier, W.: Nanoreactors from 
 Polymer-Stabilized Liposomes. Langmuir 2001, 17, 919-923. 
(14) Karlsson, M.; Davidson, M.; Karlsson, R.; Karlsson, A.; 
 Bergenholtz, J.; Konkoli, Z.; Jesorka, A.; Lobovkina, T.; Hurtig, J.; 
 Voinova, M.; Orwar, O.: BIOMIMETIC NANOSCALE 
 REACTORS AND NETWORKS. Annu. Rev. Phys. Chem. 2004, 
 55, 613-649. 
(15) Vriezema, D. M.; Aragones, M. C.; Elemans, J. A. A. W.; 
 Cornelissen, J. J. L. M.; Rowan, A. E.; Nolte, R. J. M.: Self-
 Assembled Nanoreactors. Chem. Rev. (Washington, DC, U. S.) 
 2005, 105, 1445-1489. 
(16) Ma, Y.; Li, C.; Cai, T.; Li, J.; Hu, W.: Role of block junctions in 
 the interplay of phase transitions of two-component polymeric 
 systems. J. Phys. Chem. B 2011, 115, 8853-7. 
(17) Richard Di, G.; Joel, M., Reactive Oxygen Species and Oxidative 
 Stress. In The Toxicology of Fishes, CRC Press: 2008, 273-324. 
(18) Hoogenboom, R.: Poly(2-oxazoline)s: A Polymer Class with 
 Numerous Potential Applications. Angew. Chem. Int. Edit.  2009, 
 48, 7978-7994. 
(19) Batich, C.; DePalma, D.: Materials used in breast implants: 
 silicones and polyurethanes. J. Long-Term Eff. Med. Implants 
 1992, 1, 255-68. 
(20) Satomi, T.; Nagasaki, Y.; Kobayashi, H.; Tateishi, T.; Kataoka, K.; 
 Otsuka, H.: Physicochemical characterization of densely packed 
 poly(ethylene glycol) layer for minimizing nonspecific protein 
 adsorption. J. Nanosci. Nanotechnol. 2007, 7, 2394-2399. 
(21) Nehring, R.; Palivan, C. G.; Casse, O.; Tanner, P.; Tuxen, J.; 
 Meier, W.: Amphiphilic Diblock Copolymers for Molecular 
 Recognition: Metal-Nitrilotriacetic Acid Functionalized Vesicles. 
 Langmuir 2008, 25, 1122-1130. 
(22) Kidane, A.; McPherson, T.; Shim, H. S.; Park, K.: Surface 
 modification of polyethylene terephthalate using PEO-
 polybutadiene-PEO triblock copolymers. Colloid Surface B 2000, 
 18, 347-353. 
(23) Nehring, R.; Palivan, C. G.; Moreno-Flores, S.; Mantion, A.; 
 Tanner, P.; Toca-Herrera, J. L.; Thuenemann, A.; Meier, W.: 
 Protein decorated membranes by specific molecular interactions. 
 Soft Matter 2010, 6, 2815-2824. 
Engineering artificial organelles  
 
137 
(24) Kita-Tokarczyk, K.; Grumelard, J.; Haefele, T.; Meier, W.: Block 
 copolymer vesicles-using concepts from polymer chemistry to 
 mimic biomembranes. Polymer 2005, 46, 3540-3563. 
(25) Balasubramanian, V.; Onaca, O.; Enea, R.; Hughes, D. W.; 
 Palivan, C. G.: Protein delivery: From conventional drug delivery 
 carriers to polymeric nanoreactors. Expert Opin. Drug Del.  2010, 
 7, 63-78. 
(26) Discher, D. E.; Eisenberg, A.: Polymer vesicles. Science 2002, 
 297, 967-73. 
(27) Caruso, F.: Modification, Organization and Utilization of Colloid 
 Particles: Colloids and Colloid Assemblies; Wiley-VCH Verlag 
 GmbH & Co. KGaA, 2004. 
(28) Smart, T.; Lomas, H.; Massignani, M.; Flores-Merino, M. V.; 
 Perez, L. R.; Battaglia, G.: Block copolymer nanostructures. Nano 
 Today 2008, 3, 38-46. 
(29) Förster, S.; Plantenberg, T., From Self-Organizing Polymers to 
 Nanohybrid and Biomaterials. Angew. Chem. Int. Edit. 2002, 41 
 (5), 688-714. 
(30) Lazzari, M.; Liu, G.; Lecommandoux, S.; Editors: Block 
 Copolymers in Nanoscience; Wiley-VCH Verlag GmbH & Co. 
 KGaA, 2006. 
(31) Discher, B. M.; Won, Y.-Y.; Ege, D. S.; Lee, J. C. M.; Bates, F. S.; 
 Discher, D. E.; Hammer, D. A.: Polymersomes: Tough vesicles 
 made from diblock copolymers. Science (Washington, D. C.) 
 1999, 284, 1143-1146. 
(32) Korobko, A. V.; Backendorf, C.; van, d. M. J. R. C.: 
 Plasmid DNA Encapsulation within Cationic Diblock Copolymer 
 Vesicles for Gene Delivery. J. Phys. Chem. B 2006, 110, 14550-
 14556. 
(33) Schillen, K.; Bryskhe, K.; Mel'nikova, Y. S.: Vesicles Formed 
 from a Poly(ethylene oxide)-Poly(propylene oxide)-Poly(ethylene 
 oxide) Triblock Copolymer in Dilute Aqueous Solution. 
 Macromolecules 1999, 32, 6885-6888. 
(34) Antonietti, M.; Foerster, S.: Vesicles and liposomes: A self-
 assembly principle beyond lipids. Adv. Mater.2003, 15, 1323-
 1333. 
(35) Egli, S.; Schlaad, H.; Bruns, N.; Meier, W.: Functionalization of 
 Block Copolymer Vesicle Surfaces. Polymers 2011, 3, 252-280. 
P. Tanner 
 
138 
(36) Onaca, O.; Enea, R.; Hughes, D. W.; Meier, W.: Stimuli-
 Responsive Polymersomes as Nanocarriers for Drug and Gene 
 Delivery. Macromol. Biosci. 2009, 9, 129-139. 
(37) Dimova, R.; Seifert, U.; Pouligny, B.; Forster, S.; Dobereiner, H. 
 G.: Hyperviscous diblock copolymer vesicles. Eur. Phys. J. E. 
 2002, 7, 241-250. 
(38) Battaglia, G.; Ryan, A. J.: Bilayers and Interdigitation in Block 
 Copolymer Vesicles. J. Am. Chem. Soc. 2005, 127, 8757-8764. 
(39) Evans, E.; Needham, D.: Physical properties of surfactant bilayer 
 membranes: thermal transitions, elasticity, rigidity, cohesion and 
 colloidal interactions. J. Phys. Chem. 1987, 91, 4219-28. 
(40) Malinova, V.; Belegrinou, S.; Bruyn Ouboter, D. d.; Meier, W.: 
 Biomimetic Block Copolymer Membranes. In Polymer 
 Membranes / Biomembranes; Springer Berlin / Heidelberg, 2009; 
 pp 113-166. 
(41) Nardin, C.; Hirt, T.; Leukel, J.; Meier, W.: Polymerized ABA 
 Triblock Copolymer Vesicles. Langmuir 2000, 16, 1035-1041. 
(42) Burchard, W.: Static and dynamic light scattering from branched 
 polymers and biopolymers. Adv. Polym Sci. 1983,  48, 1-124. 
(43) Pata, V.; Ahmed, F.; Discher, D. E.; Dan, N.: Membrane 
 Solubilization by Detergent:  Resistance Conferred by Thickness. 
 Langmuir 2004, 20, 3888-3893. 
(44) Sauer, M.; Haefele, T.; Graff, A.; Nardin, C.; Meier, W.: Ion-
 carrier controlled precipitation of calcium phosphate in giant ABA 
 triblock copolymer vesicles. Chem. Commun. 2001, 2452-2453. 
(45) Schermelleh, L.; Heintzmann, R.; Leonhardt, H.: A guide to super-
 resolution fluorescence microscopy. J. Cell. Biol. 2010, 190, 165-
 175. 
(46) Onaca, O.; Hughes, D. W.; Balasubramanian, V.; Grzelakowski, 
 M.; Meier, W.; Palivan, C. G.: SOD Antioxidant Nanoreactors: 
 Influence of Block Copolymer Composition on the Nanoreactor 
 Efficiency. Macromol. Biosci. 2010, 10, 531-538. 
(47) van Dongen, S. F. M.; Verdurmen, W. P. R.; Peters, R. J. R. W.; 
 Nolte, R. J. M.; Brock, R.; van Hest, J. C. M.: Cellular Integration 
 of an Enzyme-Loaded Polymersome Nanoreactor. Angew.  Chem. 
 Int. Edit. 2010, 49, 7213-7216. 
(48) Zhang, X.; Tanner, P.; Graff, A.; Palivan, C. G.; Meier, W.: 
 Mimicking the cell membrane with block copolymer membranes. 
 J. Polym. Sci. A1 2012, 50,  2293-2318. 
Engineering artificial organelles  
 
139 
(49) Sleytr, U. B.; Robards, A. W.: Freeze-fracturing: a review of 
 methods and results. J. Microsc-Oxford 1977, 111, 77-100. 
(50) Ahmed, F.; Pakunlu, R. I.; Brannan, A.; Bates, F.; Minko, T.; 
 Discher, D. E.: Biodegradable polymersomes loaded with both 
 paclitaxel and doxorubicin permeate and shrink tumors, inducing 
 apoptosis in proportion to accumulated drug. J. Control. Release 
 2006, 116, 150-158. 
(51) Axthelm, F.; Casse, O.; Koppenol Willem, H.; Nauser, T.; Meier, 
 W.; Palivan Cornelia, G.: Antioxidant nanoreactor based on 
 superoxide dismutase encapsulated in superoxide-permeable 
 vesicles. J. Phys. Chem. B 2008, 112, 8211-7. 
(52) Egli, S.; Nussbaumer, M. G.; Balasubramanian, V.; Chami, M.; 
 Bruns, N.; Palivan, C.; Meier, W.: Biocompatible 
 Functionalization of Polymersome Surfaces: A New Approach to 
 Surface Immobilization and Cell Targeting Using Polymersomes. 
 JACS 2011, 133, 4476-4483. 
(53) Grzelakowski, M.; Onaca, O.; Rigler, P.; Kumar, M.; Meier, W.: 
 Immobilized Protein-Polymer Nanoreactors. Small 2009, 5, 2545-
 2548. 
(54) Rigler, P.; Meier, W.: Encapsulation of fluorescent molecules by 
 functionalized polymeric nanocontainers: investigation by confocal 
 fluorescence imaging and fluorescence correlation spectroscopy. J 
 Am. Chem. Soc. 2006, 128, 367-373. 
(55) Tanner, P.; Ezhevskaya, M.; Nehring, R.; Van Doorslaer, S.; 
 Meier, W. P.; Palivan, C. G.: Specific His6-tag Attachment to 
 Metal-Functionalized Polymersomes Relies on Molecular 
 Recognition. J. Phys. Chem. B 2012. 
(56) Tanner, P.; Onaca, O.; Balasubramanian, V.; Meier, W.; Palivan, 
 C. G.: Enzymatic Cascade Reactions inside Polymeric 
 Nanocontainers: A Means to Combat Oxidative Stress. Chem-Eur. 
 J. 2011, 4552-4560. 
(57) De Vocht, C.; Ranquin, A.; Van Ginderachter, J.; Vanhaecke, T.; 
 Rogiers, V.; Van Gelder, P.; Versées, W.; Steyaert, J.: Polymeric 
 nanoreactors for enzyme replacement therapy of MNGIE. J. 
 Control. Release 2010, 148, e19-e20. 
(58) Broz, P.; Benito, S. M.; Saw, C.; Burger, P.; Heider, H.; Pfisterer, 
 M.; Marsch, S.; Meier, W.; Hunziker, P.: Cell targeting by a 
 generic receptor-targeted polymer nanocontainer platform. J. 
 Control. Release 2005, 102, 475-488. 
P. Tanner 
 
140 
(59) Torchilin, V. P.: Recent advances with liposomes as 
 pharmaceutical carriers. Nat. Rev. Drug Discov. 2005, 4, 145-160. 
(60) Baumann, P.; Balasubramanian, V.; Onaca-Fischer, O.; 
 Sienkiewicz, A.; Palivan, C. G.: Light-responsive polymer 
 nanoreactors: a source of reactive oxygen species on demand. 
 Nanoscale 2013, 5, 217-224. 
(61) Ben-Haim, N.; Broz, P.; Marsch, S.; Meier, W.; Hunziker, P.: Cell-
 Specific Integration of Artificial Organelles Based on 
 Functionalized Polymer Vesicles. Nano Lett. 2008, 8, 1368-
 1373. 
(62) Balasubramanian, V.; Onaca, O.; Ezhevskaya, M.; Van Doorslaer, 
 S.; Sivasankaran, B.; Palivan, C. G.: A surprising system: 
 polymeric nanoreactors containing a mimic with dual-enzyme 
 activity. Soft Matter 2011, 7, 5595-5603. 
(63) Dobrunz, D.; Toma, A. C.; Tanner, P.; Pfohl, T.; Palivan, C. G.: 
 Polymer nanoreactors with dual functionality: simultaneous 
 detoxification of peroxynitrite and oxygen transport. Langmuir 
 2012. 
(64) Geibel, B.; Merschky, M.; Rether, C.; Schmuck, C.: Artificial 
 Enzyme Mimics. In Supramolecular Chemistry; John Wiley & 
 Sons, Ltd, 2012. 
(65) Ahmed, F.; Discher, D. E.: Self-porating polymersomes of PEG-
 PLA and PEG-PCL: hydrolysis-triggered controlled release 
 vesicles. J. Control. Release 2004, 96, 37-53. 
(66) Graff, A.; Sauer, M.; Van Gelder, P.; Meier, W.: Virus-assisted 
 loading of polymer nanocontainer. Proc. Natl. Acad. Sci. USA 
 2002, 99, 5064-5068. 
(67) Kumar, M.; Grzelakowski, M.; Zilles, J.; Clark, M.; Meier, W.: 
 Highly permeable polymeric membranes based on the 
 incorporation of the functional water channel protein Aquaporin Z. 
 Proc. Natl. Acad. Sci. USA 2007, 1-6. 
(68) Nardin, C.; Thoeni, S.; Widmer, J.; Winterhalter, M.; Meier, W.: 
 Nanoreactors based on (polymerized) ABA-triblock copolymer 
 vesicles. Chem. Commun. 2000, 1433-1434. 
(69) Graff, A.; Fraysse-Ailhas, C.; Palivan, C. G.; Grzelakowski, M.; 
 Friedrich, T.; Vebert, C.; Gescheidt, G.; Meier, W.: Amphiphilic 
 copolymer membranes promote NADH:ubiquinone oxidoreductase 
 activity: Towards an electron-transfer nanodevice. Macromol. 
 Chem. Physic. 2010, 211, 229-238. 
Engineering artificial organelles  
 
141 
(70) Ranquin, A.; Versees, W.; Meier, W.; Steyaert, J.; Van Gelder, P.: 
 Therapeutic Nanoreactors: Combining Chemistry and Biology in a 
 Novel Triblock Copolymer Drug Delivery System. Nano Lett. 
 2005, 5, 2220-2224. 
(71) Nallani, M.; Benito, S.; Onaca, O.; Graff, A.; Lindemann, M.; 
 Winterhalter, M.; Meier, W.; Schwaneberg, U.: A 
 nanocompartment system (Synthosome) designed for 
 biotechnological applications. J. Biotechnol. 2006, 123, 50-59. 
(72) Prilipov, A.; Phale, P. S.; Van Gelder, P.; Rosenbusch, J. P.; 
 Koebnik, R.: Coupling site-directed mutagenesis with high-level 
 expression: large scale production of mutant porins from E. coli. 
 FEMS  Microbiol. Lett. 1998, 163, 65-72. 
(73) Phale, P. S.; Philippsen, A.; Kiefhaber, T.; Koebnik, R.; Phale, V. 
 P.; Schirmer, T.; Rosenbusch, J. P.: Stability of Trimeric OmpF 
 Porin:  The Contributions of the Latching Loop L2†. Biochemistry 
 1998, 37, 15663-15670. 
(74) Koebnik, R.; Locher, K. P.; Van Gelder, P.: Structure and function 
 of bacterial outer membrane proteins: barrels in a nutshell. Mol. 
 Microbiol. 2000, 37, 239-253. 
(75) Meier, W.; Nardin, C.; Winterhalter, M.: Reconstitution of channel 
 proteins in (polymerized) ABA triblock copolymer membranes. 
 Angew. Chem. Int. Edit. 2000, 39, 4599-4602. 
(76) Cowan, S. W.; Schirmer, T.; Rummel, G.; Steiert, M.; Ghosh, R.; 
 Pauptit, R. A.; Jansonius, J. N.; Rosenbusch, J. P.: Crystal 
 structures explain functional properties of two E. coli porins. 
 Nature (London) 1992, 358, 727-33. 
(77) Wallace, B. A.: Gramicidin Channels and Pores. Annu. Rev. 
 Biophys. Bio. 1990, 19, 127-157. 
(78) Tanner, P.; Balasubramanian, V.; Palivan, C. G.: Aiding Nature’s 
 Organelles: Artificial Peroxisomes Play Their Role. Nano Lett. 
 2013. 
(79) Ahmed, F.; Pakunlu, R. I.; Srinivas, G.; Brannan, A.; Bates, F.; 
 Klein, M. L.; Minko, T.; Discher, D. E.: Shrinkage of a rapidly 
 growing tumor by drug-loaded polymersomes: pH-triggered 
 release through copolymer degradation. Mol. Pharmaceut. 2006, 3, 
 340-350. 
(80) Uchegbu, I. F.: Pharmaceutical nanotechnology: polymeric 
 vesicles for drug and gene delivery. Expert Opin. Drug Del. 
 2006, 3, 629-640. 
P. Tanner 
 
142 
(81) Lomas, H.; Canton, I.; MacNeil, S.; Du, J.; Armes, S. P.; Ryan, A. 
 J.; Lewis, A. L.; Battaglia, G.: Biomimetic pH sensitive 
 polymersomes for efficient DNA encapsulation and delivery. 
 Adv. Mater. (Weinheim, Ger.) 2007, 19, 4238-4243. 
(82) Arifin, D. R.; Palmer, A. F.: Polymersome encapsulated 
 hemoglobin: a novel type of oxygen carrier. Biomacromolecules 
 2005, 6, 2172-2181. 
(83) Wittemann, A.; Azzam, T.; Eisenberg, A.: Biocompatible Polymer 
 Vesicles from Biamphiphilic Triblock Copolymers and Their 
 Interaction with Bovine Serum Albumin. Langmuir 2007, 23, 
 2224-2230. 
(84) Christian, D. A.; Cai, S.; Bowen, D. M.; Kim, Y.; Pajerowski, J. 
 D.; Discher, D. E.: Polymersome carriers: From self-assembly to 
 siRNA and protein therapeutics. Eur. J. Pharm. Biopharm. 2009, 
 71, 463-474. 
(85) Lomas, H.; Du, J. Z.; Canton, I.; Madsen, J.; Warren, N.; Armes, 
 S. P.; Lewis, A. L.; Battaglia, G.: Efficient Encapsulation of 
 Plasmid DNA in pH-Sensitive PMPC-PDPA Polymersomes: Study 
 of the Effect of PDPA Block Length on Copolymer-DNA Binding 
 Affinity. Macromol. Biosci. 2010, 10, 513-530. 
(86) Cosentino-Gomes, D.; Rocco-Machado, N.; Meyer-Fernandes, J. 
 R.: Cell signaling through protein kinase C oxidation and 
 activation. Int. J. Mol. Sci. 2012, 13, 10697-10722. 
(87) Hileman, E. A.; Achanta, G.; Huang, P.: Superoxide dismutase: An 
 emerging target for cancer therapeutics. Expert Opin. Ther. Targets 
 2001, 5, 697-710. 
(88) Sampayo, J. N.; Gill, M. S.; Lithgow, G. J.: Oxidative stress and 
 aging - the use of superoxide dismutase/catalase mimetics to 
 extend lifespan. Biochem. Soc. Trans. 2003, 31, 1305-1307. 
(89) Droege, W.: Oxidative stress in HIV infection. Oxid. Stress, Dis. 
 Cancer 2006, 885-895. 
(90) Lomri, A.: Role of reactive oxygen species and superoxide 
 dismutase in cartilage aging and pathology. Future Rheumatol. 
 2008, 3, 381-392. 
(91) Onaca-Fischer, O.; Liu, J.; Inglin, M.; Palivan, C. G.: Polymeric 
 nanocarriers and nanoreactors: a survey of possible therapeutic 
 applications. Curr. Pharm. Des. 2012, 18, 2622-2643. 
Engineering artificial organelles  
 
143 
(92) Waris, G.; Ahsan, H.: Reactive oxygen species: Role in the 
 development of cancer and various chronic conditions. J. Carcinog. 
 2006, 5, 14-14. 
(93) Grivennikova, V. G.; Vinogradov, A. D.: Generation of superoxide 
 by the mitochondrial complex I. Biochim. Biophys. Acta, 
 Bioenerg. 2006, 1757, 553-561. 
(94) Bonekamp, N. A.; Völkl, A.; Fahimi, H. D.; Schrader, M.: 
 Reactive oxygen species and peroxisomes: Struggling for balance. 
 BioFactors 2009, 35, 346-355. 
(95) Horiguchi, H.; Yurimoto, H.; Kato, N.; Sakai, Y.: Antioxidant 
 System within Yeast Peroxisome: Biochemical and  physiological 
 characterisation of CbPmp20 in the methylotrophic yeast 
 candida Boidinii. J. Biol. Chem. 2001, 276, 14279-14288. 
(96) Silva, J. P.; Coutinho, O. P.: Free radicals in the regulation  of 
 damage and cell death - basic mechanisms and prevention. Drug 
 Discoveries Ther. 2010, 4, 144-167. 
(97) Heukamp, I.; Kilian, M.; Gregor, J. I.; Neumann, A.; Jacobi, C. A.; 
 Guski, H.; Schimke, I.; Walz, M. K.; Wenger, F. A.: Effects of the 
 antioxidative vitamins A, C and E on liver metastasis and 
 intrametastatic lipid peroxidation in BOP-induced pancreatic 
 cancer in syrian hamsters. Pancreatology 2005, 5, 403-409. 
(98) Jadot, G.; Vaille, A.; Maldonado, J.; Vanelle, P.: Clinical 
 pharmacokinetics and delivery of bovine superoxide dismutase. 
 Clin. Pharmacokinet. 1995, 28, 17-25. 
(99) Muzykantov, V. R.: Delivery of antioxidant enzyme proteins to the 
 lung. Antioxid. Redox Signaling 2001, 3, 39-62. 
(100) Petelin, M.; Pavlica, Z.; Ivanuša, T.; Šentjurc, M.; Skalerič, U.: 
 Local delivery of liposome-encapsulated superoxide dismutase and 
 catalase suppress periodontal inflammation in beagles. J. Clin. 
 Periodontol. 2000, 27, 918-925. 
(101) Kling, J.: PEGylation of Biologics. BioProcess International 2013, 
 11, 9. 
(102) Hochuli, E.; Döbeli, H.; Schacher, A.: New metal chelate 
 adsorbent selective for proteins and peptides containing 
 neighbouring histidine residues. J. Chromatogr. A  1987, 411, 
 177-184. 
(103) Terpe, K.: Overview of tag protein fusions: from molecular and 
 biochemical fundamentals to commercial systems. Appl. 
 Microbiol. Biot. 2003, 60, 523-533-533. 
P. Tanner 
 
144 
(104) Dietrich, C.; Schmitt, L.; Tampe, R.: Molecular organization of 
 histidine-tagged biomolecules at self-assembled lipid interfaces 
 using a novel class of chelator lipids. Proc. Natl. Acad. Sci. 1995, 
 92, 9014-18. 
(105) Gamsjaeger, R.; Wimmer, B.; Kahr, H.; Tinazli, A.; Picuric, S.; 
 Lata, S.; Tampe, R.; Maulet, Y.; Gruber, H. J.; Hinterdorfer, P.; 
 Romanin, C.: Oriented Binding of the His6-Tagged Carboxyl-Tail 
 of the L-type Ca2+ Channel alpha 1-Subunit to a New NTA-
 Functionalized Self-Assembled Monolayer. Langmuir 2004, 20, 
 5885-5890. 
(106) Hoffmann, C.; Gaietta, G.; Zurn, A.; Adams, S. R.; Terrillon, S.; 
 Ellisman, M. H.; Tsien, R. Y.; Lohse, M. J.: Fluorescent labeling 
 of tetracysteine-tagged proteins in intact cells. Nat. Protocols 2010, 
 5, 1666-1677. 
(107) Soh, N.: Selective Chemical Labeling of Proteins with  Small 
 Fluorescent Molecules Based on Metal-Chelation  Methodology. 
 Sensors 2008, 8, 1004-1024. 
(108) Wilchek, M.; Bayer, E. A.: Avidin-biotin immobilization 
 systems. Immobilized Biomolecules in Analysis 1998, 15-34. 
(109) Buckland, R. M.: Strong signals from streptavidin-biotin. Nature 
 (London) 1986, 320, 557-8. 
(110) Conroy, P. J.; Hearty, S.; Leonard, P.; O’Kennedy, R. J.: Antibody 
 production, design and use for biosensor-based applications. 
 Developmental Biology 2009, 20, 10-26. 
(111) Sine, S. M.: The nicotinic receptor ligand binding domain. J. 
 Neurobiol. 2002, 53, 431-446. 
(112) Jamieson, A. C.; Wang, H.; Kim, S.-H.: A zinc finger directory for 
 high-affinity DNA recognition. Proc. Natl. Acad. Sci. 1996, 93, 
 12834-12839. 
(113) Stadlbauer, S.; Riechers, A.; Späth, A.; König, B., Utilizing 
 Reversible Copper(II) Peptide Coordination in a Sequence-
 Selective Luminescent Receptor. Chem-Eur. J. 2008, 14 (8), 2536-
 2541. 
(114) Kruppa, M.; König, B.: Reversible Coordinative Bonds in 
 Molecular Recognition. Chem. Rev. 2006, 106, 3520-3560. 
(115) Knecht, S.; Ricklin, D.; Eberle, A. N.; Ernst, B.: Oligohis-tags: 
 mechanisms of binding to Ni2+-NTA surfaces. J. Mol. Recognit. 
 2009, 22, 270-279. 
Engineering artificial organelles  
 
145 
(116) Vomasta, D.; Högner, C.; Branda, N. R.; König, B.: Regulation of 
 Human Carbonic Anhydrase I (hCAI) Activity by Using a 
 Photochromic Inhibitor. Angw. Chem. Int. Edit. 2008, 47, 7644-
 7647. 
(117) Block, H.; Maertens, B.; Spriestersbach, A.; Brinker, N.; Kubicek, 
 J.; Fabis, R.; Labahn, J.; Schaefer, F., Immobilized-metal affinity 
 chromatography (IMAC): a review. Methods Enzymol. 2009, 463, 
 439-473. 
(118) Huang, Z.; Hwang, P.; Watson, D. S.; Cao, L.; Szoka, F. C.: Tris-
 Nitrilotriacetic Acids of Subnanomolar Affinity Toward 
 Hexahistidine Tagged Molecules. Bioconjugate Chem. 2009, 20, 
 1667-1672. 
(119) Lata, S.; Gavutis, M.; Tampé, R.; Piehler, J.: Specific and Stable 
 Fluorescence Labeling of Histidine-Tagged Proteins for Dissecting 
 Multi-Protein Complex Formation. J. Am. Chem. Soc. 2006, 128, 
 2365-2372. 
(120) 陳錦文; 劉宣良; 林進中; 何意: Molecular Dynamics 
 Simulations of Metal Ion Binding to the His-tag Motif. J. Chin. 
 Chem. Soc-Taip. 2005, 52, 1281-1290. 
(121) Rajesh; Bisht, V.; Takashima, W.; Kaneto, K., Development of a 
 potentiometric urea biosensor based on copolymer poly(N-3-
 aminopropyl pyrrole-co-pyrrole) film. React. Funct. Polym. 2005, 
 62 (1), 51-59. 
(122) Chen, Q.; Schoenherr, H.; Vancso, G. J.: Block-copolymer 
 vesicles as nanoreactors for enzymatic reactions. Small 2009, 5, 
 1436-1445. 
(123) Henderson, J. R.; Swalwell, H.; Boulton, S.; Manning, P.; McNeil, 
 C. J.; Birch-Machin, M. A.: Direct, real-time monitoring of 
 superoxide generation in isolated mitochondria. Free Radical Res. 
 2009, 43, 796-802. 
(124) Chen, D.; Xi, T.; Bai, J.: Biological effects induced by nanosilver 
 particles: in vivo study. Biomed. Mater. 2007, 2, S126-8.  
(125) Slemmer, J. E.; Shacka, J. J.; Sweeney, M. I.; Weber, J. T.: 
 Antioxidants and free radical scavengers for the treatment of 
 stroke, traumatic brain injury and aging. Curr. Med. Chem. 2008, 
 15, 404-414. 
(126) Igarashi, R.; Hoshino, J.; Ochiai, A.; Morizawa, Y.; Mizushima, 
 Y.: Lecithinized superoxide dismutase enhances its pharmacology 
P. Tanner 
 
146 
 potency by increasing its cell membrane affinity. J. Pharmacol. 
 Exp. Ther. 1994, 271, 1672-7.  
(127) Gaspar, M. M.; Boerman, O. C.; Laverman, P.; Corvo, M. L.; 
 Storm, G.; Cruz, M. E. M.: Enzymosomes with surface-exposed 
 superoxide dismutase: In vivo behaviour and therapeutic activity in 
 a model of adjuvant arthritis. J. Control. Release 2007, 117, 186-
 195. 
(128) Jubeh, T. T.; Antler, S.; Haupt, S.; Barenholz, Y.; Rubinstein, A.: 
 Local Prevention of Oxidative Stress in the Intestinal Epithelium 
 of the Rat by Adhesive Liposomes of Superoxide Dismutase and 
 Tempamine. Mol. Pharm. 2005, 2, 2-11. 
(129) Lee, S.; Yang, S. C.; Heffernan, M. J.; Taylor, W. R.; Murthy, N.: 
 Polyketal Microparticles: A New Delivery Vehicle for Superoxide 
 Dismutase. Bioconjugate Chem. 2007, 18, 4-7.  
(130) Coyle, C. H.; Kader, K. N.: Mechanisms of H2O2-induced 
 oxidative stress in endothelial cells exposed to physiologic shear 
 stress. ASAIO J. 2007, 53, 17-22. 
(131) Michel, E.; Nauser, T.; Sutter, B.; Bounds, P. L.; Koppenol, W. H.: 
 Kinetics properties of Cu,Zn-superoxide dismutase as a function of 
 metal content. Arch. Biochem. Biophys. 2005, 439, 234-240. 
(132) Kussendrager, K. D.; Van Hooijdonk, A. C. M.: Lactoperoxidase: 
 physico-chemical properties, occurrence, mechanism of action and 
 applications. Br. J. Nutr. 2000, 84, S19-S25. 
(133) Nardin, C.; Winterhalter, M.; Meier, W.: Giant Free-Standing 
 ABA Triblock Copolymer Membranes. Langmuir 2000, 16, 7708-
 7712. 
(134) Deisseroth, A.; Dounce, A. L.: Catalase: Physical and chemical 
 properties, mechanism of catalysis, and physiological role. Physiol 
 Rev. 1970, 50, 319-75. 
(135) Adrian, G.; Huang, L.: Entrapment of proteins in 
 phosphatidylcholine vesicles. Biochemistry 1979, 18, 5610-4. 
(136) Cornish-Bowden, A.: Fundamentals of Enzyme Kinetics, Third 
 Edition, 2004. 
(137) Zámocký, M.; Koller, F.: Understanding the structure and function 
 of catalases: clues from molecular evolution and in vitro 
 mutagenesis. Prog. Biophys. Mol. Bio. 1999, 72, 19-66. 
(138) Zhu, Z.; Momeu, C.; Zakhartsev, M.; Schwaneberg, U.: Making 
 glucose oxidase fit for biofuel cell applications by directed protein 
 evolution. Biosens. Bioelectron. 2006, 21, 2046-2051. 
Engineering artificial organelles  
 
147 
(139) English, B. P.; Min, W.; van Oijen, A. M.; Lee, K. T.; Luo, G.; 
 Sun, H.; Cherayil, B. J.; Kou, S. C.; Xie, X. S.: Ever-fluctuating 
 single enzyme molecules: Michaelis-Menten equation revisited. 
 Nat. Chem. Biol. 2006, 2, 87-94. 
(140) Kita-Tokarczyk, K.; Itel, F.; Grzelakowski, M.; Egli, S.; Rossbach, 
 P.; Meier, W.: Monolayer Interactions between Lipids and 
 Amphiphilic Block Copolymers. Langmuir 2009, 25, 9847-9856. 
(141) Lazarow, P. B.; Fujiki, Y.: Biogenesis of Peroxisomes. Annu.
 Rev. Cell Biol. 1985, 1, 489-530. 
(142) van Dongen, S. F. M.; Nallani, M.; Cornelissen, J. J. L. M.; Nolte, 
 R. J. M.; van Hest, J. C. M.: A three-enzyme cascade reaction 
 through positional assembly of enzymes in a polymersome 
 nanoreactor. Chem-Eur. J. 2009, 15, 1107-1114. 
(143) Cho, E. C.; Zhang, Q.; Xia, Y.: The effect of sedimentation and 
 diffusion on cellular uptake of gold nanoparticles. Nat. Nano. 
 2011, 6, 385-391. 
(144) Chithrani, B. D.; Ghazani, A. A.; Chan, W. C. W.: Determining the 
 Size and Shape Dependence of Gold Nanoparticle Uptake into 
 Mammalian Cells. Nano Lett. 2006, 6, 662-668. 
(145) Kim, J. A.; Åberg, C.; Salvati, A.; Dawson, K. A.: Role of cell 
 cycle on the cellular uptake and dilution of nanoparticles in a cell 
 population. Nat. Nanotechnol. 2012, 7, 62-68. 
(146) Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M. V.; 
 Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M.: 
 Understanding biophysicochemical interactions at the nano-bio 
 interface. Nat. Mater. 2009, 8, 543-557. 
(147) Nam, H. Y.; Kwon, S. M.; Chung, H.; Lee, S.-Y.; Kwon, S.-H.; 
 Jeon, H.; Kim, Y.; Park, J. H.; Kim, J.; Her, S.; Oh, Y.-K.; Kwon, 
 I. C.; Kim, K.; Jeong, S. Y.: Cellular uptake mechanism and 
 intracellular fate of hydrophobically modified glycol chitosan 
 nanoparticles. J. Control. Release 2009, 135, 259-267. 
(148) Kim, H.; Lee, S. W.; Baek, K. M.; Park, J. S.; Min, J. H.: 
 Continuous hypoxia attenuates paraquat-induced cytotoxicity in 
 the human A549 lung carcinoma cell line. Exp. Mol. Med. 2011, 
 43, 494-500. 
(149) Jyothi, G.; Surolia, A.; Easwaran, K. R. K.: A23187 -- channel 
 behavior: fluorescence study. J. Biosci. 1994, 19, 277-82. 
P. Tanner 
 
148 
(150) Cukierman, S.; Quigley, E. P.; Crumrine, D. S.: Proton conduction 
 in gramicidin A and in its dioxolane-linked dimer in different lipid 
 bilayers. Biophys. J. 1997, 73, 2489-2502. 
(151) Killian, J. A.; Prasad, K. U.; Hains, D.; Urry, D. W.: The 
 membrane as an environment of minimal interconversion. A 
 circular dichroism study on the solvent dependence of the 
 conformational behavior of gramicidin in 
 diacylphosphatidylcholine model membranes. Biochemistry 1988, 
 27, 4848-4855. 
(152) He, H.; Uray, G.; Wolfbeis, O. S.: A thiamine-selective optical 
 sensor based on molecular recognition. Anal. Lett. 1992, 25, 405-
 14. 
(153) Perinoto, A. C.; Maki, R. M.; Colhone, M. C.; Santos, F. R.; 
 Migliaccio, V.; Daghastanli, K. R.; Stabeli, R. G.; Ciancaglini, P.; 
 Paulovich, F. V.; de, O. M. C. F.: Biosensors for Efficient 
 Diagnosis of Leishmaniasis: Innovations in Bioanalytics for a 
 Neglected Disease. Anal. Chem. 2010, 82, 9763-9768. 
(154) Murphy, B.; Hathaway, B.: The stereochemistry of the copper(II) 
 ion in the solid-state—some recent perspectives linking the Jahn–
 Teller effect, vibronic coupling, structure correlation analysis, 
 structural pathways and comparative X-ray crystallography. 
 Coordin. Chem. Rev. 2003, 243, 237-262. 
(155) Stauch, O.; Schubert, R.; Savin, G.; Burchard, W.: Structure of 
 artificial cytoskeleton containing liposomes in aqueous solution 
 studied by static and dynamic light scattering. Biomacromolecules 
 2002, 3, 565-78. 
(156) Gruenwald, D.; Cardoso, M. C.; Leonhardt, H.; Buschmann, V.: 
 Diffusion and binding properties investigated by Fluorescence 
 Correlation Spectroscopy (FCS). Curr. Pharm. Biotechnol. 2005, 6, 
 381-386. 
(157) Dorn, I. T.; Neumaier, K. R.; Tampe, R.: Molecular Recognition of 
 Histidine-Tagged Molecules by Metal-Chelating Lipids Monitored 
 by Fluorescence Energy Transfer and Correlation Spectroscopy. 
 JACS 1998, 120, 2753-2763. 
(158) Peisach, J.; Blumberg, W. E.: Structural implications derived from 
 the analysis of electron paramagnetic resonance spectra of natural 
 and artificial copper proteins. Arch. Biochem. Biophys. 1974, 165, 
 691-708. 
Engineering artificial organelles  
 
149 
(159) Baute, D.; Arieli, D.; Neese, F.; Zimmermann, H.; Weckhuysen, B. 
 M.; Goldfarb, D.: Carboxylate Binding in Copper Histidine 
 Complexes in Solution and in Zeolite Y: X- and W-band Pulsed 
 EPR/ENDOR Combined with DFT Calculations. J. Am. Chem. 
 Soc. 2004, 126, 11733-11745. 
(160) Drew, S. C.; Noble, C. J.; Masters, C. L.; Hanson, G. R.; Barnham, 
 K. J.: Pleomorphic Copper Coordination by Alzheimer’s Disease 
 Amyloid-β Peptide. JACS 2009, 131, 1195-1207. 
(161) Grommen, R.; Manikandan, P.; Gao, Y.; Shane, T.; Shane, J. J.; 
 Schoonheydt, R. A.; Weckhuysen, B. M.; Goldfarb, D.: Geometry 
 and Framework Interactions of Zeolite-Encapsulated 
 Copper(II)−Histidine Complexes. J. Am. Chem. Soc. 2000, 122, 
 11488-11496. 
(162) Manikandan, P.; Epel, B.; Goldfarb, D.: Structure of 
 Copper(II)−Histidine Based Complexes in Frozen Aqueous 
 Solutions As Determined from High-Field Pulsed Electron Nuclear 
 Double Resonance. Inorg. Chem. 2001, 40, 781-787. 
(163) Valko, M.; Morris, H.; Mazúr, M.; Telser, J.; McInnes, E. J. L.; 
 Mabbs, F. E.: High-Affinity Binding Site for Copper(II) in Human 
 and Dog Serum Albumins (an EPR Study). J. Phys. Chem. B 1999, 
 103, 5591-5597. 
(164) Schosseler, P. M.; Wehrli, B.; Schweiger, A.: Complexation of 
 Copper(II) with Carbonate Ligands in Aqueous Solution:  A CW 
 and Pulse EPR Study. Inorganic Chemistry 1997, 36, 4490-4499. 
(165) Atherton, N. M.; Horsewill, A. J.: Proton ENDOR of Cu(H2O)6 
 2+ in Mg(NH4)2(SO2)4.6H2O. Mol. Phys. 1979, 37, 1349- 1361. 
(166) Hunt, M. J.; Mackay, A. L.; Edmonds, D. T.: Nuclear quadrupole 
 resonance of 14N in imidazole and related compounds. Chem. 
 Phys. Lett. 1975, 34, 473-475. 
(167) Van Doorslaer, S.; Cereghetti, G. M.; Glockshuber, R.; Schweiger, 
 A.: Unraveling the Cu2+ Binding Sites in the C-Terminal Domain 
 of the Murine Prion Protein:  A Pulse EPR and ENDOR Study†. J 
 Phys. Chem. B 2001, 105, 1631-1639. 
(168) van Gastel, M.; Coremans, J. W. A.; Jeuken, L. J. C.; Canters, G. 
 W.; Groenen, E. J. J.: Electron Spin−Echo Envelope Modulation 
 Spectrum of Azurin at X-Band. J. Phys. Chem. A 1998, 102, 4462-
 4470. 
P. Tanner 
 
150 
(169) Burns, C. J.; Field, L. D.; Hambley, T. W.; Lin, T.; Ridley, D. D.; 
 Turner, P.; Wilkinson, M., P.: X-Ray crystal structural 
 determination of copper(II)-nitrilotriacetic 
 acid-bis(N-methylimidazol-2-yl)ketone ternary complex. 
 ARKIVOC 2001, vii, 157-165. 
(170) Neese, F.: Prediction of molecular properties and molecular 
 spectroscopy with density functional theory : From fundamental 
 theory to exchange-coupling. Anglais 2009, 253, 38. 
(171) Nguyen, T.; Swift, J.; Cramb, D.: Fluorescence Correlation 
 Spectroscopy: The Measurement of Molecular Binding. In 
 Reviews in Fluorescence 2010; Geddes, C. D., Ed.; Springer New 
 York, 2012; Vol. 2010; pp 45-66. 
(172) Stoll, S.; Schweiger, A., EasySpin, a comprehensive software 
 package for spectral simulation and analysis in EPR. J. Mag. Res. 
 2006, 178 (1), 42-55. 
(173) Madi, Z. L.; Van, D. S.; Schweiger, A., Numerical Simulation of 
 One- and Two-Dimensional ESEEM Experiments. J. Magn. 
 Reson. 2002, 154, 181-191. 
(174)  Neese, F., Prediction of electron paramagnetic resonance g values 
 using coupled perturbed Hartree-Fock and Kohn-Sham theory. J. 
 Chem. Phys. 2001, 115, 11080-11096. 
(175)  Neese, F., Theoretical Study of Ligand Superhyperfine Structure. 
 Application to Cu(II) Complexes. J. Phys. Chem. A 2001, 105, 
 4290-4299. 
(176) Neese, F., Metal and ligand hyperfine couplings in transition metal 
 complexes: the effect of spin-orbit coupling as studied by coupled 
 perturbed Kohn-Sham theory. J. Chem. Phys. 2003, 118, 3939-
 3948. 
(177) Neese, F., Efficient and accurate approximations to the molecular 
 spin-orbit coupling operator and their use in molecular g-tensor 
 calculations. J. Chem. Phys. 2005, 122, 34107. 
  
  
  
 
 
  
Engineering artificial organelles  
 
151 
9.  Acknowledgements 
I cordially thank Prof. Dr. Cornelia Palivan for giving me all the 
important support and the necessary possibilities to intensively work this 
thesis out. I also thank Prof. Wolfgang Meier giving me the possibility to 
work on the projects in his group. 
I thank Dr. Vimalkumar Balasubramanian for all his efforts during our 
collaboration in the group and beyond that. Especially, I appreciate this 
power in performing all the important cell experiments and giving me 
advice. I also owe Prof. Sabine Van Doorslaer and Dr. Maria Ezhevskaya 
a debt of gratitude for successful collaboration on EPR experiments. In 
addition, I thank Dr. Ozana Fischer, Patric Baumann, Dr. Karolina 
Langowska, and Adrian Nayer for fruitful discussion and suggestions 
during all the time of my research at the University of Basel. 
Many thank go to Gaby Persy and Vesna Olivieri for TEM 
measurements and to Dr. Mariusz Grzelakowski and Dalin Wu for 
providing polymers. I want to thank Dr. Dirk de Bruyn for helping me to 
synthetise the peptides. 
Furthermore, I want to thank all the group members for a very friendly 
atmosphere in and outside the Lab. This work is based on the financial 
support provided by the Swiss National Science Foundation, and the 
National Centre of Competence in Nanoscale Science. This is gratefully 
acknowledged. The financial support for a Short Term Scientific Mission 
at the University of Antwerp is also honoured. 
  
P. Tanner 
 
152 
  
Engineering artificial organelles  
 
153 
10.  Abbreviations 
 %  Percent 
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 G  Autocorrelation amplitude 
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 GSSG  Gluthatione disulphide 
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 He-Ne  Helium-Neon 
 HPLC  High-performance liquid chromatography 
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 HYSCORE  Hyperfine sub-level correlation 
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 K  Binding constant 
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 kDa  kilo Dalton 
 kHz  kilo Hertz 
 KM  Michaelis Menten constant 
 LPO  Lactoperoxidase 
 M  Weight-average molar mass 
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 mW  milli Watt 
 Ni  Nickel 
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 NTA  Nitrilotriacetic acid 
 OmpF  Outer membrane protein F 
 OPOE  N-Octyl-oligo-oxyethylene 
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 P  Packing parameter 
 PBS  Phosphate buffered saline 
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 PEG  Polyethylene glycol 
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 methyloxazoline) 
 PRX  Peroxiredoxin 
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 Rg  Radius of gyration 
Engineering artificial organelles  
 
155 
 RH  Hydrodynamic radius 
 RNA  Ribonucleic acid 
 RNS  Reactive nitrogen species 
 ROS  Reactive oxygen species 
 s  Second 
 SA  Succinic anhydride 
 SEM  Scanning electron microscopy 
 SLS  Static light scattering 
 SOD  Superoxide dismutase 
 STED  Stimulated emission depletion 
 STORM  Stochastic optical reconstruction microscopy 
 T  Temperature 
 TEM  Transmission electron microscopy 
 TFE  Trifluoroethanol 
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 TRX  Thioredoxin 
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 XA  Xanthine 
 XO  Xanthine oxidase 
 Zn  Zinc 
 λ  Wavelength 
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 λex  Excitation wavelength 
 µg  micro gram  
 µs  micro second 
 τd  Diffusion time 
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